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Abstract 
Drosophila is a valuable experimental organism can be used as a reverse genetics 
model. Drosophila Malpighian (renal) tubules are important epithelial tissue in 
which to study transport mechanisms. RNA-seq has been chosen to  investigate 
Drosophila Malpighian (renal) tubules to identify novel genes following a three-
way comparison between three popular transcriptome profiling methods. Two 
types of novel gene have been found in Drosophila tubules, coding genes and 
noncoding genes. Reverse genetics has been applied to identify novel coding 
gene function in Drosophila tubules. 
Three-way analysis of Drosophila expression microarrays, Drosophila tiling 
micrarrays and Drosophila RNA-seq reveal that most gene expression levels are 
well correlated between the three technologies. Drosophila expression 
microarrays and RNA-seq are correlated better than the correlation between 
Drosophila tiling microarrays and RNA-seq. Drosophila expression arrays and  
Drosophila tiling arrays all suffered from cross-hybridization, miss target 
detection and hybridization background noise, and also have low dynamic range 
for detecting lowly and highly expressed genes. Drosophila tiling microarrays 
also have a high false-positive detection rate, which may lead to overestimate 
the transcriptional activities of the genome. RNA-seq has overcome the 
drawbacks of microarrays and become the leading technology for genome 
sequencing, transcriptome profiling, novel gene discovery, and novel alternative 
splicing discovery with wide dynamic range. However, Drosophila expression 
microarrays and tiling microarrays still remain useful. Three-prime expression 
microarrays offer a means to measure the differential three-prime end 
processing, and tiling microarrays can be used for novel gene discovery. In this 
sense, the three technologies complement each other.  
Poly(A) selected RNA-seq has been used as a discovery tool for searching novel 
genes in Drosophila Malpighian tubules in this thesis. A TopHat and Cufflinks 
pipeline has been used as an analytical pipeline for novel gene discovery and 
differential gene expression analysis between Drosophila tubules and whole flies 
in order to find the tubule-enriched genes. 
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Reverse genetics has been applied to Drosophila to achieve a gene knockdown 
and overexpression by using the unique Gal4/UAS system to achieve the novel 
gene knockdown or overexpression in specific tissue and cell types. Novel coding 
gene CG43968 has been discovered. The location of this gene has been 
confirmed in tubule main segments, principle cell cytoplasm or apical 
membrane. The function of this gene has been identified as involvement in 
tubule secretion, which may relate to calcium transport. Reverse genetics has 
been confirmed as particularly important for the functional study of novel genes. 
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1. Introduction 
Summary 
Since the genome sequence for the model organisms had completed more than 
ten years ago, great efforts have been made to annotate the genes’ structures, 
predict and search for novel genes. The methods for predicting novel genes 
include experimental and computational approaches. The experimental 
approach includes ‘open technologies’ and ‘close technologies’. The ‘open 
technologies’ refer to analysis of the transcriptome without a priori knowledge 
of the transcript sequences; technologies such as expression sequencing tags 
(ESTs), the serial analysis gene expression (SAGE) and next generation 
sequencing (NGS) are suitable for novel genes discovery.  Next generation 
sequence has shown a great power for discovery of novel splicing and novel 
genes discovery in the whole genome level. The ‘close technologies’, such as 
microarrays, rely on previous sequence knowledge, and are suitable for 
comparing gene expression in different conditions. The computational gene 
prediction approaches include ‘Extrinsic approaches’, ‘Ab initio approaches’, 
‘Combined approaches’ and ‘Comparative genomic approaches’. In many areas, 
experimental and computational approaches still provide complementary 
information. Drosophila is a powerful model organism for functionally 
characterising novel genes. Such novel coding and non-coding RNAs may play 
important roles in Drosophila development and functions. This study presents 
the tissue specific novel genes by using NGS technology and studies novel gene 
function by using Drosophila as a model organism. 
1.1 Experimental prediction approaches 
1.1.1 Expressed sequence tags (ESTs) 
ESTs are historically important, from days when Sanger sequencing was 
relatively expensive. Rather than fully sequence every clone in a cDNA library, 
effort was concentrated on sequencing just 5’ and 3’ ends cDNA using universal 
primers. ESTs are a single-pass sequence which is created by sequencing the 5’ 
and/or 3’ ends of randomly isolated gene transcripts that have been converted 
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into cDNA, ESTs represent partial sequences of cDNA clones, and are typically 
within the range from 100-700 nucleotides. 
1.1.1.1 ESTs and gene discovery 
ESTs have applications in the discovery of new genes, identification of coding 
regions in genomic sequences (Adams et al., 1991; Adams et al., 1993a; Adams 
et al., 1993b) and identification of predicted genes. The first ESTs project was 
begun in 1991, and found 337 ESTs representing new genes out of 600 randomly-
selected human brain cDNA clones (Adams et al., 1991). Since then, the 
identification of sequence using ESTs has developed rapidly, partly because EST 
collection is relatively quick and inexpensive by comparison with fully 
sequencing a given clone. The construction methods for EST libraries were 
improved gradually to facilitate the novel gene discovery, with random primed 
libraries or directional clones being most efficient method for discovering novel 
genes by ESTs (Adams et al., 1993b). Two large public sequence projects, the 
EST project and the Cancer and Genome Anatomy project (CGAP 
http://www.ncbi.nlm.nil.gov/ncigap) (Riggins and Strausberg, 2001), have been 
initiated to rapidly identify or partially identify all expressed genes (Martin and 
Pardee, 2000). To date, it has accumulated sequences for a total of 
approximately 74 million different ESTs; these are available in public databases 
(Genebank dbEST database 01 January 2013) for all species. The rates for novel 
gene discovery by the EST project were initially high, but declined sharply in 
recent years.  Wang and his colleagues gave examples in whereby 10.4% of 
human ESTs collected in 1996 were novel sequences (36,000 novel sequences) 
whilst only 2.7% of ESTs collected in 1998 ( 638 novel sequences) were novel 
sequences (Chen et al., 2002b). This result indicates that the identification of 
novel genes by ESTs in human genome has nearly reached saturation. More 
methods are needed to identify the rest of the novel genes in the human genome 
and the genome of other species. 
1.1.1.2 ESTs and phylogenetic analysis 
ESTs are also a tool for phylogenetic analysis.  The 5’ ESTs, representing the 
coding sequence of the genes, are more conserved between species, the 3’ ESTs, 
representing the 3’ untranslated region, are more specific for the species. The 
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3’ ESTs can help to separate closely related transcripts. Phylogenetic analysis 
reveals the relations and evolution of the species (Kullberg et al., 2007; 
Nishiyama et al., 2003). The EST approach allows, at a reasonable cost, a fast 
extension of data sampling from species outside the genome projects (Kullberg 
et al., 2007). 
1.1.1.3 ESTs and genome map 
EST information helps to construct the genetic map and physical map, and serves 
as a foundation for initiating the genome sequencing project. Sequence-tagged 
sites (STSs) are becoming standard markers for the physical mapping of the 
human genome. These short sequences from physically-mapped clones represent 
uniquely identified chrosomal locations (Adams et al., 1991). Yeast artificial 
chromosomes (YACs), bacterial artificial chromosomes (BACs) and other genomic 
resources facilitated by the use of STSs and PCR have been employed in building  
the physical map and gene map for different species (Hong-Bin Zhang, 2001). In 
1998, the entire genome sequence of Caenorhabditis  elegans was reported (The 
C. elegans Sequence Consortium, 1998). In 2000, the sequences of the 
euchromatic portion of the Drosophila  melanogaster genome (Adams et al., 
2000), the draft of rice genome sequence have been completed (Pennisi, 2000) 
and the entire genome of Arabidopsis had been completed by late 2000 (The 
Arabidopsis Genome Initiative, 2000). Other model species have been sequenced 
subsequently. The entire human genome project was finished in 2003 (Lander 
and Doyle, 2001) 
All these physical maps of the model organisms provide the basis for the 
development of expression arrays, also known as DNA chips. Microarray 
technology emerged after the majority of the genomes of the model organisms 
being sequenced around 1998, and provided the opportunity to investigate gene 
expression pattern in specific stages, specific states and specific cell types to 
find out its biological role. 
EST databases 
In 1992, a database called dbEST (Boguski et al., 1993) was established to serve 
as a collection point for ESTs which were then distributed to the scientific 
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community via the EST division of GenBank. The GenBank, which is maintained 
by the National Centre for Biotechnology Information (NCBI) also contains the 
CGAP information. The EST division continues to dominate the GenBank, 
accounting for roughly two-thirds of submissions. GenBank and dbEST sequences 
are organised into a non-redundant unique gene lists by the UniGene project, 
(http://www.ncbi.nlm.nih/gov/UniGene), which is considered the most 
regularly updated source for high quality, non-redundant information on 
expressed genes. Collections of full-length non-redundant cDNA clones are 
critical reagents for functional genomics. Drosophila Gene Collection release 1 
(DGCr1) comprises full-length clones from approximately 40% of the 13,474 
genes predicted in D. melanogaster. The second release of the DGC (DGCr2) 
extends the collection to more than 70% of the predicted genes in Drosophila 
(Rubin et al., 2000a; Stapleton et al., 2002). One of the most interesting 
applications of the EST database (dbEST) is gene discovery. Novel genes can be 
found by query the dbEST with a protein or DNA sequence (Boguski et al., 1994; 
Verdun et al., 1998). 
1.1.1.4 The disadvantages of ESTs 
Expressed sequence tag collection also has limitations when being used for 
genomic analysis from the accurate representation of genome content, gene 
sequence, and as windows into the transcriptome activity (Alba et al., 2004). 
The fact ESTs reflect the actively transcribed genes and represent transcriptome 
of the certain time and conditions of the tissue. So it is difficult to use EST 
sequence alone to represent an organism’s gene content. Additionally, the 
fraction of the sequence data is erroneous due to enzyme used to generate the 
library, the technology for sequence and the analysis algorithms of the sequence 
data (Bebenek et al., 1989; Metzker, 2005). EST libraries have been shown to be 
biased towards highly expressed transcripts ; low abundance transcripts are 
rarely sequenced (Reese et al., 2000). So normalization and subtraction methods 
had applied in the cDNA library construction facilitate gene discovery in order to 
identify the lower expressed and specific type genes (Bonaldo et al., 1996; Gu et 
al., 2011; Verdun et al., 1998). Despite these limitations, it has been shown that 
EST database can be valid and reliable sources of gene expression and gene 
discovery data. 
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1.1.2  Serial analysis of gene expression (SAGE) 
SAGE is a technique that allows a rapid, detailed analysis of thousands of 
transcripts (Velculescu et al., 1995). It is designed to provide qualitative and 
quantitative information on gene expression at the genome level. 
In SAGE, short tags of length 9-10 bp obtained from the precise location of the 3’ 
end of the transcripts are concatenated to form long DNA fragments, which can 
be cloned and sequenced. It allows many genes to be detected in a single lane 
sequence, and increases the efficiency of the sequence-based transcriptome 
analysis. Details of the principles underlying SAGE are shown in Figure 1.1. 
 
Figure 1-1 Schematic of SAGE.  
A short sequence tag (10-14bp) contains sufficient information to uniquely identify a transcript 
provided that the tag is obtained from a unique position within each transcript; Sequence tags can 
be linked together to form long serial molecules that can be cloned and sequenced; and 
quantitation of the number of times a particular tag is observed provides the expression level of the 
corresponding transcript. Figure adapted from (Velculescu et al., 1995). 
1.1.2.1 SAGE and novel gene discovery 
The use of ESTs for novel gene discovery had reached saturation in human 
genome; SAGE as an ‘open architecture’ system that provided another approach 
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to identify novel genes. One study by Chen et al, for example, used SAGE to 
identify novel genes and transcripts in the human genome. This study found 
about 70% of the unmapped SAGE tags are derived from the novel transcripts but 
were difficult to identify by previously available methods (Chen et al., 2002b). 
Some of these genes were completely novel genes with no matches in any of the 
expressed gene databases; some of them were from alternative splicing 
transcripts of known genes. 
Another study applied the SAGE technique to identify the novel transcripts and 
used the SAGE tags as specific polymerase chain primers to amplify the unknown 
cDNA (van den Berg et al., 1999). 
SAGE tags can be converted into cDNA for identifying novel genes to increase its 
accuracy. GLGI (Generation of long cDNA fragments from SAGE tag for gene 
identification) can be used for large scale identification of novel genes by 
converting novel SAGE tags into 3’ cDNAs (Chen et al., 2002a). In this way, GLGI 
can be used as high-throughput procedure to identify the novel SAGE tags. 
1.1.2.2 SAGE and cancer research 
SAGE can use to compare the gene expression patterns in various developmental 
and disease states, and so has been a valuable approach for the identification of 
diagnostic and prognostic markers as well as therapeutic markers and 
transcriptional pathways (Argani et al., 2001; Polyak and Riggins, 2001). Hough 
et al constructed 10 different SAGE libraries to identify the makers that were 
up-regulated in ovarian cancer such as MUCI, HE4, Claudin3, Claudin4, SLPI and 
many more (Hough et al., 2000). An example of pathway analysis by SAGE led to 
the identification of 216 c-MYC-induced genes and 260 c-MYC-repressed genes 
that are potential drug targets or cellular markers of transformation (Menssen 
and Hermeking, 2002). 
SAGE can detect gene expression in any cell type or tissue, and can determine 
the absolute gene expression level. Therefore, SAGE has been selected as the 
major platform technology for the Cancer Genome Anatomy project. Over 5 
million SAGE tags derived from over one hundred human cell types have been 
assembled and released to the public domain through this project. 
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1.1.2.3 SAGE and ESTs 
In comparison to the use of ESTs, SAGE offers a number of advantages. Firstly, 
SAGE can be performed without a priori knowledge of gene sequences, so it is 
useful for the identification of novel genes or the analysis of poorly 
characterized transcriptome (Hu and Polyak, 2006; Yamamoto et al., 2001). 
Secondly, it can quantify gene expression, describe absolute mRNA level and 
enable comparison of gene expression at different conditions, whereas ESTs can 
only deliver a single-pass sequence. Thirdly, it allows relatively high-throughput 
to produce information on genes in a short time; ESTs can only generate a 
partial gene sequence at each time. Fourthly, SAGE exhibits no bias in the 
analysis of gene expression especially for low abundance genes, whilst it is 
difficult to detect low expression genes using ESTs because of the expression 
bias towards to the high expression genes. Lastly and importantly, the transcript 
variations from alternative initiation and termination, alternative splicing, trans-
splicing and antisense transcription can be revealed by using SAGE. 
There are, however, also disadvantages to using SAGE. Firstly, SAGE requires a 
high amount of input RNA to start with. SAGE cannot be used for the generation 
of expression profiles when RNA is limited (Datson et al., 1999). Secondly, a 9-
10bp tag can unambiguously identify the cDNAs, whereas it is not sufficient to 
map a gene to a genome precisely (Yamamoto et al., 2001). Thirdly, SAGE is 
expensive and still time consuming compared to the high-throughput sequencing 
nowadays due to the need to perform several thousands of PCR and sequence 
reactions. Lastly, since SAGE tags are cut by a specific enzyme most commonly 
for example NlaIII, any gene which doesn’t contain the restriction enzyme 
cutting site will be missed (Yamamoto et al., 2001). 
1.1.3 LongSAGE 
As shown in Figure 1-2, LongSAGE is a modified version of SAGE that generates 
21bp tags derived from 3’ ends of transcripts by using the type IIS restriction 
endonuclease (Mmel), which  can rapidly be analysed and matched to genomic 
sequence data (Saha et al., 2002). 
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1.1.3.1 LongSAGE and novel gene discovery 
 
Figure 1-2 Schematic of LongSAGE methods.  
LongSAGE is a modified version of SAGE that generates 21bp tags derived from 3’ ends of 
transcripts by using the type IIS restriction endonuclease (Mmel), which can rapidly be analysed 
and matched to genomic. Figure adapted from (Saha et al., 2002). 
The Saha group used LongSAGE to find 575 out of approximately 28,000 
transcript tags that matched regions within introns of known genes representing 
either unknown exons of annotated genes or novel genes embedded in the intron 
of the known genes. They also found  803 out of approximately 28,000 transcript 
tags that matched regions at least 5KB from the terminal exons of known or 
predicted genes, representing completely novel genes. This study demonstrates 
how LongSAGE tags can identify previously unrecognized internal exons and 
uncharacterized genes (Saha et al., 2002). 
LongSAGE tags are much more efficient for the identification of novel genes in 
the complex genome in comparison with conventional SAGE tags (9-10bp). The 
first LongSAGE analysis in mouse (Mus Musculus) found 2098 LongSAGE tags that 
fell into a region containing putative genes predicted by GenScan, providing the 
experimental evidence for the presence of real genes (Wahl et al., 2005b). The 
same study of mouse genome by LongSAGE also revealed a large number of novel 
antisense genes in the mouse genome (Wahl et al., 2005a). 
1.1.3.2 LongSAGE and SAGE 
LongSAGE and SAGE use the same principle to generate the sequence tags, but 
LongSAGE uses a different type IIS restriction endonuclease such as MmeI and 
incorporates other modifications to generate 21bp tags whereas SAGE uses type 
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IIS restriction endonuclease such as Fok I to produce 9-10 bp tags. Due to this 
increased tag length, LongSAGE can uniquely map the genome and transcriptome 
whilst SAGE will sometimes map the genome at multiple places. Consequently, 
LongSAGE is a more precise method for novel gene discovery. 
1.1.4 SuperSAGE 
SuperSAGE is a variant of SAGE technology, which supports transcripts profiling 
using 26bp tags extracted from cDNA employing the typeIII restriction enzyme 
EcoP151as a tagging enzyme. This tag length is the longest in use across all the 
versions of SAGE, and is advantageous for tag-gene annotation, thereby allowing 
the SuperSAGE technique to be applicable to any eukaryotic organism 
(Matsumura et al., 2008). 
1.1.4.1 Advantages   
SuperSAGE retains the benefit of using longer sequence tags whilst addressing a 
technical problem inherent in LongSAGE. LongSAGE improves on SAGE by 
generating longer tags to map the genome more precisely. However the 
digestion of a DNA fragment with MmeI generates a two-nucleotide recessed 5’ 
terminus, which is difficult to fill in. To solve this technical problem, SuperSAGE 
uses EcoP151 digestion to generate a two nucleotide recessed the 3’ terminus, 
which is easier to fill in. 
1.1.4.2 Applications 
The 26bp tag sequences can be used directly to design PCR primers for 
amplifying cDNA of corresponding genes; it can thus direct novel gene discovery. 
The sequencing of the Nicotiana benthamiana genome was assisted by this 
method (Matsumura et al., 2003). 
SuperSAGE can be applied to interaction transcriptomes, analysing gene 
expression during host-pathogen interactions. This is possible since the method 
allows the simultaneous gene expression analysis of two or more eukaryotic 
organisms. This approach has, for example, been applied to study the gene 
expression profiles of both rice plants infected with blast disease and the 
causative fungus Magnaporthe grisea (Matsumura et al., 2003). 
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The SuperSAGE technology has been directly used to make a 26bp 
oligonucleotide array called “SuperSAGE array”. It combines the advantages of 
high quantitative SuperSAGE expression analysis with high-throughput microarray 
technology, allowing precise gene annotation and the monitoring of large-scale 
gene expression in many samples at a time (Matsumura et al., 2006). 
SuperSAGE has also been combined with next generation sequencing to achieve 
high-throughput, high sensitivity, high reproducibility and accuracy in the 
analysis of gene expression and interpretation of the genome (Matsumura et al., 
2010). 
1.1.5 Functional Genomics 
Functional genomics is a field of molecular biology that enables exploration of 
genes, protein functions and interactions on a global scale. The goal of 
functional genomics is to elucidate function in the context of an organism’s 
genome (Dow and Davies, 2003). A key characteristic of functional genomics 
studies is using a genome-wide approach, generally involving high-throughput 
methods to study the functions of genes. Now that obtaining genome sequence 
has become routine, assigning function to genes is the current frontier in 
research (Hawkins et al., 2010). The functions of many genes and proteins are 
still unknown, or only partially described. Around 40% only of functions of 
Drosophila genes have been determined (Dow and Davies, 2003; Roy et al., 
2010). 
Microarray technologies have consistently been prominent in functional genomic 
studies as detailed in section1.2.6. This technology allows the researcher to take 
a snapshot of the gene expression under certain conditions and identify any 
change in gene expression between conditions that indicates when a gene is 
functionally active. The function of genes of interest or their encoded proteins 
can then be selected and studied using different molecular or physiological 
techniques. Microarray assays allow massive parallel data acquisition and 
analysis at a global level (Schena et al., 1998). 
Next-generation sequencing is the cutting-edge technology applied in functional 
genomics as described in section 1.2.7. This technology, which overcomes the 
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disadvantage of microarray, is now predominant in the field of gene expression 
studies (Shendure, 2008). Advance in DNA-sequencing technology delivers 
unprecedented insights into the entire collection of a genome’s transcribed 
sequences. In this sense, the technology heralds a new era in the study of gene 
regulation and genome function (Graveley, 2008). It can quantify gene 
expression, address how alternative splicing affects the protein function, and 
determine the function of the non-coding genes, especially novel genes 
(Graveley et al., 2011). RNA sequencing (RNA-seq), small RNA sequencing (Small 
RNA-seq) and chromatin immunoprecipitation followed by sequencing (ChIP-seq) 
are the main methods applied in next-generation sequencing to address the 
function of coding genes, noncoding genes and also gene regulation in functional 
genomics (Bellingham et al., 2012; Chen et al., 2013; Mortazavi et al., 2008). 
Functional genomics studies can also be undertaken using proteomics 
technologies. The classic proteomics method uses two-dimensional gel 
electrophoresis (2DE) to separate proteins. The identities of proteins in 
individual spots from the gel are then identified by mass spectrometry of their 
tryptic peptides. There are several different so-called workflows that can be 
used to characterize a proteome. They all use either 2DE or (High-performance 
liquid chromatography) HPLC as the separation methods and Electrospray (ES) or 
matrix-assisted laser desorption/ionization (MALDI) mass spectrometry as the 
identification methods. This technology can be used to investigate protein 
expression, protein-protein interaction, post-transcriptional modification, and to 
determine the protein function. 
Functional genomics can also be applied to closing the phenotype gap. Finding 
all the genes that contribute to the phenotypes will help identify gene functions. 
Functional genomics draws heavily on reverse genetics (as detailed in section 
1.4.3) to elucidate the function of novel genes. The phenotype gap (the 
mismatch between what a genetic model organism’s genome encodes and the 
reasons that it has historically been studied) emphasizes the need to attract and 
empower functional biologists (Brown and Peters, 1996; Dow, 2007). 
The field of systems biology is especially interested in the interpretation 
of large post-genomic datasets in a mechanistic context, from 
transcriptomics, proteomics and metabolomics to the dynamic modelling 
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of systems behaviour and system-level datasets using a diverse collection 
of computational tools. To understand biology at the system level, we 
must examine the structure and dynamics of cellular and organismal 
function, rather than the characteristics of isolated parts of a cell or 
organism. A system-level understanding of a biological system can be 
achieved by understanding four key points, system structures, system 
dynamics, the control method and the design method (Kitano, 2002). This 
represents another level to achieving the goal of functional genomics. 
In the future, integrative genomics and integrative biology will focus on 
integrating all the high-throughput data from multiple biological 
techniques to achieve an integrated multi-dimensional view of genomic 
function; integrative analysis offers the promise of a unified, global view 
(Hawkins et al., 2010). 
1.1.6 Microarrays 
Once the whole genome sequences of the major organisms had been completed, 
searching the function and the structure of the genes is a long term task. This is 
“functional genomics”. Obtaining an overview of the global gene expression 
patterns in normal and disease conditions will enable researchers to develop 
understanding of gene spatio-temporal interactions and regulations. Microarray 
technology led the transition from studies of the individual biological functions 
of a few related genes, proteins or pathways towards more global investigations 
of cellular activity. Microarray technology began in 1989, and was announced to 
the wider scientific community in a publication by Schena et al that made 
researcher aware of the potential of array technology (Schena et al., 1995). 
Schena and colleagues described the high capacity of cDNA microarray 
technology to monitor the gene expression of 45 Arabidopsis genes in parallel. 
This represented a major advance over Northern blotting, which reported 
expression level of only one gene at a time. Since then, the use of microarray 
technologies has been reported for multiple organisms, including yeast (Lashkari 
et al., 1997), Drosophila (White et al., 1999) and human. 
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1.1.6.1 Types of microarray 
Microarray technology varies in terms of manufacturing method and detection 
method. There are two types of arrays in terms of manufacturing method, 
namely spotted arrays and oligonucleotide arrays. In spotted microarrays, the 
probes are oligonucleotides (oligos), cDNA or small fragments of PCR products 
that correspond to the genes that are “spotted” on the glass slide. 
Oligonucleotide microarrays, typically refers to the specific technique of 
manufacturing used by companies such as Agilent where the oligos are longer 
sequences  such as 60-mer probes and Affymetrix where the oligos are shorter 
sequences 25-mer probes; in both cases, the oligos are synthetic in origin, rather 
than derived from DNA clones. 
There are two detection methods: one-colour microarrays or two colour 
microarrays. In one-colour microarray, one sample is processed, labelled for 
example with fluorescent dye, and applied to a microarray, such as those 
available for Affymetrix. In two-colour microarrays, two samples that are to be 
compared are labelled with different fluorophores and put on one microarray. 
The relative intensities of each fluorophore are used in ratio-based analysis to 
identify up-regulated and/or down-regulated genes. The fact that samples share 
the same background will significantly reduce any background effect and 
increase the sensitivity of detection (Tang et al., 2007). 
Affymetrix microarrays 
Affymetrix (www.affymetrix.com) is a company based in United States that 
manufactures DNA microarrays (also called GeneChips). The company 
manufactures different types of array; expression arrays, exon arrays, tiling 
arrays and miRNA arrays of different organisms. The company now designs chip 
technology aimed towards clinical diagnosis. 
Three-prime expression microarrays 
The expression arrays are the first generation of the Affymetrix microarrays. The 
probes are designed to be complementary to the target sequences at the 3’UTR 
of the annotated, predicted genes and ESTs which called a consensus sequence 
in Affymetrix parlance (Cui and Loraine, 2009). Each gene is represented by 
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multiple probe pairs (also known as probe sets) which are used to measure the 
level of transcription of each ORF sequence represented on the Genechip. Each 
probe set has 25mer probe pairs selected from the target sequence to be perfect 
match and mismatch oligos. Each probe-pair consists of a perfect-match (PM) 
and mismatch (MM) probe. The PM probe is a 25-base sequence complementary 
to the target gene, whilst the MM probe is identical to the PM probe but a single 
mismatch at 13th base. The sequences on the expression arrays are believed to 
recognize unique regions of the three-prime of the gene. Figure 1.3 detailed the 
Genechip design method. 
 
Figure 1-3 A schematic of a Affymetrix probe set.  
Each gene is represented by multiple probe pairs. Each probe-pair consists of a perfect-match 
(PM) and mismatch (MM) probe. The PM probe is a 25-base sequence complementary to the 
target gene, whilst the MM probe is identical to the PM probe but a single mismatch at 13th base 
Picture taken from www.vsni.co.uk/software/genstat/htmlhelp/marray/AffymetrixChips.htm  
The Drosophila Genome 2.0 Array was designed with sequence and annotation 
from FlyBase Drosophila Genome draft version 3.1, the Berkeley Drosophila 
Genome Project (BDGP) and additional public content from the Drosophila 
community. The array contains 18,880 probe sets covering over 18,500 
transcripts. Fourteen pairs of oligonucleotide probes are used to measure the 
level of transcription of each ORF sequence represented on the Genechip 
Drosophila Genome 2.0 Array. 
36 
Tiling Microarrays  
Tiling arrays are designed with the probes tiled across the whole target genome. 
The probes for some arrays are partially overlapping such as the S. cerevisiae 
Tiling 1.0R Array, whilst some arrays have non-overlapping probes such as the 
Drosophila tiling 2.0R Array (details also in chapter 3.2.1.2). Tiling arrays can be 
used for a range of applications including genome mapping, novel gene 
discovery, DNA-protein interaction (ChIP-chip) and DNA methylation studies. The 
comparison of different types of microarray design are illustrated in Figure 1.4, 
the probes of 3’-end expression array are at the 3’-end of the genes, exon array 
probes are designed in each known exons of the genes and tiling array probes 
are tiled across the whole genome. 
 
Figure 1-4 Diagram of different types of Affymetrix Microarrays. 
The picture shows the design strategy of different type arrays. 3’ expression arrays’ probes at 3’ 
end, exon arrays’ probes at major exons and tiling microarrays’ probes across the genome. 
Pictured adapted from Affymetrix Web http//: www. Affymetrix.com. 
1.1.6.2 Microarray and transcriptional profiling 
A transcriptional profile is the main application of microarray that can measure 
gene expression patterns, gene structure and gene functions at the whole 
genome level. The whole genome expression array is designed for this purpose. 
The first whole genome microarray was employed for yeast in 1997; the arrays 
contained up to 2,479 yeast open reading frames (ORFs). The results of three 
experiments showed that many genes were differentially expressed under the 
three environmental conditions (Lashkari et al., 1997). Transcriptional profiling 
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analysis can be used in disease diagnosis, and the analysis of gene expression in 
cancer including disease pathology, progression, resistance to treatment, 
response to cellular microenvironments, and may ultimately lead to improve 
early diagnosis and innovative therapeutic approaches for cancer (DeRisi et al., 
1996). Expression analysis using microarray has also been applied in the 
toxicological research to define how the regulation and expression of genes 
mediate the toxicological effects associated with exposure to a chemical 
(Bartosiewicz et al., 2001a; Bartosiewicz et al., 2001b). For Drosophila, the 
Dow/Davies lab created a FlyAtlas website (www.flyatlas.org). This web helps 
the researchers all over the world to design the correct experiments to look for 
the gene expression pattern in specific tissues (Chintapalli et al., 2007; Wang et 
al., 2004). 
1.1.6.3 Microarray and genotyping  
Another main application of microarrays is their use for comparative genomic 
analysis. The use of microarray technology for genotyping is further advanced 
than for transcript profiling as illustrated. Single nucleotide polymorphism (SNP) 
is the most frequent type of variation in the genome. A single nucleotide 
polymorphism array (SNP array) is a useful tool for studying slight variations 
between whole genomes. Specific uses of this technology include determining 
individual genome information (Redon et al., 2006), determining disease 
susceptibility (Botstein and Risch, 2003) and measuring the efficacy of drug 
therapies (Martinelli et al., 2009), SNPs can also be used to study genetic 
abnormalities in cancer (Bacolod et al., 2009). 
1.1.6.4 Microarray and novel gene discovery 
Traditional molecular approaches to identifying genes, including cloning and 
sequencing large collection of cDNAs (ESTs), have succeeded at identifying tens 
of thousands genes, they eventually reach a point of greatly diminished returns. 
Transcripts that are low abundance or expressed in rare cell types or in response 
to specific stimuli may never be identified by these methods (Mockler et al., 
2005). Microarray can be used to solve some of these problems, allowing 
confirmation of the predicted genes models such as expression arrays as well as 
a tool for novel gene discovery for example Tiling arrays. Tiling arrays have the 
probes tiled the whole genome, covering essentially all nonrepetitive regions of 
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the genome, and so enable the discovery of novel genes or novel alternative 
splicing. Human tiling arrays have been used to interrogate chromosomes 21 and 
22 via 25-mer probes spaced on average every 35bp. The human tiling array 
studies used human cells line and tissue samples. The results indicated that a 
much larger portion of human genome is transcribed than was previously 
predicted and also revealed the activity of novel noncoding genes in human 
genome (Cawley et al., 2004; Kampa et al., 2004; Kapranov et al., 2002). 
Drosophila tiling arrays has been used 25-mer oligonucleotide probes, spaced 
evenly across the Drosophila genome at intervals of approximately 35 base pairs.  
The studies using tiling arrays of Drosophila  genome show that 85% of the fly 
genome is transcribed and processed into mature transcripts, representing 30% 
of the fly genome and 30% of detected embryonic transcription is unannotated 
(Manak et al., 2006). Tiling array studies of 25 Drosophila cell lines also revealed 
more than one thousand novel transcribed regions (Cherbas et al., 2011). 
Drosophila tiling arrays will be discussed further in chapter 3. Custom exon 
arrays can also be used as a gene discovery tool for detecting novel splice 
junctions, which can subsequently use to find novel genes. 
1.1.6.5 Genomic DNA mask for probe selection method 
Although oligo-nucleotide arrays are a powerful and widely used tool for large-
scale gene-expression profiling, most commercial arrays (Affymetrix arrays) are 
only available for model species. For example, Drosophila expression arrays are 
only available for Drosophila melanogaster but not available for other Drosophila 
species. Hammond and his colleagues developed a method to improve the 
sensitivity of high-density oligonucleotide arrays when applied to heterologous 
species by using ‘Genomic DNA based probe selection strategy’ on the available 
species’ arrays (cross-hybridization) to mask off the heterologous sequences 
between the two species to improve the sensitivity of the gene expression 
detection.  This is a potential gene discovery method for non-model species 
(Davey et al., 2009; Hammond et al., 2005). 
1.1.6.6 Microarray data analysis 
Microarray data analysis is the most difficult challenge in microarray 
development. Microarray results are different from chip to chip, from lab to lab, 
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and even from operator to operator. The issue here is how to normalize the 
results to make them comparable? The normalization method is the key step. 
Normalization is a process that adjusts microarray data for effects that arise 
from the variation in the technology rather than from the biological differences. 
There are a variety of normalization schemes in use, including total-intensity, 
ratio-based and both linear and nonlinear regression techniques (Quackenbush, 
2001, 2002). 
RMA (Robust Multiarray Average) and GC-RMA are a very popular normalization 
method for microarrays especially for Affymetrix microarrays (Irizarry et al., 
2003). Details also referred to Chapter 2, Section 2.7.4. 
It is important to deposit microarray data in a format that can be used by 
others, such as NCBI, Geo and Array express repositories. Minimum information 
about a microarray experiment (MIAME) is the first successful submission method 
for microarray data to bring at least some basic standard to a microarray-based 
assay (Brazma et al., 2001). This standard information makes microarray data 
more useful and comparable. 
There are no definite methods for data analysis but some commercial software 
and self-made pipelines are applied to the analysis of microarray data, such as 
Partek (Downey, 2006), Genespring, and Bioconductor which is a major package 
written in the R statistical language. 
1.1.6.7 Advantages and disadvantages of microarrays 
The microarray is the first technology that allows a global view of the gene 
expression patterns in the genome. It allows comparative genome analysis to 
find the SNP, copy number variation, novel genes and alternative splicing. 
The disadvantage is that microarray technology uses the hybridization values 
rather than digital count values to measure genes expression. As a result, 
microarray doesn’t generate absolute gene expression values and the 
hybridization values are subjected to background noise. Microarrays require 
prior knowledge of the genome and do not support de novo sequences. For novel 
gene discovery, the background noise effects inherent in the technology 
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interfere with the identification of gene boundaries so that the information 
necessary for novel genes is subject to error. Normalization methods are rather 
difficult to apply to ensure that the microarray analyses can be compared to 
each other. 
1.1.7 Next-generation sequencing 
In theory, a superior approach would to be sequence every RNA in a sample 
completely. This has recently become possible. The automated Sanger method 
for sequences is considered as a ‘first–generation’ technology and newer 
methods are referred to as next-generation sequencing (NGS). Unlike the 
expensive, low throughput, single-pass Sanger sequencing, these newer 
technologies constitute various strategies that rely on a combination of template 
preparation, sequencing, imaging, and genome alignment and assembly 
methods. The major advance offer by NGS is the ability to produce an enormous 
volume of data cheaply. This will completely change our view in basic, applied 
and clinical research. There are several platforms used in NGS, based on 
different principles that have different advantages. RNA-seq is a revolutionary 
application of NGS for transcriptome profiling and novel gene/novel isoform 
discovery that will change the outlook for the genome annotation. Third-
generation technologies are emerging quickly, for which the reduction in 
equipment size together with the ability to sequence more cheaply will 
eventually allow the technology to enter clinical diagnosis. Personalized 
genomes will benefit everybody. 
1.1.7.1 Commercial platforms currently on the market 
The four dominant commercial platforms currently on the market are the Roche 
454 Genome sequencer, the Illumina Genome Analyser (GAI, GAIIx, Hiseq, 
Miseq), the Life Technologies SOLiD system and the IonTorrent system (IonProton 
and PGM). 
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The comparisons of the four technologies are listed in table 1-1. 
Table 1-1 Comparison of next-generation sequencing platforms 
Platform Roche454 IonProton IlluminaGAIIx Illumina Hiseq2500  ABI SOliD3 
 
Sequence mechanisms Pyrosequencing SBS SBS SBS  Ligation and 
      two-base coding 
Instrument Cost  $128,000 $243,000 $695,000 $740,000 $595,000 
 
Read length (bases) up to 1kb 200 75 2x100 50 
 
Gb per  run 1 M 60-80 M  18- 35Gb 600 Gb 30-50 Gb 
  
Run time (days) 0.4 0.15 4-9 11 7-14 
 
Pair-end No No Yes Yes Yes 
   
Observed Raw Error Rate 1.07% 1% 0.76% 0.26% 0.1% 
 
Reported Accuracy 99.9% 99% 98% 98% 99.94% 
 
Sequence cost per Gb $310 $16.67 $148 $46 $40 
 
Insert size 700 bases 150 bases up to 700 bases up to 700 bases 200-10.000bases 
 
Typical DNA requirement 50-1000ng 100-1000ng 50-1000ng 50-1000ng  10ng-5ug 
 
Advantage read length, fast  cheap, fast high throughput high throughput  accuracy 
  
Disadvantage	   error rate with short read assembly short read assembly short read assembly short read assembly 
 polybase more than 6, 
 high cost, low throughput	  	   	  
 
1.1.7.2 Main applications of Next-generation sequencing 
Due to the low cost and high throughput, NGS technologies have a range of 
application areas. A number of possibilities have arisen due to the fact that it 
can sequence the genome, provides a digital measure of gene expression, and 
does not require prior knowledge. The main applications are: 
De novo sequencing and assembly 
De novo sequencing is the initial sequence analysis performed to obtain the 
primary genetic sequence of a particular organism. Many non-model organisms 
don’t have their genomes sequenced, due to the cost and time involved in 
determining the sequence. Next generation sequencing makes possible de novo 
sequencing with low cost, less labour and high throughput. By now a number of 
species have been sequenced.  Up to March 2010, 740 sequence projects have 
been submitted to NCBI, of which 23 have been completed. The other projects 
are in progress or in draft form (Zhou et al., 2010). 
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Whole genome resequencing 
Due to the fact that reference genomes are now available for many organism, 
cataloguing sequence variation and understanding its biological consequences 
has become a major research aim (Stratton, 2008). Whole genome resequencing 
for chicken successfully found more than 7,000,000 single nucleotide 
polymorphisms, almost 1,300 deletions and a number of putative selective 
sweeps. This information reveals the loci under selection during the 
domestication of chicken (Rubin et al., 2010). Whole genome resequencing is 
another genome-wide method for genotyping and copy number analysis that 
follow on from the use of microarray technology but offers greater accuracy and 
a more direct means of revealing the genetic variation and risk of disease 
(Michaelson et al., 2012). In addition to de novo mutations, DNA translocation 
can also be discovered by whole genome resequencing. Whole genome 
resequencing can also identify viruses, bacteria and other organisms present in 
complex biological samples by identifying their genome signature, in what is 
called the subtractive approach (Wilson, 2012). 
Transcriptome profiling analysis – RNA-seq 
RNA-seq is a recently developed deep sequencing technology for both mapping 
and quantifying transcriptomes. This technology overcomes the limitation of 
microarray to become an alternative technology that is able to measure the 
whole genome expression by measuring the sequenced reads of the 
transcriptome. 
Under the RNA-seq process, the RNA population is fragmented and converted to 
a cDNA library with adaptors attached to one end or both ends. The DNA with 
adaptor will become attached to solid flow cells under bridge amplification, and 
then be sequenced by synthesis in a high-throughput manner to obtain short 
sequences from either one end (single end) or both ends (pair-end). This is just 
one method. The other method is strand-specific RNA-seq. Details of these 
approaches as used in the research conducted for this thesis is given in methods 
2.8. 
RNA-seq differs from the previous technologies in specific area. Firstly, RNA-seq 
doesn’t require the prior knowledge to detect the expression of transcriptome. 
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As a result, RNA-seq is particularly attractive for non-model organisms for which 
the genomic-sequence has not been determined, a scenario where it would be 
very difficult to apply to microarray technology. 
Secondly, RNA-seq can clearly detect the boundaries of genes, including 
particularly novel splicing junctions. The technique can also identify noncoding 
genes and anti-sense RNAs (Young et al., 2012). It is the most advanced 
technology for analysis the whole genome for novel gene and isoform discovery. 
The results from RNA-seq suggest the existence of a large number of transcribed 
regions in every genome surveyed, including Drosophila (Graveley et al., 2011), 
mouse (Mortazavi et al., 2008), Human (Pickrell et al., 2010; Wang et al., 2008), 
S.cerevisiae (Nagalakshmi et al., 2008) and S. pombe. (Wilhelm et al., 2008). 
Thirdly, RNA-seq is not based on hybridization so RNA-seq is not affected by 
background noise. RNA-seq can detect abundant expression without saturation; 
microarrays suffer saturation when the signals are too high. 
 Detail of comparison of the technologies is summarized in table 1-2, and further 
discussed in chapter 3 of this thesis. 
Table 1-2 Comparison of technologies for transcriptomes analysis 
Technologies EST SAGE Microarray  RNA-seq 
 
Principle Sanger sequence  Sanger sequence Hybridization High- throughput sequence 
 
Throughput Low Better than  EST High High 
 
Resolution Single base Single base 25-100 bp Single base 
 
Background noise  NO NO YES NO 
 
Quantitation NO YES Relative YES 
 
Mapping Portion Portion High High 
 
De novo sequence YES YES NO YES 
 
Novel gene detection Limited YES NO YES 
 
Novel splice junction YES NO Limited YES 
 
Novel isoform detection Limited NO Limited YES 
 
Gene structure detection YES NO NO YES 
 
RNA required High High High  Low 
 
Cost for mapping 
large genome High High Low Relative low 
 
44 
Small RNA profiling analysis- miRNA-seq 
miRNA-seq is another application of next generation sequencing. MicroRNA, 
which is normally 19-25bp long in length, modulates protein expression through 
transcript degradation, inhibition of translation, or sequestering transcripts. 
miRNA-seq uses size selection from the total RNA, followed by the addition of 
sequencing adaptors, and RT-PCR amplification and then sequencing. miRNA-seq 
has been successfully applied to the discovery of novel miRNA (Morin et al., 
2008);  and the identification of biomarkers for cancer classification, response to 
therapy, and prognosis (Keller et al., 2011). Further difference expression 
pattern analysis can identify the regulatory networks of miRNA involved in 
particular disorders. 
ChIP-seq 
ChIP-seq is a method to analyze DNA-binding proteins and DNA interactions. 
ChIP-seq combines chromatin immunoprecipitation (ChIP) with massively parallel 
DNA sequencing to identify the binding sites of DNA-associated proteins. Firstly, 
ChIP applies the immunoprecipitation method using antibodies against 
transcription factors to pull down the DNA and DNA-binding protein complex. 
The DNA and protein are then unlinked. Secondly, all the resulting ChIP-DNA 
fragments are sequenced simultaneously after size selection using a genome 
sequencer. ChIP can be applied to discover novel noncoding RNAs that regulate 
the promoters of genes (Guttman et al., 2009). ChIP-seq also has the potential 
to detect mutations in binding-site sequences, which may directly support any 
observed changes in protein binding and gene regulation (Northrup and Zhao, 
2011). 
1.1.7.3 Main analysis programs applied in next generation sequencing  
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Different next generation sequencing analysis programs are listed in table 1-3.  
Table 1-3 RNA-seq analysis programs 
 
 
Note this table includes the different mapping methods (the popular unspliced aligner is Bowtie, the 
popular spliced aligner is TopHat); different transcription reconstruction methods (the most popular 
methods are Cufflinks, Scripture, and Velvet) and different transcription quantification methods (the 
popular methods are Cufflinks for expression quantification and Cuffdiff for differential expression 
quantification). Table adapted from (Garber et al., 2011). 
 
Commercial software: Typical example of integrated software packages in use  
for analysis NGS Include CLC bio Genomic Workbench (www.clcbio.com), Partek 
Genomic Suite (www.partek.com) and Galaxy (www.galaxy.org). 
CLC bio Genomic Workbench is commercial NGS software package extends the 
CLCbio. Main Workbench to provide support for SNP detection, CHIP-seq 
analysis, browser visualization and other features. This integrated software 
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package offers tools for de novo and reference assembly of Sanger, Roche FLX, 
Illumina, Helicos and SOLid data. 
Partek Genomic Suite is next-generation sequencing and microarray analysis 
software, including support for gene expression and digital gene expression 
(DGE), exon/alternative splicing and RNA-Seq, copy number and association, 
ChIP-chip, ChIP-seq, and microRNA in a single software package that allows for 
analysis of multiple applications in one complete solution. 
Galaxy is an open, web-based, easy to setup platform for the analysis of next 
generation sequencing and genomic data. Galaxy provides tools to manipulate 
large dataset from RNA-seq and ChIP-seq to genome mapping and annotation. 
Open source software : TopHat (Trapnell et al., 2009), Cufflinks (Trapnell et al., 
2010), Bowties, Cuffdiff, Cuffmerge and CummeRbund pipeline. Details are also 
listed in Chapter 2, Section 2.8.6. 
 
1.1.7.4 Future trends in next-generation sequencing  
Next-generation sequencing has already been used in clinical research will likely 
enter clinics soon, but there remains a lot of challenges. 
With the availability of a multitude of platforms and dramatically lower costs of 
sequencing, NGS technologies are expected to have a major impact on the way 
we practice medicine in the near future. It is not far for next generation 
sequencing to enter the clinical diagnosis if the whole human genome sequences 
reach to $1000 (Service, 2006). The third generation sequencer Ion Proton is 
expected to reach this $1000 goal by the end of this year with the P3 chip. 
The combination of genomic information along with a detailed molecular 
analysis of the samples will be important for understanding the onset, 
progression, and prevalence of disease states (Chen et al., 2012). Building a 
personalized genome database is important step for health care and drug 
treatment to be made unique to different patients. 
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There are still more challenges for NGS to overcome beyond the £1000 limit and 
the lack of personalized genome information. Firstly, improved sample 
preparation techniques, PCR-free sequencing will bring down the cost and 
simplify data analysis by eliminating the major source of artefacts; single 
molecule sequence will much less than pair-end and mate-end due to its 
inaccuracy. Secondly, more robust analytical tools that have open source 
flexibility combined with friendly and efficient user interface and proper data 
storage software are key issues for next-generation sequencing goes into clinics. 
Thirdly, NGS data needs to be more accessible through visualization will reduce 
reliance on specialised bioinformatician. In summary, making NGS ready for 
clinical use will require personalized genome and technological advances that 
reduce the cost, complexity of use and equipment size. So it can enter the GP’s 
surgery. 
1.2 Computational prediction approaches 
There are two approaches for novel gene discovery; one is experimental 
approach which we had discussed in the previous section. The following section 
will focus on the analysis and prediction by using computational approach. 
1.2.1 Extrinsic (similarity or evidence-based) gene finding 
systems  
 Extrinsic gene finding systems locate target genes by comparing the RNA or 
protein sequences under study with all other RNA or protein sequences 
registered in databases to look for similarity. A high degree of similarity to a 
known RNA or protein product is strong evidence that a target gene is a protein-
coding gene. Approximately 20-50% of newly found genes contain an ancient 
conserved region that is represented in the database (Fickett, 1996). Basic Local 
Alignment Tool (blast.ncbi.nlm.nih.gov) is a widely used system designed for this 
purpose, with several variants. This system provides task specific tools such as 
blastn (nucleotide blast) for searching a nucleotide sequence database using a 
nucleotide query; blastp (protein blast) for searching a protein sequence 
database using protein query; blastx for searching a protein sequence using a 
translated nucleotide query; tblastn for searching translated nucleotide 
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database using a protein query; tblastx for searching a translated nucleotide 
database using a translated nucleotide query. 
As extensive transcript and protein sequence databases have been generated for 
human as well as other important model organisms in biology, such as mouse, 
yeast, Drosophila and C.elegans so these extrinsic methods are quite popular to 
use. However, to apply this approach systemically requires extensive sequencing 
of mRNA and protein products. Although the RefSeq database, Ensembl system 
and NCBI database contain transcripts and protein sequence for many species, 
these databases however are both incomplete and contain a number of errors. 
One specific issue needs to be addressed is the limited availability sequences 
and protein products for tissue-specific genes, and for some genes that are only 
expressed at certain times. These limitations mean that the extrinsic evidence 
for many genes is not yet available. 
1.2.2 Intrinsic (Ab initio approaches) 
Ab initio gene prediction approaches use statistical and computational methods 
to detect coding regions, splice sites, and start and stop codes in genomic 
sequences. These signs can be broadly categorized as either, specific sequences 
that indicate the presence of a gene nearby termed ‘signals’, or statistical 
properties of protein–coding sequence itself termed ‘content’. The Ab initio 
approach is the predominant gene prediction approach, due in large part to the 
fact that it doesn’t depend on sequence similarity and is therefore not limited 
by the availability of sequence data. Instead, understanding gene structure is 
the key step to predicting genes. 
In the prokaryotic genomes, genes have specific and relatively well-understood 
promoter sequences (signals), such as the Pribnow box (TATAAT) and 
transcription binding sites that are easy to identify systematically. Genes that 
code for proteins comprise open reading frames (ORFs) consisting of a series of 
codons that specify the amino acid sequence of the protein for which the gene 
codes. The ORF begins with an initiation codon, usually but not always ATG, and 
ends with a termination codon that can be TAA, TAG or TGA. Searching for a 
DNA sequence that begins with an ATG and ends with a termination triplet is a 
start towards gene annotation. Statistically, one would expect a stop codon 
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approximately every 60-75bp in a random sequence so a much longer stretch 
without a stop codon is good evidence for an open reading frame. These 
characteristics make prokaryotic gene finding relatively straightforward and 
well-designed systems will achieve a high level of accuracy. 
Ab initio gene finding in eukaryotes, especially complex organisms like humans, 
is considerably more challenging for several reasons. Firstly, the promoter and 
other regulatory signals in these genomes are more complex and less well 
understood than in prokaryotes. Secondly, the main problem for the human 
genome and those of other higher eukaryotes is that gene sequences are often 
split by introns and so do not appear as continuous ORFs. Many ORFs that 
continue into introns are subject to termination due to the presence of stop 
codon within introns. Due to the relatively small length of exons compared to 
introns, simple ORF scanning cannot locate gene sequences. For example, many 
exons are smaller than 100 codons whilst some are less than 50 codons in length. 
Thirdly, there is substantially more space between real genes in the human 
genome and those of higher eukaryotes (70% of human genome is intergenic), 
increasing the chance of finding spurious ORFs. 
Given these issues, three modifications to the basic procedure for ORF scanning 
have been adopted for eukaryotes. The first of these modifications is codon bias 
by which not all codons are used equal frequently for particular organism. The 
second modification is that exon-intron boundaries can be used as a signal to 
identify genes. The third modification is that upstream control sequences can be 
used to locate the regions where genes begin. Additional strategies are also 
possible for specific organisms, such as the identification of CPG islands and 
binding sites for a poly(A) tails. 
GLIMMER and GeneMark software programs are widely used, highly accurate 
gene finders for prokaryotes (Aggarwal and Ramaswamy, 2002). Eukaryotic ab 
initio gene finders, by comparison, have achieved only limited success, as in the 
GENSCAN and Geneid programs (Peters et al., 2007). Advanced gene finders for 
both prokaryotic and eukaryotic genomes typically use complex probabilistic 
models, such as Hidden Markov models (HMMs), in order to combine information 
from a variety of different signals and content measurements. Seven ab intio 
programs were evaluated on a nonhomologous mammalian data set by Rogic et 
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al. They reported that among the evaluated programs only GeneScan and  HMMs 
gene were able to predict the precise location of 70-80% coding exons with low 
false positive rates (Rogic et al., 2001). 
1.2.3 Combined approaches 
Combined approaches bring together extrinsic and ab initio approaches by 
mapping protein and EST data to the genome in order to validate ab initio 
predictions. The ab initio approaches have delivered maximum accuracy of 70-
80% (Rogic et al., 2001). The similarity search programs are very effective in 
improving the accuracy of gene prediction. In particular, combining the two 
methods can improve the overall accuracy by 4-10% (Issac and Raghava, 2004). 
Usually, ab initio gene prediction and similarity searches are run independently 
with the output from these two approaches being manually integrated for gene 
annotation. Many automated programs have been developed to combine the two 
approaches such as GenomeWise, the TwinScan, GenomeScan and EGPred (Issac 
and Raghava, 2004). The GenomeScan program for gene prediction was 
developed as an extension of Genescan and incorporates similarity searching for 
protein detected by BLASTX. GenomeScan is able to predict coding regions 
missed by using both GeneScan and BLASTX alone, leading to an improvement in 
the accuracy of gene prediction by 10% (Mathe et al., 2002). 
1.2.4 Comparative genomic approaches 
Comparative genome approaches rely on the sequence similarity to predict 
genes in a new species by comparison with an already sequenced relative. This 
approach is based on the principle that nature selection causes genes and other 
functional elements to undergo mutation at a slower rate than the rest of the 
genome. This means that the coding regions of genes are more conserved than 
noncoding regions under evolutionary pressure. Comparison of a few closely 
related genomes has proved successful for the discovery of protein-coding genes 
(Kellis et al., 2003). Stark et al. used a comparative analysis of twelve 
Drosophila genomes to predict non-protein-coding RNA genes and structure, and 
new microRNA (miRNA) genes (Stark et al., 2007). Comparative genomic analysis 
constitutes a powerful approach for the systematic understanding of any 
genome. 
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1.3 Drosophila is an ideal model organism for novel gene 
discovery 
1.3.1 Drosophila as a genetic model organism 
Drosophila has proven to be an excellent model organism for genetics studies. In 
part, this is due to the organism’s small physical size, short development 
lifecycle and ease of culturing. These facts contribute to Drosophila being 
efficient and cheap to maintain in the lab. More importantly, Drosophila 
provides an excellent balance between genetic power and biomedical similarity 
to humans; 70% of Drosophila  genes have clear human homologs (Chien et al., 
2002); Genetically, Drosophila has a well-defined, fully sequenced, mid-sized 
genome. The genome encodes approximately 13,600 genes, In comparison to 
that of Caenorhabditis elegans, another widely used model organism, the 
Drosophila genome is longer but encodes somewhat fewer genes with greater 
functional diversity (Adams et al., 2000). Furthermore, Drosophila is a less 
complicated genome, having a core proteome only twice the size of that of 
yeast (Rubin et al., 2000b). The relative simplicity and manipulability of the fly 
genome means we can address some of these biological questions much more 
readily than in vertebrates (Rubin et al., 2000b). Consequently, Drosophila is a 
very good experimental model. 
Drosophila has four pairs of chromosomes, named, X, 2L, 2R, 3L, 3R, 4 in the 
female, and Y, 2L, 2R, 3L, 3R, 4 in the male. The chromosome X and 4 both have 
a major left arm and significantly smaller right arm. The Drosophila genome is 
approximately 180Mb in size, which is roughly the size of a single human 
chromosome. One third of the Drosophila genome is centric heterochromatin. 
The two large autosomes and the X chromosome contain 120Mb of euchromatin; 
the small fourth chromosome contains only approximately 1Mb of euchromatin 
(Adams et al., 2000). 
Drosophila has a fully sequenced genome (so far 12 different species have been 
sequenced) and detailed annotations. In addition, a number of online resources 
have been created for Drosophila that offers a wealth of genetic and 
physiological information. Examples include (flybase.org) and FlyAtlas 
(flyatlas.org). Fly genetics is enriched with powerful genetic markers and 
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balancer chromosomes that facilitate marking genes of interest (the knockdown 
or overexpress) and tracing the lineages over the generations. The Drosophila 
stock centres maintain 40,000 genetically characterized lines, some of which are 
human disease models, together with RNAi stocks for all Drosophila genes. In 
addition, classic mutants and P-element insertional alleles, tissue-specific and 
cell type-specific drivers enable the generation of millions of transgenic flies for 
research. 
1.3.2 The Drosophila malpighian tubules as a model for epithelial 
fluid transport 
For functional genomics, it is important to be able to study function in a specific 
tissue. For many genes, Malpighian tubule is ideal. This section is detailed in 
Chapter 5, Section 5.1.6. 
1.3.3 Drosophila and reverse genetics  
Reverse genetics is an approach to discovering the function of a gene by 
analyzing the phenotypic effects of specific gene sequences obtained by DNA 
sequencing (Adams and Sekelsky, 2002). This has been proposed as a quick and  
promising way of inferring function for a novel gene (Dow and Davies, 2003) . 
This approach is illustrated in Figure 1-5. The success of the reverse genetics 
approach depends on the model organisms, and gene homology and phenotypes 
available. A variety of model organisms with appropriate genetic power, full 
genomic sequence and defined physiological knowledge can be chosen to serve 
as reverse genetic models. Drosophila is an excellent model organism for 
creating a gene knock-down because of its unique GAL4/UAS system (details in 
Chapter 5, Section 5.1.1), and its use in this context benefits from the higher 
level of homology to higher organisms. There are various RNAi lines for all genes 
available in stock centres; In particular, the UAS/GAL4 system is particularly 
advantages for creating gene knock-downs in specific cell types. 
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Figure 1-5 Diagram of reverse genetics.  
Reverse genetics is a popular method for investigating novel gene function.  The reverse genetic 
method firstly requires choosing a suitable model organism (Drosophila is an ideal model 
organism). Thereafter, the predicted novel gene is mutated (by gene knock-down or gene 
overexpression), so that potential changes in the phenotype and the function of the novel gene can 
be investigated. Picture adapted from (Dow and Davies, 2003), modified by Jing Wang. 
There are two main methods in reverse genetics, gene knock-down (RNA 
interference, RNAi) and gene overexpression. There are two ways to introduce 
RNAi into Drosophila in search of associated phenotypes: one is through 
microinjection into the embryo. The other method is expressing RNA with a long 
inverted repeat that can fold back on itself to become double-stranded (Lam and 
Thummel, 2000). Different vectors have been developed to introduce RNAi into 
the cells or embryos. In several Drosophila RNAi vectors, a functional intron used 
as the linker sequence increases the effectiveness of RNAi (Lee and Carthew, 
2003). One such novel vector that has been developed for RNAi is pRISE (Figure 
1-8a). The pRISE vector contains a characteristic repeat of the Gateway 
recombination cassette attR1-cm1-ccdB-attR2 enabling insertion of the same 
target sequence in both orientations using Gateway Technology (Invitrogen). 
This involves cloning a trigger sequence into an appropriate entry vector, such as 
pENTR/D-TOPO (Invitrogen), and placing it between the attL1 and attL2 
recombination sequences. An inverted repeat sequence between an intron can 
be transferred easily to pRISE by an in vitro reaction mediated by LR, which also 
has a pentameric GAL4 binding sequence for conditional expression (Kondo et 
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al., 2006) Details can been see in Figure 1-6. This method is especially suitable 
for investigating novel gene function in Drosophila. 
 
Figure 1-6 Rapid construction of RNAi transgene by pRISE. 
a. Physical map of pRISE. b. Schematic representation of RNAi transgene construction 
using pRISE. Clone a trigger sequence into an appropriate entry vector, placing it between the 
attL1 and attL2 recombination sequences. An inverted repeat sequence in both orientations 
between an intron can be transferred easily to pRISE by an in vitro reaction mediated by LR, which 
also has a pentameric GAL4 binding sequence for conditional expression. Picture adapted from 
(Kondo et al., 2006). 
Other ready-to-go vectors for generating overexpress (PTW) transgene lines by 
using Gateway technology which attached the downstream of UAS can combine 
with the GAL4 line create a powerful tool for functional analysis of the novel 
genes. 
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Tagged fusion proteins are priceless tools for monitoring the activities of 
biomolecules in living cells. PTWV is the destination Entry/Gateway® vectors for 
expressing fluorescent fusion proteins in Drosophila melanogaster (Akbari et al., 
2009). 
1.3.4 Drosophila and transgenesis 
Transgenesis in general can be defined as a group of technologies that allow DNA 
to be introduced into an organism of choice. The main goal of transgenesis is to 
integrate a foreign piece of DNA (a transgene) into an organism’s genome to 
result in germline transmission (Venken and Bellen, 2007). In order to identify a 
novel gene, the P element construct or P element mediated RNAi vector with the 
novel gene (reporter gene) will be introduced into the organism’s genome by 
germline transformation. In subsequent generations produced after crossing with 
the RNAi driver line, the novel gene will be identified by a specific expression 
pattern or specific tissue expression.  
• P element-mediated transgenesis 
The classic method for fly transgenesis is P element-mediated transgenesis, 
which has been one of the most important breakthroughs in germline 
transgenesis in Drosophila. P elements are transposable elements, or 
transposons, that were originally identified within the fly's own genome; these 
can cause gene mutation by ‘random jumping’ around the genes. The P element-
mediated fly germline transformation is also detailed in Chapter 5, Section 
5.1.2. Enhancer trapping which involves generating a P element construct that 
carries a reporter gene is widely used in Drosophila for generation of cell type 
markers that are often exquisitely specific. This enables identification of novel 
genes on the basis of expression pattern. Specification of expression patterns 
will indicate the location and function of the gene. The first generation of 
enhancer trapping used P-element-mediated trangenesis to detect tissue-
specific genes and reveal regional specification in Drosophila tubules (Sozen et 
al., 1997). However, The P element-mediated transgenesis has two major 
drawbacks: the size of the DNA that can be integrated is limited and the 
insertion sites cannot be controlled (Venken and Bellen, 2007).
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• GAL4/UAS system 
The second generation of the enhancer trap is the UAS/GAL4 system, which also 
used the P element-mediated method.  
Transposon-mediated transgenesis enable the development of the GAL4/UAS 
binary system of adapted P elements, for tissue-specific expression of 
introduced DNA sequences. Target gene expression in a temporal and spatial 
fashion has proven to be one of the most powerful techniques to address gene 
function in vivo (Duffy, 2002). The GAL4/UAS system was first developed for 
targeted gene expression in Drosophila (Brand and Perrimon, 1993). At present, 
it is a technique specific for Drosophila. Details are listed in Chapter 5, Section 
5.1.1. 
• RNA interference (RNAi) 
Due to the several disadvantages of P element-mediated transgenesis, various 
improvements in fly transgenic techniques have been made. The most popular 
method used with fly is RNA interference (RNAi). Details about how the RNAi 
works are detailed in Chapter 1, Section 1.3.3. 
1.4 Categories of RNA in Drosophila cells 
As summarized in Table 1-4, multiple categories of RNA can be found in 
Drosophila cells. Understanding the categories of RNA is important to determine 
the novel genes categories which were found in RNA-seq technology later in this 
thesis. 
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Table 1-4 Types of Total RNA 
   Types  Name  Size Location Number in 
Drosophila 
Functions Poly-A 
tail 
   Coding 
RNA 
  mRNA    cytoplasm 13,6000 Coding Protein Yes 
     tRNA    cytoplasm 297 deliver amino acid NoRNNA 
rRNA   cytoplasm 101 place to make protein   No 
   Short ncRNAs 
    miRNAs 19–24 bp widespread 
locations 
78 Targeting of 
mRNAs and 
many others 
   Yes 
   Noncoding 
RNA 
piRNAs 26–31bp nuclei and 
cytoplasm 
50 
 
Transposon 
repression, 
DNA 
methylation 
   No 
    Mid-size ncRNAs 
    snoRNAs 60–300 bp Nuclei and 
cytoplasm 
255 rRNA 
modifications 
   No SnoR66 
    Long ncRNAs 
    lincRNAs >200 bp widespread 
loci 
1,00 Examples 
include 
scaffold DNA–
chromatin 
complexes 
        No 
    mlncRNA >200 Cytoplasm 
And nuclei 
100     Yes 
         
 
 
tRNA (transfer RNA), rRNA (ribosomal RNA), microRNA (miRNA), piRNA (Piwi-interacting RNA), 
snoRNA (small nucleolar RNA), lincRNA (lonng intergenic non-coding RNA), mlnRNA (mRNA-like 
non-coding RNA). Location (position in cell) 
The coding RNAs of Drosophila are very well studied. The noncoding RNAs have 
been extensively studied in recent years especially following the development of 
high-throughput sequencing technology. As a result, more and more noncoding 
RNAs have been discovered (Table 1-5) such as mRNA-like noncoding RNA 
(mlncRNA). 
As is the case for mRNA, polyadenylation also plays a role in mRNA-like 
noncoding RNAs. In particular, mlncRNAs that are like mRNAs are spliced 
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capped, and polyadenylated just like protein-coding genes, and so may play 
important role in cellular processes. The introns of these RNAs are conserved in 
species. They lack open reading frames so they are unlikely to make protein, but 
these RNAs have important functions in cellular processes (Hiller et al., 2009; 
Jiang et al., 2011). Exons and introns of mlncRNA can be processed into 
microRNAs (miRNA) or small nucleolar RNAs (snoRNAs) (Kapranov et al., 2007). 
Other mlncRNAs exert their function as large RNAs such as the hsrw RNA which is 
key to the heat shock response in Drosphila (Arya et al., 2007). None of the 
mlncRNAs have been well studied across Drosophila species. 
1.5 Aims of the project 
1.5.1 Primary aim/Searching for novel genes in Drosophila 
tubules 
The Drosophila genome project is essentially complete and effort is being made 
to annotate the 13,600 genes discovered to date. There may still be a number of 
novel genes that are not yet discovered in Drosophila genome. New technology 
developments have led to the discovery of novel genes and novel transfragments 
(transcribed fragments of the genome) in Drosophila as well as other organisms.  
These are novels genes and novel transfragments that have been found to be 
transcribed but have not yet been annotated. These novel genes and novel 
transfragments may play an important role in the Drosophila genome. 
The project presented in this thesis draws on the wealth of physiological and 
genomic data available for the Drosophila tubule, and particularly on the 
extensive experience and knowledge gained within Dow/Davies lab from working 
with this tissue over a period of 30 years (Wang et al., 2004). 
The primary aim of this project is to look for novel genes of Drosophila tubules. 
The project will start with comparing the three technologies, Drosophila 
expression microarrays, Drosophila tiling microarrays and the recently developed 
next-generation sequencing technology RNA-seq in order to evaluate which 
technology is best for profiling the Drosophila genome  in terms of novel genes 
and novel splicing, particularly in relation to Drosophila tubules based on the 
measurement of expression level of the annotated Drosophila genes. 
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The reverse genetics technology will be applied to the tissue-specific novel 
genes (completely new transcribed units in tubules) which are generated by this 
work in order to search for the function. This will involve validation using 
reverse transcript polymerase chain reaction (RT-PCR) and transgenic resources 
such as the GAL4/UAS system. Data generated during the project will be 
deposited in FlyBase, FlyAtlas, Ensembl and other resources to benefit the fly 
research community. 
Other new features which generated within this work, such as features which 
change coding sequences, regions transcribed from both strands, and novel 
splicing forms will be studied as well.  
1.5.2  Secondary aim/Application of standard array technology to 
investigate gene expression of different Drosophila species 
The secondary aim of the work presented in this thesis is to evaluate the use of 
genomic DNA-based probe selection method as means of improving the 
sensitivity for gene detection when applying the standard microarrays to 
heterologous species. 
Standard Affymetrix three-prime expression microarrays will be applied to 
different Drosophila species that are related-to Drosophila melanogaster by 
varying distances.  Both a closely related Drosophila species D. simulans and a 
medium distanced Drosophila species D. pseudoobscura will be assessed by 
applying both D. simulans and D. pseudoobscura genomic masks. In this way, a 
similar sequence of Drosophila probes will be chosen after assessment by 
genomic hybridization from the related species in order to evaluate the 
sensitivity of the genomic selection technology. 
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2. Materials and Methods 
2.1 Fly stocks 
The original stocks used in this study are presented in Table 2-1. Each fly stock is 
characterized in terms of fly line identifier, genotype, description, and source of 
origin for this project. 
Table 2-1 Fly stocks used in this study.  
Flies were either obtained from the stock centres or made in house. Each fly stock is characterized 
in terms of fly identification; genotype; description explaining what the fly stock is; reference, where 
it was obtained from (if it is so). The genotype of a chromosome is indicated only if there is a 
mutation or some other kind of variant on it. Chromosomes are listed in order: X/Y; 2; 3; 4, where 
semi-colons separate the genotype symbols for each different chromosome. w+, indicates the wild 
type allele of white gene on sex chromosome. w- , indicates no allele of white gene on sex 
chromosome. A chromosomal genotype written on a single line indicates that the stock is 
homozygous for that genotype; heterzygosity is denoted by a two-line genotype. + indicates wild 
type. TM3, CYO indicates the balancer chromosome.  
Fly ID Genotype Description Reference 
Canton S w+; +; +; 
wild type 
Wild type - Drosophila 
melanogaster  
http://flybase.org/r
eports/FBst0000001.
html 
c42-GAL4 w-; +; c42-
GAL4/c42-GAL4 
GAL4 enhancer trap specific to the 
tubule principal cells. 
(Sozen et al., 1997); 
Dow/Davies Lab 
c724-GAL4 w-; +; c724-
GAL4/c724-GAL4 
GAL4 enhancer trap specific to the 
tubule stellate cells. 
(Sozen et al., 1997); 
Dow/Davies Lab 
Tubulin-GAL4 
UAS 
Dicer/Tm3Sb 
w-; +; Tubulin-
GAL4 UAS 
Dicer/TM3Sb 
Universal driver has GAL4 
transcription factor 
Dow/Davies Lab 
Actin-GAL4- cyo w-; actin-
GAL4/cyo; + 
Universal driver has GAL4 
transcription factor 
Dow/Davies Lab 
Simulans w+; +;+ Wild type-Drosophila simulans Dow/Davies Lab 
Pseudoobscura w+;+;+ Wild type-Drosophila 
pseudoobscura  
Steven Goodwins 
Lab 
 
OregonR 
w+; +;+ 
Wild type 
Wild type – Drosophila 
melanogaster 
 
Dow/Davies Lab 
UAS-3L1a-RNAi w-; +; 3L1a 3L11a double stranded RNA BestGene Jing Wang 
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Fly ID Genotype Description Reference 
RNAi/Tm3 (dsRNA) fusion with upstream UAS Dow/Davies Lab 
UAS-3L3a-RNAi w- ; +; 3L3a 
RNAi/TM3,sb 
3L13a double stranded RNA 
(dsRNA) fusion with upstream UAS 
BestGene Jing Wang 
Dow/Davies Lab 
UAS-3L4a-RNAi w-; 3L4aRNAi/ 
cyo;+ 
3L14a double stranded RNA 
(dsRNA) fusion with upstream UAS 
BestGene Jing Wang 
Dow/Davies Lab 
UAS-3L5a-RNAi w-; +; 3L5a 
RNAi/TM3 
3L15a double stranded RNA 
(dsRNA) fusion with upstream UAS 
BestGene Jing Wang 
Dow/Davies Lab 
UAS-3L6a-PTW w-; 3L6aPTW/ 
cyo;+ 
3L6a PTW cDNA fusion with 
upstream UAS promoter  
BestGene Jing Wang 
Dow/Davies Lab 
UAS-3L7a-
PTWV-YFP 
w-; 3L7aPTWV/ 
cyo;+ 
3L7a PTWV cDNA fusion with 
upstream UAS promoter and 
downstream yellow fluorescent 
protein (YFP) 
BestGene Jing Wang 
Dow/Davies Lab 
 
2.2 Normal fly husbandry 
Drosophila melanogaster (Canton S strain, RNAi and overexpressed flies before 
cross, c42 and c724 driver lines et al) flies were normally raised on standard 
medium (Appendix I) on a 12:12 h L:D cycle, at 23ºC, and at 55% room humidity. 
The flies were transferred to new vials after two days cross and lay eggs. Adults’ 
flies emerged in ten days normally; they were subsequently transferred to fresh 
vials on the day of emergence, and used seven days later. 
2.3 Transgenesis fly husbandry 
RNAi and overexpressed crossed flies were raised on standard medium on a 12:12 
L:D cycle, in a 26ºC SANYO incubator, and at 60-70% relative humidity. The flies 
were transferred to new vials every two days after flies crossed for three times. 
The GAL4/RNAi or GAL4/overexpressed flies merged in eight days after cross, 
then the new emerged flies were transferred to a fresh vials. The flies had 
transferred to fresh food every two days. The flies were used for seven days 
after they were emerged. 
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2.4 Tissue dissections 
Flies were anaesthetised briefly by chilling on ice, then immediately dissected 
for tissues in Drosophila Schneider’s medium (Invitrogen UK). 
Table 2-2 Different tissue amount for RNA-seq, tiling microarrays, species arrays and cDNA. 
Tissue Definition Number 
per sample 
Total amount of 
RNA obtained (ng) 
Adult Head Severed at the neck. Includes 
brain, eyes, cuticle and some fat 
body. 
100-150 2-9µg 
Adult Tubule Both anterior and posterior tubules 
with their common ureters, 
severed at the junction with the 
gut. 
20 each 
separately 
total 20-80  
2-9µg 
Adult Testis Testis excluding the accessory 
glands. 
20 each 
separately 
total 50-60 
2-9µg 
Whole fly Whole animal. 15-20 2-9µg 
	  
Equal number of males and females contributed to each RNA sample. Sufficient 
tissues were dissected in Schneider’s medium to obtain 2-9 µg total RNA. As this 
involves significant pooling for such tiny tissues, tissues were collected 
immediately after each dissection into RLT buffer for RNA extraction (Section 
2.5). This procedure was repeated 3 times for each tissue; that is, each RNA-seq 
sample corresponds to an independent biological replicate. For whole fly RNA 
extraction, at least 20 flies were used for each sample. 
2.5 Total RNA extraction 
2.5.1 Extraction method 
RNA extraction was carried out in a nuclease-free environment using RNeasy Mini 
kit (for whole flies, heads), or RNAeasy Micro kit (for tubules, testis) according 
to the manufacturer’s protocol (Qiagen UK). After the dissections and/or 
collection of whole flies in RLT buffer, homogenizations were performed 
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manually using a small blue rod/pestle for whole flies and heads, or an 
ultrasonic cell disruptor (Misonix, Inc., USA) for tubules and testis. The tissues  
were immediately frozen at -80°C then processed later or processed 
immediately. 
Then the homogenate was centrifuged for 3 min and supernatant was collected 
into a fresh 1.5 ml micro centrifuge tube. The rest of the protocol was according 
to Qiagen kit. An on column DNA digestion step (using Qiagen DNAase kit) was 
included for reducing genomic DNA contamination. RNA was eluted using 14-30 
µl of nuclease-free water from the column and it was stored at -80°C until 
further use. 
2.5.2 Quantification and quality check 
Three quality controls were performed on the isolated RNA to check quantity, 
purity and integrity. 
The quantity and purity of RNA were tested by Nanodrop (ND-1000 V3.7.1). 1µl 
RNA is required to load the machine. The optical density (OD) of the sample at 
260nm was used to determine the concentration of the RNA in a solution. The 
ratio of OD of the sample measured at 260nm and 280nm was used to determine 
the purity of RNA. A 260/280 ratio in the range 1.8-2.0 inclusive indicated a 
good level of purity, a 260/280 ratio less than 1.8 or greater than 2.0 indicated 
the contamination of the RNA. A 260/230 ratio helped to determine the purity of 
RNA as well. The 260/230 ratio in the range 1.8-2.0 inclusive indicated the good 
purity of RNA, 260/230 less than 1.8 or greater than 2.0 indicated the 
contamination of the RNA. 
The integrity of RNA was checked using Agilent 2100 Bioanalyzer. An example 
RNA profile for RNA extracted from a sample of Drosophila tubules is shown in 
Figure 2-1. The RNA integrity number (RIN) software algorithm allows 
classification of total RNA based on a number system from 1-10. Higher RIN 
indicates greater integrity. RIN values about 7-8 were considered to indicate an 
acceptable level of RNA purity for experiment work. RIN less than 7 was taken to 
indicate degradation of the total RNA. Microarray and mRNA-seq require the RIN 
of total RNA to be above 8. 
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Figure 2-1 Good quality of Drosophila tubules Agilent profile.  
Profile from Agilent Bioanalyzer indicating good quality for RNA extracted from Drosophila tubules. 
Note that the Drosophila RNA profile is different from human with two peaks at 18S and one peak 
at 28S. 
 
2.6 Genomic DNA extraction 
Two methods were used in genomic DNA extraction. The 30 fly genomic DNA 
protocol was used for generating a large amount of Drosophila genomic DNA. 
The DNeasy Blood and Tissue kit (Qiagen, Cat No. 69504) for high quality DNA 
extraction was used for genomic DNA array. 
2.6.1 30 fly Genomic DNA extraction  
30 Canton S flies were put in a 1.5ml eppendorf tube containing 200µl buffer A 
(100mM Tris-Hcl pH 7.5, 100mM EDTA pH 8.0, 100mM Nacl, 0.5% SDS). The flies 
were grounded using a pestle. The grounded samples were incubated at 650C for 
30 mins. Then 800µl buffer B (mix one part 5M potassium acetate with 2.5 parts 
6M lithium chloride) was added, followed by incubation on ice for more than 10 
mins. The sample was spun for 15mins at room temperature (RT), 13,000rpm. 
1ml of the supernatant was transferred into a new tube to avoid crud. If crud 
was carried over, the transfer and spin step was repeated. 600µl isopropanol was 
added, mixed and spun for 15 mins at RT, 13,000rpm. The supernatant was 
removed, and the remaining pellet was washed with 200 µl 70% ethanol, and 
spun 5mins at 13,000rpm. The DNA pellet dried in 370C hybridization oven. The 
pellet was resuspended in 150 µl TE. The pellets that didn’t dissolve were left 
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overnight in the fridge to dissolve and stored at -200C. The quality of genomic 
DNA was tested by running PCR using the same primers to span an intron using 
the genomic DNA and cDNA samples to compare the size. 
2.6.2 DNeasy Blood and Tissue kit 
DNeasy Blood and tissue kit (Qiagen, Cat No. 69504) was used to accelerate the 
high quality genomic DNA extraction for use with genomic DNA array. 
10 flies (5 females and 5 males) around 8-10mg were put in 1.5 µl eppendorf 
tubes, and 180 µl Buffer ATL added and the tissue was homogenized by small 
pestle. 20µl proteinase K was added, mixed by vortexing, and incubated at 550C 
until the tissue was completely lysed, with vortexing occasionally during the 
incubation. Vortexed for 15s then 200 µl Buffer AL was added to the sample, 
mixed thoroughly by vortexing, and incubated at 70C for 10 min. 200 ul ethanol 
(96-100%) was added to the sample, and mixed thoroughly by votexing. The 
mixture was transferred by pipette to the DNeasy Mini spin column and placed in 
a 2ml collection tube, centrifuged at > 6000g (8000rpm). The flow-through and 
collection tube were discarded. Placed the column in a new collection tube, 
added 500µl Buffer AW1 (add 25ml ethanol), and centrifuged for 1 min at >6000g 
(8000rpm). The flow-through and collection tube was discarded. Placed the 
column in a new collection tube, added 500 ul Buffer AW2, and centrifuged for 3 
min at 20, 000g (14,000rpm) to dry the column membrane. Discarded flow-
through and collection tube. Placed the DNeasy Column in a clean 1.5ml 
eppendorf tube and pipette 200µl Buffer AE , incubated at room temperature for 
1 min, and then centrifuged for 1 min at >6000g 98000rpm) to elute. The elution 
was repeated once in a new tube. 
2.6.3 DNA quality control 
DNA and RNA quantification was performed using a NanoDrop 1000 
spectrophotometer (Thermo UK) in 1.5µl sample volume. The 260/280 ratio 
between 1.8 -2.0 indicates a good quality of DNA. A 260/230 ratio of greater 
than 1.8 indicates no buffer or ethanol contamination. 
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2.7 Microarray 
2.7.1 Three-prime expression microarrays (Drosophila Genome 
2.0 Array) 
Targets were prepared using the One-Cycle Eukaryotic Target labelling Assay 
protocol and kit (PN 900431) from Affymetrix were used in this experiment. 2ug 
RNA was used in line with the manufacture’s protocol. Four replicate samples 
were used when preparing targets from tubules of Drosophila Simulans, 
Drosophila Pseudoodbscura and Drosophila melanogaster. The outline of the 
assay is shown in Figure 2-2. The RNA quality, quantities and integrity were 
checked by Nanodrop and Agilent bioanalyzer (chapter 2.5.2). 2ug total RNA, 
PolyA control and T7 oligo (dT) primer mixture were denatured at 700C for 10 
mins to open the RNA second structure. First strand synthesis was performed 
using superscript II. Second strand synthesis was performed DNA ligase and DNA 
polymerase and T4 DNA polymerase was used to polish the end of dsDNA. The 
dsDNA was then cleaned up by the DNA clean up kit. The Biotin-labelled 
ribonucleotides and T7 RNA polymerase were used in ‘In Vitro Transcription’ to 
make the biotin-labelled complementary RNA (cRNA). The quality of cRNA was 
then determined by Agilent 2100 Bioanalyzer. 
Target Hybridization was performed by first fragmenting 10ug corrected cRNA. 
200µl array target was made with control oligo B2 and 20x hybridization control. 
130ul of the target was hybridized in Drosophila Genome 2.0 Array at 60rpm, 
450C oven for 16-18 hours. 
Fluidic Station Setup: Fluidic station 450 was set up by prime wash using the 
GeneChip Operating software (GCOS) in line with Affymetrix’s instruction to 
operate the whole process. The samples and project information was entered 
and saved as an experiment file. 
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Figure 2-2 Overview of the GeneChip 3' IVT Express Labelling Assay 
The process of 3’end expression microarrays includes one cycle (2µg RNA) and two cycles (100ng 
RNA) reverse transcription, in vitro transcription and labelling procedure. Picture is taken from 
www.affymetrix.com. 
Probe Array Wash and Staining: SAPE, Antibody and SAPE stain were performed 
using fluidic station in line with Affymetrix’s instruction using the Midi_euk2v3 
protocol in this process. 
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Probe Array Scan: The array was scanned by Affymetrix Scanner 3000 7G. The 
cell files were created as in raw data format for further analysis by other 
software such as Partek. 
2.7.2 Drosophila tiling microarrays 
GeneChip Whole Transcript (WT) Double-Strand Target Assays protocol and kit 
(PN 900652) were used in this experiment. The outline of this procedure is 
shown in FIgure2-3. Four replicates of Drosophila whole flies, testes, heads and 
tubules were processed. The quality of total RNA of all the samples was checked 
on Nanodrop ND-1000 (Chapter 2.2.5.2) and Agilent 2100 Bioanalyzer (Chapter 
2.2.5.2). The experiment was started with 7µg good quality total RNA. First 
strand cDNA synthesis used random primer and superscript II, second strand 
synthesis used DNA polymerase I, dUTP was incorporated in both strands for 
later recognition by the fragment enzyme. The double-stranded DNA was 
cleaned up by GeneChip Sample Clean up Module (PN 900371). The 7.5µg dsDNA 
was then fragmented by using enzyme UDG and APE to recognize the dUTP in the 
dsDNA. The fragmented dsDNA was labelled by TdT for the end labelling 
procedure (terminal labelling). The quality of the terminal labelling fragmented 
dsDNA can be checked by ‘gel shift assay’. The hybridization target was made by 
the labelled dsDNA, control oligoB2, herring sperm DNA and BSA. The Fluidic 
Setup, Wash and Stain, Scan was performed as in Section 2.7.1. The Tiling chips 
in this experiment were GeneChip Drosophila Tiling 2.0R Array. 
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Figure 2-3 GeneChip Whole Transcript Double-Stranded Target Assay Schematic  
The process of tiling microarrays includes reverse transcription, fragmentation and end labelling 
producture. Picture is taken from www.affymetrix.com. 
2.7.3 Genomic DNA Array 
Invitrogen BioPrime® DNA Labelling System (Cat. No. 18094-011) was used to 
generate DNA target in this experiment. 500ng DNA was used; Random primers 
were annealed to the denatured DNA template and extended by Klenow 
fragment in the presence of biotin-14-dCTP to produce sensitive biotinylated-
DNA probes. The entire labelled genomic DNA with Control oligo B2, 20x 
Hybridization control, BSA, Herring sperm to produce the hybridization cocktail. 
The hybridization, Fluidic Setup, Wash and Stain, Scan protocols were performed 
as in Section 2.7.1. The labelled DNA was hybridized to Drosophila Genome 2.0 
Array. 
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2.7.4 Microarray data analysis 
2.7.4.1 Normalization method 
Three popular normalization methods applied to microarray are MAS5.0, RMA 
and GC-RMA. This can be referred to as low-level microarray analysis. 
MAS 5.0 method. Li and Wong (2001) were the first to propose model-based 
expression measures. They observed a very strong probe effect in that PM-MM 
values, the need for non-linear normalization, and the advantages of using 
multi-array summaries for detection and removal of outliers (Li and Hung Wong, 
2001; Li and Wong, 2001)(Li and Hung Wong, 2001; Li and Wong, 2001)(Li and 
Hung Wong, 2001; Li and Wong, 2001). 
 
RMA (Robust Multiarray Average) normalization method. It is linear and performs 
the background correction, normalization across arrays, probe level intensity 
calculation and probe set summarization. The RMA method is notable for 
employing quantile normalization that forces the distributions of probe-level 
measurements to be equal across multiple arrays before median-polish probe-set 
summaries are calculated. 
GC-RMA normalization method. A modification to RMA, GC-RMA performs the 
background correction by considering the GC contents. G/C in sequence leads to 
stronger hybridization because each G-C pair forms three hydrogen bonds 
whereas each A-T pair forms two. GC-RMA uses the mismatch data that RMA 
ignores to model the effects of GC-content on nonspecific binding. 
 
The diﬀerential gene expression using statistical hypothesis testing methods 
including analysis of variance (ANOVA) can be referred to as high-level 
microarray analysis. The fundamental idea behind analysis of variance (ANOVA) 
is that, given an appropriate experimental design, variability in the quantity 
being measured (gene expression) can be partitioned into various identifiable 
sources. The assumed sources of variability will include the experimental 
factors, as well as random noise (Pavlidis, 2003). 
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2.8 mRNA Sequencing (mRNA-seq) 
RNA sequencing experiments were carried out using the  Illumina protocol and 
the mRNA-seq Sample Prep kit part (Part No1004814) in line with manufacturer’s 
instructions. Samples were prepared using three replicates of tubules, three 
replicates of heads, three replicates of testes, three replicates of heads. 
Experiments were performed in two batches where the first batch was a pilot 
study including one sample of tubules, testes, whole flies and heads and the 
second batch included two replicates of tubules, testes, whole flies and heads. 
2.8.1 mRNA-seq samples library preparation 
Library preparation of mRNA-seq was carried out using 1-10ug total RNA (use 9ug 
for first batch, 2ug for second batch). The mRNA was purified and fragmented by 
using Sera-Mag oligo (dT) beads. The fragmented mRNA was precipitated by 
using 3M NaoAC, pH 5.2, Glycogen, 100% ETOH. Synthesis of first strand cDNA 
was performed using random primers and superscript II system. Second strand 
cDNA synthesis and purification of the dsDNA used the QIAquick PCR Purification 
Kit (Cat. No. 28104). Ends were repaired by using T4 DNA polymerase and klenow 
DNA polymerase. ‘A’ base to 3’ ends was added. Ligation of adapters (including 
the sequences of primers, sequences of flow cell and sequences for PCR 
amplification) was performed and the ligation product purified by using Qiagen 
PCR purification kit. The cDNA templates were purified on a gel to select the 
200bp (±25bp) range. PCR was used to enrich the purified cDNA templates. PCR 
was performed with two primers that anneal to the end of the adaptors. The 
library was validated on an Agilent Technologies 2100 Bioanalyzer using Agilent 
DNA-1000 chip (Figure 2-4). The size, purity and the concentration of the 
samples was decided. The final product should be at approximately 200bp. 
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Figure 2-4 RNA-seq library run by Agilent Bioanalyzer 2100  
The RNA-seq libraries indicated in Agilent Bioanalyzer 2100 around 220bp peak, and the 
concentration also can be determined by Agilent. Picture was run on Agilent DNA-1000 chip. The 
first and the third peak are marker peaks. The middle peak is the peak of RNA-seq library. 
 
2.8.2 Cluster generation on Illumina Cluster station 
The Single-read cluster generation kit v2 was used to generate the cluster on the 
flow cell. The flow cell contains adapters which are complementary to the 
adapters of the library samples. 1-4pM libraries samples hybridize to the lawn of 
primers on the flow cell; bound molecules are then extended by polymerases; 
double-stranded molecule is denatured; original template is washed away. 
Newly synthesized template is covalently attached to the flow cell surface. 
Single-strand flips over to form bridges. Hybridized primer is extended by 
polymerase. Bridges amplification cycle repeated till multiple bridges are 
formed. Double strand bridges are denatured; reverse strands are cleaved and 
washed away leaving a cluster with forward strand only. Free 3’-ends are 
blocked to prevent unwanted DNA priming. Sequencing primers are hybridized to 
adapters. 
2.8.3 Sequencing by synthesis on Illumina GAII  
After the cluster generation, the flow cell is then cleaned and put in the Illumina 
GAII Genome Analyser Reader. The Illumina sequencing kits are used in the 
sequencing process. 18 cycles and 36 cycle kits was for the first replicate of the 
four samples (a wholes flies, tubules, testes and heads). The total sequence 
length is 54bp. Two 36 cycles kits were used for the remaining samples which 
the sequence length is 72bp. The first base incorporation is performed on the 
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Illumina GAII Genome Analyzer, and then the quality was checked from the 
machine report. The report shows the clusters of the eight lanes of the flow cell. 
Validation was performed by checking Goodness of fit is greater than 0.9900 and 
the absolute value of the sensitivity is in the range 350-400. Sequencing 
commerces if the specification is met. To determine the sequence, four types of 
reversible terminator bases (RT-bases) are added and non-incorporated 
nucleotides are washed away. A camera takes images of the fluorescently 
labelled nucleotides, then the dye along with the terminal 3' blocker is 
chemically removed from the DNA, allowing the next cycle. The DNA chains are 
extended one nucleotide at a time and image acquisition can be performed at a 
delayed moment, allowing for very large arrays of DNA colonies to be captured 
by sequential images taken from a single camera. 
2.8.4 Integrated Data Analysis and Pipeline 
Integrated Data Analysis (IPA) and reporting was carried out by IPA instrument 
control software, which performs real-time reporting. IPA displays values for 
signal intensity, focus quality and cluster number. Images from each cycle of 
sequencing by synthesis are moved from the instrument control PC (IPA) into a 
run folder (pipeline) residing on a LINUX server. A series of programs in the 
pipeline perform image analysis, base calling, quality assessment and either 
sequence alignment and allele calling or tag alignment, binning and counting. 
Data analysis to the point of alignment (ChIP), allele identification 
(resequencing) or tag counts (gene expression and small RNA analysis) are 
provided with the system (see chapter 4 for details). 
2.8.5 Directional mRNA-Seq (Strand specific mRNA-seq) 
This experiment used the directional mRNA-seq Pre-release Library. Prep. 
Protocol v 1.0. The kit is from Illumina mRNA-seq library pre kit (RS-100-0801). 
library preparation started with 2ug of good quality total RNA (260/280 1.9-2.1, 
260/230 1.8-2.0, Agilent Bioanalyzer RIN is greater than 8). Firstly, polyA 
selection of mRNA from total RNA was performed by using Sera-mag oligo (dT) 
beads, then mRNA were fragmented by fragmentation buffer and purified by 
Qiagen RNeasy MinElute clean up kit (Cat. No. 28004). Secondly, end repair was 
performed of RNA with phosphatase & PNK treatment and purified by Qiagen 
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RNeasy MinElute clean up kit. Thirdly, the 3’ and 5’ adaptors was ligated (the 
diluted v1.5 sRNA 3’ Adaptor and the NEB supplied 10xT4 RNL2 truncated 
buffer), so that the adaptors have the desired sequences (including the 
sequences primers, sequences of flow cell and sequences for PCR amplification). 
Fourthly, RT-PCR amplification was performed, with the reverse transcription 
reaction using superscript II and SRA RT primer. The amplification PCR used GX1, 
GX2 primers that bind the sequences on the adapters. The purification of library 
uses Agencourt AMPure beads (Item No.A63880). Characterization of the library 
was determined by Agilent 2100 bioanalyzer. The peak size and range is 
indicative of the purity and quantity of the library. The normally size is between 
200-250bp.The library was now ready for amplifying on the cluster station 
(section 2.8.2) and sequencing on GAII (section 2.6.3).  
2.8.6 RNA-seq and Directional RNA-seq analysis methods 
A TopHat and Cufflinks analysis pipeline was the main analysis tool applied in 
this thesis. This is the only pipeline for RNA-seq analysis so far.  
RNA-seq results from Illumina technology (GAIIx) were trimmed by in-house 
script then aligned by Bowtie; the unaligned reads were split and realigned by 
TopHat. All the alignment files were merged together by Cuffmerge, and the 
merged files were compared with the reference annotation by Cuffcompare to 
find the novel unannotated features. The tubule-, testes- and head-specific 
novel expression genes were found by Cuffdiff combined with the Cuffcompare 
results. The results can be visualized using CummeRbund.  
2.9 Complementary DNA (cDNA) synthesis 
cDNAs for PCR and qPCR were synthesised using 500 - 1000 ng of total RNA. 
Recombinant reverse transcriptase (SuperScript® II; Invitrogen UK) was used to 
reverse transcribe the RNA in a total of 20 µl of reaction volume. Firstly, Oligo 
(dT)12-18mers (500 µg/ml), 500 – 1000 ng total RNA, 1 µl dNTP (10 mM each of 
dCTP, dGTP, dATP and dTTP) and nuclease free water (Ambion, Cat.No.9932) to 
make up to 12 µl total volume were assembled in a PCR tube. This mixture was 
heated to 65°C for 5 min and chilled for 2 min on ice (PCR machine). 
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The contents were collected by brief centrifugation and mixed with 4µl of 5x 
first-strand buffer, 2 µl of 0.1 M DTT and 1 µl of RNAaseOUT® (40 units/µl; 
Invitrogen). The reaction mixture was then incubated for 2 min at 42°C. After 
the incubation, 1 µl (200 units) of SuperScript® II RT was added and mixed by 
pipetting gently up and down. Then mixture was incubated at 42°C for further 
50 min in a Peltier thermal cycler (MJ Research). Finally, the reaction was 
terminated by heating at 70°C for 15 min and centrifuged briefly to collect the 
cDNA contents at the bottom. The cDNA was stored on ice for subsequently use 
or stored in -20°C. The cDNA was used for normal PCR, qPCR or Pfu-based PCR 
as described in the following sections. 
2.10 Oligonucleotide (primer) synthesis  
2.10.1 Standard PCR primer design 
Oligonucleotide primers were designed using MacVector 11.1.1 (MacVector, Inc. 
UK) or other web resources (Primer3, NCBI; OligoPerfect ™ designer, Invitrogen 
UK; SnapDragon - dsRNA Design). The sequences were sent to the MWG Biotech 
custom primer service for synthesis on a 0.01 µmol scale. Primer stock 
concentrations at 100 µM were obtained for each primer by resuspending the 
lyophilised powder in ddH2O and a working concentration of 6.6µM was prepared 
from the stocks. Primers were stored at -20 ºC until further use. 
2.10.2 Taqman qPCR primer design  
qPCR primers and probes were designed using Integrated DNA Technologies (IDT) 
PrimerQuest primer and probe design tool. Primers and probes sequences were 
sent to IDT customer primer service for synthesis. The qPCR Assay tubes (primers 
and probes) were centrifuged at 750g for 10 sec, then resuspended to 20X stock 
by adding 500 ul IDTE buffer (10mM Tris, 0.1mM EDTA, pH8.0). The final 1X 
concentration of 500 nM primers, 250 nM probe and 5 ng cDNA will be used in 
the assays. Taqman primers are designed on two near exons and probes are 
across the intron-exon boundary. TaqMan® Gene Expression Assays consist of a 
pair of unlabelled PCR primers and a TaqMan® probe with a fluorescent reporter 
or fluorophore such as 6-carboxyfluorescein FAM™ or VIC® dye label on the 5' 
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end, and minor groove binder (MGB) nonfluorescent quencher (NFQ) on the 3' 
end. 
2.11 Polymerase chain reaction (PCR) 
2.11.1 Standard PCR 
Standard PCR protocols were used for most amplifications of DNA. Amount of 
template DNA varied, however, 0.5 µg of genomic DNA or 0.1 µg of plasmid DNA 
were typically used per reaction. Standard PCR (Table 2-3) was performed using 
pre-aliquoted ready-to-use master mix in a Peltier Thermal Cycler (MJ 
Research). 
Table 2-3 Typical cyclic conditions for PCR. 
Step Number 
of 
cycles 
Temperature Duration Principle 
Initial 
denaturation 
1 95°C 5 - 10 min To denature secondary 
structures 
Denaturation 30 95°C 30s To denature the end products 
of each PCR cycle 
Annealing 55 - 62°C 30s Temperature is set depending 
on the melting temperature of 
the primers used; typically 
~5°C lower than Tm 
Extension 72°C 30s - 5 min Extension time is set at the 
rate of 20 base pairs/sec 
Final extension 1 72°C 10 min For the final extension of 
incomplete ssDNA 
 
This mix uses the Taq-Polymerase (modified) which has 5’ to 3’ polymerization 
and exonuclease activity but lacks 3’ to 5’ exonuclease (proofreading) activity. 
The master mix includes Thermoprime plus DNA polymerase (1.24 U) (Thermo 
UK), Tris-HCl (75 Mm; pH 8.8 at 25°C), (NH4)2 SO4 (20 Mm), MgCl2 (1.5 Mm), 
Tween 20 (0.01%), dNTPs (0.2 mM each). PCR reactions were normally performed 
in a total of 25 µl (1µl cDNA, 1µl forward primer, 1µl reverse primer and 23µl 
master mix) volume. The cycling parameters used are presented in the table 
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below. PCR products were separated by agarose gel electrophoresis described in 
section 2.13. 
2.11.2 Pfu-based Herculase II Fusion polymerase PCR 
Pfu-based Herculase II fusion polymerase (Agilent UK) was used for amplifying 
longer products. It has a high affinity double-stranded DNA binding domain that 
enhances the processivity and increases the yield. The PCR products were used 
for pENTR clone, in situ hybridization. The protocol used is presented in the 
Table 2-4 below. 
Table 2-4 Pfu-based Herculase II fusion polymerase PCR reaction mix and protocol. 
Parameter Targets <1 kb Targets 1 - 10 kb cDNA Targets 
Input template 
DNA 
100 - 300 ng 
genomic DNA or 1 
- 30 ng vector DNA 
100 - 400 ng 
genomic DNA or 1 - 
30 ng vector DNA 
1 - 2 µl cDNA from RT-PCR 
reaction 
Herculase II 
polymerase 
0.5 µl 1 µl 1 µl 
DMSO 0 - 8% final 
concentration 
0 - 8% final 
concentration 
0 - 8% final concentration 
Primers (each) 0.25 µm 0.25 µm 0.25 µm 
dNTPs 250 µm each dNTP 250 µm each dNTP 400 µm each dNTP 
Extension time 30s 30s per kb 60s per kb 
Denaturing 
temperature 
95°C 95°C 95°C 
Extension 
temperature 
72°C 72°C 68°C 
 
2.12 Quantitative reverse-transcriptase PCR (qPCR) 
qPCR was performed using TaqmanGene Expression Master Mix (Part No. 
4374657) and the primers and probes mixture from IDT (see section 2.10 qPCR 
primer designs). 
qPCR was performed using cDNA as the starting material. The cDNA was diluted 
5ng/ul assuming 1ng RNA reverse transcript to 1 ng cDNA. The mixture for qPCR 
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includes 10 µl Taqman master mix, 1 µl 20x Taqman probe, 8ul water and 1 µl 
cDNA (5 ng/µl) making the total volume 20 µl. The negative controls (without 
Superscript II) and/or a blank (without cDNA) were maintained to monitor and 
subtract the genomic DNA contamination and background fluorescence 
respectively. The standard curve was generated using target gene primers and 
the reference control primers by adding a serial dilution of fly cDNA. PCR 
conditions commonly used included denaturation of the primers at 50°C for 
2mins, 95 ºC 10mins, followed by 95 ºC for 15mins and 60 ºC for 1mins for total 
number of PCR cycles used of 40. The amplification curve shows the amplified 
PCR product, the Taqman probe has fluorophore on 5’-end and a quencher on 3’-
end. When the forward and reverse primers are extended by Taqman DNA 
polymerase and degraded of the probe releasing the fluorophore, then 
fluorescence is detected. 
The expression data were further analysed. The alpha-Tubulin84B used as a 
reference controls (being house-keeping genes) to normalize the data. The fold 
change data was obtained using relative standard analysis by calculating the 
ratio of the two compared samples’ CT values using the 2-∆∆CT method (van 
Iterson et al., 2009). The standard error means (SEM) and P-values for statistical 
significance were calculated using GraphPad Prism statistics software (GraphPad 
version 5 Software, USA). 
2.13 Agarose gel electrophoresis 
PCR products or DNA were run on 1% agarose gel to assess quality and 
specificity. Gel was casted using 0.5x TBE [90 mM Tris, 90 mM boric acid (pH 
8.3), 2 mM EDTA], containing 0.1 µg/ml EtBr as described in (Joseph Sambrook, 
2001). 6x loading dye [0.25% (w/v) bromophenol blue, 0.25% (w/v) xylene 
cyanol, 30% (v/v) glycerol in water] was added to samples, using 0.5% TBE as the 
electrophoresis buffer and a 1 kb ladder (Invitrogen) to a final concentration of 
1x 5 µl (500 ng) of ladder and 10-20 µl samples were loaded into the wells. 
Typically these were run at 100 V; the dye front was followed for electrophoresis 
termination and the DNA was visualised using high performance ultraviolet 
transilluminator (UVP UK) and compared against the ladder band size. Where 
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needed, PCR products were extracted from gel as described in section 2.14, and 
quantified using NanoDrop as described in section 2.6.3. 
2.14 PCR/Gel purification 
PCR products and the products excised from the gels were purified using Qiagen 
PCR/Gel purification kit (Part No. 28704) according to manufacturer’s 
guidelines. DNA was eluted in 20-30 µl of nuclease-free water. Purified PCR 
products were quantified on NanoDrop and are suitable for molecular cloning. 
2.15 Molecular cloning 
2.15.1 Plasmid vectors 
Table 2-5 Plasmids used in this project 
pCR®2.1-
TOPO® 
For cloning poly-adenylated PCR products according to the TOPO TA cloning kit 
protocol (Invitrogen). 
pTW 
Gateway cloning destination vector for recombining entry clones (in pENTR) to 
generate final clones for germline transformation of cDNA of interest under 
the control of the upstream UAS in the UAS/GAL4 binary induction of 
transgenes in vivo.  
pTWV 
Gateway cloning destination vector for recombining entry clones (in pENTR) to 
generate final clones for germline transformation of cDNA of interest under 
the control of the upstream UAS. It also incorporates a C-terminal yellow 
fluorescent protein (YFP) sequence for fluorescent tagging. 
pRISE 
Gateway cloning destination vector for recombining entry clones (in pENTR) to 
generate final clones for germline transformation of dsRNA of interest under 
the control of the upstream UAS (Kondo et al., 2006).  
 
2.15.2 Normal cloning procedure 
PCR products were directly cloned using the Invitrogen TOPO® cloning kit into 
appropriate TOPO® vectors according to the manufacturer’s instructions and 
transformed into E.coli TOP10 cells or DH5α (see 2.15.4). 100 µl of the 
transformed cells was then spread onto L-agar plates containing 100 µg/ml 
ampicillin or the antibiotic appropriate to the resistant marker of the plasmid, 
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and incubated overnight at 37°C. TOPO TA cloning kit required the PCR products 
to contain ‘A’ overhangs. 
The transformants were removed as single colonies and grown overnight (with 
shaking) at 37°C in 5 ml or 100 ml L-broth (Appendix IV) using appropriate 
antibiotic for selecting the clones. 
2.15.3 Gateway® cloning 
The Gateway® cloning system (Invitrogen), which uses a homologous 
recombination technique, was used to clone the cDNA or dsRNA amplicons for 
germline transformation of Drosophila embryos for GAL4/UAS system induction 
of transgene expression in vivo in the flies. The system uses entry (pENTR) and 
destination vectors (P-element containing germline transformation vectors).  
2.15.3.1 Primer design and PCR amplification 
For Gateway® entry cloning, a forward primer was designed to contain a CACC 
sequence on 5’ end for directional cloning into the entry vector: pENTR (Part No. 
45-0218) for RNAi vector pRISE. However, the sequence for overexpression 
destination vector PTW, the primers design sequence for entry cloning was used 
the longest ORF sequence with taa in the end but for PTWV which had YFP in the 
end, the primers design sequence was used without taa. PCR amplifications were 
performed using Herculase® fusion polymerase according to the protocol in 
section 2.11.2 and the PCR product was purified by QIAquick PCR purification kit 
(Cat. No. 28104). 
2.15.3.2 Entry clones 
Entry clones were made using the pENTR vector according to the manufacturer’s 
instructions (Invitrogen). pENTR/D-TOPO® vectors take advantage of fast, 
efficient Directional TOPO® cloning that delivers the insert in the correct 
orientation for expression. These vectors contain the necessary attL sequences 
for recombination into any Destination vector. 
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Figure 2-5 pENTR™ vector for Directional TOPO® cloning  
This vector is used in this project and direct access to the multitude of Gateway® expression 
vectors. The attL sequence is important to recombination into destination vector. 
 
2.15.3.3 Destination vectors 
Destination vectors used include pRISE for RNAi, pTW for normal overexpressor 
and pTWV for tagged overexpressor constructs. 
2.15.3.4 Gateway® recombination using LR Clonase 
Gateway® recombination of entry and destination clones was performed using 
LR clonase enzyme mix according to the manufacturer’s protocol (Invitrogen). 
Essentially, the enzyme catalyses the in vitro homologous recombination 
between an entry clone (pENTR-attL-GENE OF INTEREST-attL) and a destination 
vector (containing attR sites) to generate an expression clone of interest.  
 
Figure 2-6 Generate an expression clone of interest.  
LR Clonase enzymes that catalyze the in vitro recombination between an Entry clone (containing a 
gene of interest flanked by attL sites) and a Destination vector (containing attR sites) to generate 
expression clone. 
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2.15.4 Transformation of E. Coli 
Competent E. Coli cells were transformed with the construct of interest 
according to the manufacturer’s protocol. Briefly, cells were thawed on ice and 
the plasmid vector, PCR products, salt solution were mixed and incubated for 5 
min on ice. The plasmid mixture was then transferred into the cells. The positive 
clones were identified using the antibiotic resistance markers of the clones 
generated. 
Table 2-6 Competent bacteria strains used in this project 
Strain Genotype Use 
TOP10 competent 
cells (Invitrogen) 
(F- mcrA, D(mrr-hsdRMS-mcrBC), f80lacZ 
DM15, DlacX74, recA1, deoR, araD139, 
D(ara-leu)7697,galU, galK, rpsL, (StrR), 
endA1,nupG). 
For plasmid transformation 
and propagation of TOPO- 
related clones 
DH5α subcloning 
efficiency competent 
cells (Invitrogen) 
(F- f80dlacZ DM15, D (lacZYA-argF), U169, 
deoR, recA1, endA1, hsdR17 (rK-, mK+), 
phoA, supE44, l-, thi-1, gyrA96, relA1). 
For normal plasmid 
transformation and 
propagation 
 
2.15.5 Purification of plasmid DNA 
Purification of plasmid DNA was performed using Qiagen mini (Cat. No.12125) or 
maxi kits (Cat. No.12165) (Qiagen UK). The overnight grown cultures were spun 
down to pellet the cells. The cells were lysed in the lysis buffer and DNA was 
either column eluted in 30 µl of water (for minipreps) or resuspended in 500 µl 
of water (for maxipreps). 
2.15.6 Validation of cloning products 
The cloning products obtained using different cloning procedures were validated 
for sequence, direction and length using PCR, restriction enzyme digestion 
and/or sequencing. 
2.15.6.1 PCR 
For PCR validation, the clones were amplified using the combination of primers 
with one from the transgene and the other from the vector. This allows 
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confirmation at whether the transgene is inserted in the right direction and has 
the full length transgene. However, this approach was only employed for 
transgenes less than 2000 bp as the increase in length causes the cycling 
conditions to vary greatly. 
2.15.6.2 Restriction enzyme digestion 
Restriction enzyme digestion was employed to confirm whether the transgenes 
were inserted in the right direction and if they were right size. 
2.15.6.3 Sequencing 
Before they were sent off to be microinjected, DNA sequencing was performed 
on the constructs to check for any possible errors in the proof reading of the 
polymerase. 
2.15.7 Normal cDNA constructs  
pTW destination vector was used to recombine the pENTR entry clones for the 
normal overexpression constructs listed in Table 2-5. 
2.15.8 YFP fusion cDNA constructs  
pTWV destination vector with a C-terminal YFP tag was used to recombine the 
pENTR entry clones for the tagged constructs listed in Table 2-5. 
2.15.9 Double-stranded RNA constructs  
pRISE vector was used for making double-stranded RNA constructs for transgenic 
RNAi flies for GAL4/UAS system induction of RNAi in vivo. Gateway 
recombination system was used for RNAi constructs where pRISE (Kondo et al., 
2006)  is used as donor and pENTR D TOPO® as an entry vector. Three RNAi 
constructs were made for the novel gene 3L (23777335-23780626), 3L-1b, 3L-2b, 
3L-4a. These were sent for Drosophila embryo germ line transformation to 
BestGene Company (USA). 
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2.15.10 Dual promoter constructs for in situ hybridization 
RNA probe constructs for in situ hybridization were made using the PCR II TOPO 
vector. This vector has nucleotide ‘T’ overhangs and dual promoters either side 
of the multiple cloning sites. Overhangs of nucleotide ‘A’ were added to the PCR 
products obtained from pfu PCR that were to be used for in situ hybridization. 
2.16 Drosophila S2 cell culture 
2.16.1 Passaging 
Drosophila S2 cells (Invitrogen) were maintained in complete Schneider’s 
medium or CSM [Schneider’s medium supplemented with 10 % fetal calf serum 
(FCS)] at 28ºC.  15 ml of cells were kept in T75 flasks.  Cells were passaged when 
their density reached 107 cells/ml. The weakly adherent S2 cells were 
resuspended gently by pipetting and then diluted by adding 6 ml of cells into 9 
ml of CSM in a fresh flask. 
2.16.2 Transient transfection (Insect GeneJuice Protocol) 
Transient transfection was carried out in tissue culture six-well plates. The 
Insect GeneJuice Transfection Reagent (Part No. 71259) and protocol were used 
for the transfection (Novagen). Exponentially growing cells were spun and 
resuspended in Schneider’s only. The cells were counted under Microscope. 1 
million cell volumes were taken and made up to 500 µl. The cells were allowed 
in the Shneider’s plate for 1 hour in the incubator. Plasmid DNA was prepared 
using a maxi-prep kit (Qiagen) and eluted in TE buffer. For each transfection, 2-
3 µg of Plasmid DNA was added with 80 µl Schneider.12-15 µl of insect gene juice 
was added in 80ul Scheider medium. The diluted DNA was slowly added dropwise 
to the diluted Insect GeneJuice Transfection Reagent, then mix immediately by 
gently vortexing and incubated at room temperature for 15 mins. 640ul 
Schneider’s medium was added to Insect juice/DNA transfection mixture. The 
cells were incubated for 4 hours at 280C. After 4 hours the transfection medium 
was removed and replaced with 2.5ml CSM. 
If a plasmid encoding a metal inducible promoter was used, 20 µl CuSO4 was 
added to the cells, mixed by shaking to induce expression and expression was 
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allowed to proceed for 48-72 hours at 280C. Cells were then harvested by 
centrifugation at 1,500 g for 1 min at RT, washed once in PBS, pelleted and 
either frozen at -70ºC before use or used immediately. 
2.17 Protein analysis 
2.17.1 Extraction  
Table 2-7 Protein lysis buffer (RIPA) components 
Component Volume Manufacturer Catalog no. 
100mM Tris-Cl (pH 7.4), 300mM 
NaCl 
5 ml   
10% Triton®X100 1 ml Sigma T8787 
10% Na deoxycholate 1 ml Sigma D6750 
200mM PMSF (in isopropranol) 50 ul Sigma P7626 
10% SDS 100 ul Sigma Aldrich L45090 
Pierce® protease and 
phosphatase inhibitor 
1 
tablet 
Thermo NB 167568 
0.01 M EDTA (pH 7.4) 100 ul Sigma Aldrich 27285 
H2O 2.75 ml   
 
Total protein was extracted from 15 whole flies. Flies were homogenized in 100 
ul RIPA lysis buffer (see Table 2-7) using a hand-held pestle and then an 
ultrasonic cell disrupter, until the sample appeared homogeneous. The 
homogeneous protein lysate was kept on ice for 10 minutes and then clarified by 
centrifugation at 13000rpm for 5 minutes at room temperature. The supernatant 
was transferred into a fresh eppendorf tube and pellet was discarded. 
2.17.2 Protein quantification 
The Bradford assay kit (BIO-RAD, 500-0006) was used for total protein 
quantification. Assay was carried out in a 96-well microtiter plate. Six BSA 
standards of 0-5 µg in water and 5 µl of protein supernatant were set up in 
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triplicate in a final volume of 50 µl respectively. 200 µl of diluted Bradford dye 
reagent with ratio of 1:5 in distilled water was added to each well and mixed by 
pipetting. The plate was then incubated at room temperature for 5 minutes. The 
absorbance at 590 nm was read using a plate reader, and each standard 
absorbance was plotted against the known concentration to interpolate the 
unknown protein sample absorbance to calculate their quantities. 
2.17.3 SDS-PAGE separation 
Protein separation was performed using Novex NuPAGE™ electrophoresis system. 
Protein samples (20 ug) were prepared by adding 4X SDS-PAGE loading buffer to 
final volume of 28 ul. Samples were briefly vortexed and then spun down. 
Samples and protein marker (SeeBlue® Plus2 prestained standard, LC5925, and 
Life technology) were heated at 95oC for 5 minutes. Protein marker and samples 
were then loaded on 10 wells 4-12 % Bis-Tris NuPAGE® Gel (Invitrogen, NP0321). 
The gels were then run in 1x NuPAGE™ MOPS SDS running buffer (diluted from 
NuPAGE™ MOPS SDS buffer (20x), NP0001, Invitrogen) at 200 V constant for 55 
minutes (Appendix V). 
2.17.4 Western blotting 
Proteins separated on NuPAGE® Gel were then transferred onto Hyband transfer 
membrane (catalog no. RPN203B, Amersham) using Xcell II blot module at 30 V 
constant for one hour. After transfer, Hyband membrane was blocked in blocking 
solution (1 g non-fat dry milk in 20 ml 0.1% PBST) at room temperature for one 
hour. The blocked membrane was washed three times in 0.1% PBST buffer with 
10 minutes for each time. Primary antibody (anti-GFP, mouse monoclonal, 
ZYMED) was diluted in blocking solution with ratio of 1:1000. Membrane was 
then incubated in primary antibody at 4oC overnight. Membrane were washed in 
0.1% PBST three times and then incubated in secondary antibody (goat anti 
mouse IgG-HRP, SC-2031, Santa Cruz Biotechnology) diluted in blocking solution 
with ratio of 1:5000 at room temperature for one hour. The blot was washed 
well for at least three times before detection. Blot was detected by incubation 
in detection solution (ImmobilonTM Western, Catalogue no. WBKLS0100, 
Millipore) for one minute and then developed in XOMAT film processor with 
varying exposure time (15 seconds to 2 minutes). 
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Table 2-8 Antibodies used for western blotting and immunocytochemistry. 
Antibody and Source Dilution and Use 
Anti-GFP (mouse monoclonal, ZYMED) 1:1000 (Western and ICC)  
Fluorescent Goat anti-mouse- IgG-FITC  (goat  
polyclonal, Molecular Probes) 
1:500 (ICC) 
goat anti mouse IgG-HRP, SC-2031, Santa Cruz 
Biotechnology 
1:5000 (Western) 
2.18 Immunocytochemistry (ICC) 
Immunocytochemical staining of cells and tissues as described in the following 
sections was performed for in vitro and in vivo localisation studies. 
2.18.1 ICC of S2 cells 
S2 cells were resuspended and collected into 15 ml falcon tubes from the tissue 
culture flasks. These were spun at 3000 g in a free rotating bench top 
centrifuge, and supernatant was removed and cells were washed with PBS two 
times. About 100 µl of cells at a density of 6x106 cells/ml were plated and left 
for 15 min to allow the cells to settle and adhere. Excess solution was removed 
and the samples washed three times with PBS (Appendix II). Samples were then 
fixed by the addition of 4 % (w/v) paraformaldehyde in PBS for 15 min at RT. 
Samples were then washed 3 times with PBS, and blocked in PBS, 0.2 % (w/v) 
BSA, 0.1 % Triton X-100 for 10 min at RT. 
Samples were then incubated overnight at RT in a humidified box with primary 
antibody diluted to the desired concentration in PBS/BSA/Triton X-100. Samples 
were then washed 3 times with PBS and incubated for 1 h at RT with the 
appropriate secondary antibody, diluted to the desired concentration in 
PBS/BSA/Triton X-100. Samples were then washed 3 times in PBS and, if 
required, DAPI stained as described in section 2.18.2. The coverslips to which 
samples were attached were then mounted on slides using VectaShield mounting 
medium (Vector Laboratories UK) and sealed with glycerol-gelatin. Samples were 
imaged by a confocal microscope system, as described in section 2.20.2. 
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2.18.2 ICC of intact Drosophila tissues 
Intact tissues were dissected carefully in Schneider’s medium (Appendix III) and 
transferred into a 1.5 ml tube containing PBS (pH 7.4).  Then the tissues were 
washed with PBS 2 more times and the PBS was carefully removed. Tissues were 
then fixed in 4 % (w/v) paraformaldehyde in PBS at RT for 10-30 min. The tissues 
were washed three times in PBS and permeabilised using PBS, 0.3 % (v/v) Triton 
X-100 (PBT) for 30 min. This was followed by incubation with PBT with 10 % (v/v) 
goat serum (Sigma) (PBT-GS) for 3 h at RT. 
Primary antibody, diluted to the desired concentration in PBT-GS, was then 
applied and the tubes incubated in a humidified box overnight at 4ºC. 
The following day the tubules were washed in PBT 5 x 30 min and incubated in  
PBT-GS (Sigma) for 3-4 h. Secondary antibody, diluted to the desired 
concentration in PBT-GS, was then applied and the tubes were incubated in a 
dark humidified box overnight at 4ºC. 
The tissues were then washed with PBT 3 x 1 h and in PBS 3 x 5 min. Then the 
nuclei were stained using 500 ng/ml DAPI for 2 min in PBS, diluted from a 10 
mg/ml (in H2O) stock solution. Tissues were washed three times with PBS before 
mounting. They were mounted in Vectashield mounting medium on confocal 
microscopy slides (BDH UK) or plates (Matek corporation USA). For slides, a 
coverslip was used and sealed with glycerol/gelatin (Sigma UK. The samples 
were viewed using a fluorescent microscope and a confocal microscopy system 
(see section 2.20.1, 2.20.2). 
2.19 mRNA in situ hybridization 
The in situ protocol was adapted from those described by (Allan et al., 2005) 
and the Berkeley Drosophila Genome Project (BDGP) 96-well in situ protocol 
(http://www.fruitfly.org/about/methods/RNAinsitu.html). The primers used for 
pfu-PCR in the above-described method were used to generate in situ probes. 
Two pairs of primers were used for generating two probes for the same gene. 
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2.19.1 Cloning of template DNA  
The sequences of all PCR products were analysed using National Centre for 
Biotechnology Information (NCBI) and BDGP databases with Basic Local 
Alignment Search Tool (BLAST) to check the cross-hybridization potential of the 
sequences were found no significant matches with other Drosophila 
melanogaster sequences in the database. 
PCR products were added ‘A’ overhangs, then cloned into the dual promoter PCR 
II TOPO vector (Invitrogen UK), and the orientation of the insert was checked 
using colony PCR with the combination of either M13 forward or reverse with a 
forward gene specific primer. 
2.19.2 Labelling and amplifying of RNA with digoxigenin 
Two different restriction enzymes were used to generate fragments with two 
different promoters (Sp6, T7) and the size checked by the gel (chapter 2. 2.13).  
Two types of DIG-labelled RNA in situ probes (sense and anti-sense) were 
generated by in vitro transcription by using DIG RNA labelling kit (DIG RNA 
labelling Kit SP6/T7 PN 11175025910 Roche). The sense probes were used as 
negative controls. The sense and anti-sense RNA were cleaned up by RNeasy 
column (Qiagen UK). 
2.19.3 In situ hybridization 
Adult tubules were dissected in Schneider’s medium (Invitrogen UK) and placed 
into 1.5ml tubes with 100 µl of Schneider’s medium. Samples also included no 
probe control and no antibody control.  Schneider’s medium was removed by the 
20ul pipette. Postfix solution [10 mM potassium phosphate buffer (pH 7.0) 
containing 140 mM NaCl, 0.1% (v/v) Tween-20, and 5% (v/v) formaldehyde] was 
added for 20 min, followed by three washes with PBT [10 mM potassium 
phosphate buffer (pH 7.0) containing 140 mM NaCl and 0.1% (v/v) Tween-20]. 
The tissues were incubated with proteinase K in PBT (4 µg/ml) for 3 min at RT. 
The reaction was stopped with two washes of PBT containing 2 mg/ml glycine. 
The samples were washed twice with PBT before incubation with postfix for a 
further 20 min at RT. 
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The tissues were washed with five changes of PBT, followed by one wash with 
50% hybridization buffer [5x SSC containing 50% (v/v) formamide, 10 mM KH2PO4, 
140 mM NaCl, 1 mg/ml glycogen, 0.2 mg/ml sheared salmon sperm DNA, and 
0.1% Tween-20 (pH 7.0)] plus 50% (v/v) PBT. The samples were washed once 
with hybridization buffer before a 1 h pre-incubation with hybridization buffer at 
55°C and subsequently incubated for 43 h at 55°C with 100 µl of hybridization 
buffer containing 200-300 ng of either the sense or anti-sense riboprobe, taking 
care to seal the tubes with parafilm to prevent evaporation. 
After hybridization, the samples were washed four times with hybridization 
buffer at 55°C, followed by a final wash overnight with hybridization buffer at 
55°C with rotating. Samples were washed once with 50% (v/v) hybridization 
buffer and 50% (v/v) PBT, followed by four washes with PBT, and then incubated 
overnight at RT with 100 µl of pre-absorbed alkaline phosphatase-conjugated 
anti-digoxigenin Fab fragment (Roche UK) diluted 1:2,000 with PBT with shaking. 
The unbound antibody was removed with extensive washing in PBT, at least 10 
times for 5-10 min. The samples were incubated with DIG detection buffer (100 
mM Tris-HCl, pH 9.5, 100 mM NaCl, 50 mM MgCl2) for 5 min and then repeated 
again. 
The colour reaction was initiated by the addition of DIG detection buffer 5-
bromo-4-chloro-3-indolyl phosphate (BCIP) and nitro blue tetrazolium (NBT) 
(BCIP/NBT Liquid Substrate System B1911-100ml, SIGMA) and left for 10 min to 2 
h at RT. Development was stopped with extensive washing with PBT containing 
50 mM EDTA, and the tissues were removed from the wells and mounted on 
slides with 70% glycerol and viewed with the Axiocam imaging system (Carl Zeiss 
UK). 
2.20 Imaging 
2.20.1 AxioVision fluorescent microscope 
Fluorescent imaging was carried out using AxioVision fluorescent microscope 
(Carl Zeiss imaging AxioVision 40 V4.6.3.0) for imaging the tissue or selecting the 
slide for further confocal microscopy. The defaut DAPI and GFP channel defined 
for AxioVision multi-channel microscope settings were chosen for visualisation of 
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samples as appropriate. The microscope was adjusted to the required settings 
for DAPI or GFP, then the images were taken and the merged images were 
created. Control images were taken by using the same settings. 
2.20.2 Confocal Microscope 
Fluorescent imaging was carried out using the confocal microscope system 
LSM510 Meta from Zeiss Technologies UK. A HeNe1 543nm laser and a 561-625 
band pass filter were used for imaging the Alexafluor 568 secondary antibody. 
An Argon 488 laser and a 505-530 band pass filter were used for imaging the FITC 
antibody or fluorescent proteins. For visualization of DAPI, a pseudo-DAPI 
technique was used. The DAPI was excited using the standard UV source 
(mercury lamp) and the image captured using the confocal photomultipliers. The 
DAPI image was then merged with the other channels retrospectively using the 
proprietary LSM Meta software. A 40x objective was used in most cases. 
2.21 Fluid secretion assay 
The miniaturised version of classical Ramsay assay for tubule fluid secretion was 
used for measuring rates of secretion (Dow et al., 1994) as illustrated in Figure 
2-7. The pairs of tubules were dissected along with the ureter and transferred to 
a 9 µl drop of Drosophila saline: Schneider’s (50:50) under 25X Microscope. One 
end was wrapped around a metal pin under white, heavy mineral oil (Sigma UK) 
whilst the other tubule was immersed in 9 µl drop containing trace amounts of 
the red dye, Amaranth, for easy viewing of the emerging bubbles. Care was 
taken to ensure that the ureter remained in the oil but out of the 9 µl drop. 
Drops emerging from the ureter were removed with a fine glass rod; the 
diameter of each drop of the secreted fluid was measured at 10 minutes 
intervals under a microscope graticule (50x). From this diameter the volume of 
secreted fluid in nl/min was calculated using equation: volume= (4/3) πr3 
(Figure 2-7). 
Drugs including antagonists and agonists were added to the Schneider: saline as 
a 10x stock in 1 µl when required. The drugs used in these experiments were the 
neuropeptides capability-1 (capa-1) and leucokinin (also called drosokinin) (both 
custom synthesised by Research Genetics Inc.). All compounds were initially 
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dissolved in an appropriate solvent then diluted to the 10x stock in 1:1 (v/v) 
Schneider: saline. 
Results were analysed using a Microsoft Excel sheet, where the secretion in 
nl/min was calculated from the volume of fluid secreted in 10 min. All data was 
reported as mean ± SEM and viewed using GraphPad Prism software v5 
(GraphPad Software Inc) USA. 
 
Figure 2-7 Fluid secretion assay schema (Dow et al., 1994). 
Intact tubules are dissected along with their common ureter from the flies in Schneider’s medium 
using fine forceps (left panel). Tubule ureter is cut just before its joining with gut (middle panel). 
One tubule is wrapped around the needle and other tubule is in the Schneider: saline mix; all are 
immersed in the mineral oil (right panel; above). Finally tubule secreted droplets emanating from 
the ureter are measured using the microscope graticule and converted in to nl/min (right panel; 
below) 
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3. Three-way analysis of Drosophila expression 
microarray, Drosophila tiling microarray and 
RNA-seq 
Summary  
In this chapter, three technologies, Drosophila RNA-seq, Drosophila tiling 
microarray and Drosophila expression microarrays were compared in order to 
find out the correlation between them, and the advantages and drawbacks of 
each other. The results suggested that the three technologies were correlated 
well in both absolute gene expression and relative gene expression level, both 
from the technical and biological view points. The correlation between RNA-seq 
and expression microarray was better than that with tiling microarray when 
detecting gene expression. However, tiling microarray was able to discern novel 
genes and verify RNA-seq results. RNA-seq has a number of merits over both 
tiling microarrays and expression microarrays, such as large dynamic range, 
ability to detect low expression genes, and the ability to identify novel genes 
and novel alternative splicing isoforms. For these reasons, RNA-seq was chosen 
in this thesis as a tool to discover novel genes in Drosophila tubules. 
3.1 Introduction 
There are many gene expression profiling and gene discovery methods in the 
history. Northern blots, reverse-transcription PCR (RT-PCR) and the automated 
Sanger-sequence-based technologies including Expression Sequencing Tag (EST) 
(Adams et al., 1991) and Serial Analysis of Gene Expression (SAGE and 
SuperSAGE) (Velculescu et al., 1995) etc. In the past decade, there has been  
tremendous progress in the development of methods to measure gene expression 
and search for novel genes at the whole transcriptome level. Among these 
methods, RNA-seq and DNA microarrays stand out as the two most widely used 
methods for genome-wide gene expression quantification and novel gene and 
splicing discovery (Gros, 2003; Wang et al., 2009). RNA-seq and DNA expression 
microarrays are two popular methods to measure gene expression, whilst RNA-
seq and DNA tiling microarrays are two popular methods for gene discovery at 
the genome-wide scale. How are these technologies correlated to each other?  
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There were a number of publications of two-way comparison, either between 
RNA-seq and expression microarrays or between RNA-seq and tiling microarrays. 
There is no publication describing a three-way comparison of RNA-seq, tiling 
microarrays and expression microarrays so far. Such a comparison will provide a 
better understanding of how these technologies work. 
3.2  Background 
3.2.1 Description of technologies 
3.2.1.1 Drosophila RNA-seq 
RNA-seq is a recently developed approach based on the high-throughput deep 
sequencing technologies also called ‘next-generation sequencing’. 
Transcriptome analysis aims to measure all transcription within the genome 
including coding RNA (mainly mRNA) and noncoding RNA information. However 
the majority of RNA molecules are tRNAs and rRNAs, which are not transcribed 
but serve as the primary site of biological protein synthesis (translation). mRNA 
accounts for only 1–5% of whole RNA population, and can be distinguished from 
tRNA and rRNA by the presence of a poly(A) tail. In order to obtain accurate 
mRNA information, RNA-seq either has to select positively for the poly(A) 
information, or reduce the ribosome information. So RNA-seq methods can be 
separated into the poly(A) selection method and the ribosome reduction 
method. These two categories of method address different aims. The first one 
aims to measure the transcriptome of coding genes and to discover novel coding 
and poly(A) based noncoding genes by using oligo (dT) captured methods in order 
to pull poly(A) RNA out of the whole RNA population. The second one aims to 
measure all transcripts within the genome as well as discovering all novel 
transcripts at the genome level by reducing the ribosome RNA information and 
obtaining all the transcription information including coding RNA and noncoding 
RNA. The RNA-seq work flow is detailed in section 1.1.7.2 and illustrated in 
Figure 3-1. 
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Figure 3-1 RNA-seq work flow.  
Picture is taken from seq Wright Genomic Services website http://www.seqwright.com. A 
representation showing the essential protocol by which the two types RNA-seq work. Total RNA 
started with Poly(A) selection by using oligo(dT) captured method or rRNA depletion with ribosome 
reduction method. 
There are several different sequencing platforms on the market that support 
RNA-seq such as the Illumina Genome analyser, Roche 454 Genome Sequencer, 
Applied Biosystem SOliD, and Life Technologies IonTorrent. These technologies 
have their own relative advantages and disadvantages (Zhou et al., 2010). 
3.2.1.2 Drosophila tiling microarrays  
Tiling microarrays are a subtype of microarray chip. Like traditional microarrays, 
they function by hybridizing labelled DNA to probes fixed onto a solid surface. 
Tiling microarrays differ from traditional microarrays in the nature of the 
probes. Instead of probing for sequences of known or predicted genes that may 
be dispersed throughout the genome, tiling microarrays probe intensively for 
sequences that are known to exist in a contiguous region of the genome. There 
are two types of tiling microarrays design, one using partially overlapping probes 
and the other one non-overlapping probes (Figure 3-2). This is useful for 
characterizing regions of the genome that are sequenced but with local 
functions that are largely unknown. 
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Figure 3-2 Tiling microarrays probe design.  
There are two types of tiling microarrays design, one is the partially overlap probes, the other one 
is the non-overlapping probes. Picture taken from 
http://www.absoluteastronomy.com/topics/Tiling_array. 
The GeneChip Drosophila Tiling 2.0R Array (Tiling 2) was designed using the 
Drosophila sequence release from the Berkeley Drosophila Genome Project 
(BDGP), March 2006 (details also in 1.1.6.1). The array includes both 
euchromatic and heterochromatic sequences. Average probe spacing on the 
array is 39 base pairs. The Drosophila Tiling 2.0 Array is designed to detect 
sequences in the reverse (-) orientation. It contains a 25bp mismatch (MM) 
probes for each perfect match (PM) probes, with a single base mismatch is 
located in the middle at 13th base. 
There has been a number of publications report the use of Drosophila Tiling 2.0R 
Arrays for gene expression detection (Cherbas et al., 2011), novel transcript 
region detection (Graveley et al., 2011; Manak et al., 2006), and transcription 
binding site detection (Abruzzi et al., 2011; Smith et al., 2009). These 
publications confirmed that Drosophila tiling microarrays are still a useful tool 
for Drosophila research. 
3.2.1.3 Drosophila expression microarrays 
Microarrays are based on the principle of mRNA hybridization to a 
complementary probe as used in Southern blotting, which enables the detection 
of a specific transcript. The single colour type of microarray is represented by 
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Affymetrix GeneChip (Figure 3-3). The dual colour type of microarray is 
represented by Agilent technologies. 
 
Figure 3-3 The essential protocol showing how expression of an organism can be analysed 
using DNA microarrays.  
Picture was taken from http: //www. affymetrix.com 
Drosophila Genome 2.0 Array (details also in 1.1.6.1) is a three-prime expression 
microarray which has been used for Drosophila Genome profiling for nearly a 
decade, delivering results to the satisfaction of the Drosophila community. 
There are a number of publications available using these Genechips (Wang et 
al., 2004). The FlyAtlas website was set up using all the information generated 
using Drosophila Genome 2.0 Arrays to measure the gene expression of all 
individual tissues of Drosophila in comparison to a matched whole-fly sample 
(Chintapalli et al., 2007; Estrada and Michelson, 2008; Willis et al., 2010; Zhu et 
al., 2013a). The FlyAtlas presents an excellent opportunity to study gene 
expression in multiple tissues and provides a complementary resource to 
published developmental data sets (Arbeitman et al., 2002). 
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3.2.2 Previous technology comparisons 
3.2.2.1 Correlation between RNA-seq and expression microarrays 
To date, several studies have been conducted to compare the performance of 
RNA-seq and microarrays in quantifying the expression levels of genes from 
different aspects mainly focusing on reproducibility, accuracy, technical and 
biological variabilities (Kogenaru et al., 2012; Malone and Oliver, 2011; Marioni 
et al., 2008),. The two technologies have also been compared at the proteomics 
level (Fu et al., 2009). 
Comparisons between the two techniques have been reported in Candida 
parapsilolis (Guida et al., 2011), Drosophila melanogaster (Malone and Oliver, 
2011), Saccharomyces cerevisiae (Nookaew et al., 2012), on the fission yeast 
Schizosaccharomyces pombe (Wilhelm et al., 2010; Wilhelm et al., 2008), 
Lactobacillus plantarum (Leimena et al., 2012), pathogenic bacteria HrpX 
regulome (Kogenaru et al., 2012), in mouse tissues (Liu et al., 2007; t Hoen et 
al., 2008), in Canis familiaris (Mooney et al., 2013), in several human cells and 
cell lines (Bradford et al., 2010; Fu et al., 2009), and in human and non-human 
primate tissue (Liu et al., 2011a; Marioni et al., 2008; Raghavachari et al., 
2012). 
In all cases the expression levels have showed strong agreement between the 
two technologies, with correlation ranging from 0.6-0.8 for biological replicates, 
and from 0.9-0.96 for technical replicates. Correlation of the relative 
measurement of differential gene expression between the two technologies also 
agreed, with correlation range from 0.7-0.9 (Malone and Oliver, 2011; Marioni et 
al., 2008). RNA-seq had better reproducibility, accurrance and dynamic range 
than microarrays due to the microarray hybridization background, which affects 
the measurement (Mooney et al., 2013; t Hoen et al., 2008). However, both 
technologies have an increased error rate for lowly expressed genes (Liu et al., 
2011a). RNA-seq needs to increase the read coverage and microarrays need more 
density to cope with the lowly expressed genes. 
Two studies also addressed RNA-seq and microarrays in terms of having 
complementary strengths and limitations with each other. Detecting genes with 
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low expression will remain a problem for both technologies (Kogenaru et al., 
2012; Malone and Oliver, 2011). RNA-seq has been shown to be better for novel 
gene discovery and novel isoform identification than microarrays. The 
correlation between Drosophila expression microarrays (Drosophila Genome 2.0 
Array) and RNA-seq (Illumina GAIIx) will be addressed in this chapter. 
3.2.2.2  Correlation between RNA-seq and tiling microarrays  
In terms of the correlation between RNA-seq and tiling microarrays, most studies 
investigated the gene expression levels as well as the differential levels of gene 
expression detection. 
There are some different opinions regarding the correlation between RNA-seq 
and tiling microarrays. One study found the agreement for gene expression 
detection between RNA-seq and tiling microarrays to be very good with 
correlation given as a Spearman’s correlation coefficient of approximately 0.9. 
The same study also found the differential expression of genes between the two 
technologies to show a correlation given as a Spearman’s coefficient around 0.7 
(Agarwal et al., 2010). Another study found that 80% of the bases detected as 
expressed by RNA-seq overlapped with those found using DNA-tiling microarrays 
(Nagalakshmi et al., 2008). On the other hand, one studies found the comparison 
between tiling microarrays and the tag based MPSS (Massively Parallel Signature 
Sequencing) technology revealed a very good overlap only at the protein-coding 
gene loci (Sasidharan et al., 2009). There was poor agreement between tiling 
microarrays and RNA-seq for detecting certain genes expression for example; 
Wnt gene in Drosophila cell lines could be detected in RNA-seq but undetectable 
by tiling microarrays. However, other evidence confirmed RNA-seq result was 
the more accurate one for the Wnt genes (Cherbas et al., 2011; Sasidharan et 
al., 2009). 
Studies using tiling microarrays and RNA-seq report agreement at nearly 90% for 
the discovery of novel transcribed regions (Cherbas et al., 2011; Graveley et al., 
2011) and detection of the 3’ and 5’ extension of transcriptional activities of 
genes (Graveley et al., 2011). However, another report suggests that tiling 
microarrays overestimated the transcriptional signals due to the high false-
positive rates, especially overestimating the novel genes within the genome (van 
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Bakel et al., 2010). Taken together, these studies suggest that tiling microarrays 
can still be treated as a useful tool to verify RNA-seq findings at global levels. 
3.3 Experimental design for three-way comparison  
Evaluation of the three technologies was performed using a set of three-way 
comparisons, namely a comparison of absolute expression using technical 
replicate samples, a comparison of absolute expression using biological 
replicates samples, and a comparison of relative expression using biological 
replicate samples. 
Technical replicate comparison was used in order to compare the performance 
of the three technologies in measuring the expression level of known and novel 
genes. Biological replicate comparison was used to investigate how the 
difference between the three technologies affects the biological interpretation. 
3.3.1 Absolute gene expression comparison using technical 
replicate samples  
The aim of the comparison of absolute expression using technical replicate 
samples was to compare the performance of the three technologies in measuring 
the expression level of known and novel genes. The design for this comparison 
was to analyze three technical replicate samples of Drosophila whole fly (Canton 
S) using Drosophila Genome 2.0 Array, three technical replicate samples of 
whole fly using Drosophila Tiling Array 2.0R (same RNA of Canton S as Drosophila 
Genome 2.0), and one technical sample of whole fly using RNA-seq (same RNA of 
Canton S as Drosophila Genome 2.0). The absolute gene expression results 
obtained were then compared by using scatter plot analysis. 
As shown in Figure 3-4, three scatter plots were generated for technical 
replicate samples comparison; whole fly RNA-seq versus whole fly Drosophila 
Genome 2.0 Array (Dros 2), whole fly RNA-seq versus whole fly Drosophila Tiling 
Array 2.0R (Tiling 2) and whole fly Drosophila Tiling 2.0R Array versus whole fly 
Drosophila Genome 2.0 Array. 
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Figure 3-4 The flow diagram of absolute gene expression analysis using technical replicate 
samples. 
The same RNA from whole flies samples were used in these comparisons by applying to 
Drosophila  expression microarrays, Drosophila tiling microarrays and RNA-seq platform. Three 
scatter plots were generated as results. 
The results for comparison of absolute expression using technical replicates are 
shown in 3.4.1.1 to 3.4.1.3 respectively. 
3.3.2 Absolute gene expression comparison using biological 
replicate samples  
The aim of the comparison of absolute expression using biological replicate 
samples was to investigate how the difference between the three technologies 
affects the biological interpretation. The design for this comparison was to 
analyze three biological replicate samples of Drosophila whole fly (Canton S) 
using Drosophila Genome 2.0 Array, three biological replicate samples of whole 
fly using Drosophila Tiling Array 2.0R (same RNA of Canton S as Drosophila 
Genome 2.0), and two biological samples of whole fly using RNA-seq (same RNA 
of Canton S as Drosophila Genome 2.0). The absolute gene expression results 
obtained were then compared by using scatter plot analysis. 
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As shown in Figure 3-5, three scatter plots were generated for biological 
replicate samples comparison; whole fly RNA-seq versus whole fly Drosophila 
Genome 2.0 Array, whole fly RNA-seq versus whole fly Drosophila Tiling 2.0R 
Array and Drosophila Tiling Array 2.0R versus whole fly Drosophila Genome 2.0 
Array. 
 
Figure 3-5 The flow diagram of absolute gene expression analysis using biological replicate 
samples. 
The RNA from whole flies samples which all replicate samples being raised in the same conditions 
were used in these comparisons by applying to Drosophila  expression microarrays, Drosophila 
tiling microarrays and RNA-seq platform. Three scatter plots were generated as results. 
The results for comparison of absolute expression using biological replicates are 
shown in 3.4.1.4 to 3.4.1.7 respectively. 
3.3.3 Relative gene expression comparisons using biological 
replicates  
The aim of the comparison of relative expression using biological replicate 
samples was to investigate how the difference between the three technologies 
affects the biological interpretation. The design of the biological replicate 
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samples comparison was based on analysing the relative expression in tubules 
relative to whole flies. Three biological replicate samples of whole fly (Canton S) 
and tubules were analysed using Drosophila Genome 2.0 Array, three biological 
replicate samples of whole fly and tubules were analysed using Drosophila Tiling 
2.0R Array (Canton S), and three biological replicate samples of whole fly and 
tubules were analysed using RNA-seq (Canton S). The relative gene expression 
results obtained were then compared by using scatter plot analysis. 
As shown in Figure 3-6. Three scatter plots were generated for biological 
replicate samples comparison on tubule versus whole fly fold change. RNA-seq 
tubule/whole fly ratio versus Drosophila Genome 2.0 Array tubule/ whole fly 
ratio, RNA-seq tubule/whole fly ratio versus Drosophila tiling arrays 2.0R 
tubule/whole fly  ratio and Drosophila Genome 2.0 Array tubule/whole fly ratio 
versus Drosophila tiling array 2.0R tubule/whole fly ratio. 
 
Figure 3-6 The flow diagram of relative gene expression analysis using biological replicate 
samples. 
The RNA from whole fly and tubule samples which all replicate samples being raised in the same 
conditions were used in these comparisons by applying to Drosophila expression microarrays, 
Drosophila tiling microarrays and RNA-seq platform. The fold changes were calculated using 
tubule/whole fly. Three scatter plots were generated by using ratio of tubule/whole fly as results. 
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The results for comparison of relative expression using biological replicates are 
shown in 3.4.2 respectively. 
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3.4 Results 
3.4.1 Absolute gene expression level comparison 
3.4.1.1 Technical replicate samples of RNA-seq versus Drosophila Genome 
2.0 Array (three-prime expression array)  
RNA was extracted from Canton S whole flies, and the same RNA was used for 
the technical replicate sample comparison of RNA-seq, Drosophila Genome 2.0 
Array, and Drosophila Tiling 2.0R Array. 
RNA-seq was performed on Canton S whole fly using single-end Illumina GAIIx, 
76bp library preparation kit according to Illumina RNA-seq sample preparation 
manual (section 2.8.1). The result of 13.7 million raw reads was cleaned using an 
in-house script, and then the cleaned reads imported into Bowtie (Langmead et 
al., 2009; Trapnell et al., 2009); Bowtie aligned the reads to the Drosophila 
Genome (dm3.refFlat) using unique reads only, and then generated aligned bam 
files. The bam files were imported into Partek Genomic Suite and normalized in 
Partek. The signal of RNA-seq data is defined as a count of the number of reads 
overlapping at each base pair, and the reads per kilobase of exon per million 
mapped reads (RPKM) for each gene (Mortazavi et al., 2008). The in-house script 
took normalized Partek data and generated log2 (RPKM+0.01) value for genes 
characterised by one transcript only. The log2 value can’t be generated if RPKM 
is 0, so 0.01 was added to each RPKM in case the gene expression value is 0. 
Three technical replicate samples of whole fly using the same RNA as RNA-seq 
analysed using Drosophila Genome 2.0 Array started from 2.0ug RNA according 
to Affymetrix gene expression manual (section 2.7.1). The .CEL files of the 
samples were created after scanning, imported into Partek Genomic Suite 
(version 6.5), and normalized in Partek using GCRMA, which is the popular 
normalization method performs the background correction by considering the GC 
contents and increases the signal to noise ratio (annotation file Drosophila_2 
from Affymetrix). A microarray signal is defined as an intensity value for each 
probe, and each probe’s value as GCRMA normalized PM value. The signal 
intensity of 11-20 probes was combined as the signal intensity of a gene. An in-
house developed script took probe-set level data for Affymetrix replicate 
samples of whole fly and produced log2 (signal intensity) median values for 
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uniquely identified genes with only one unique probe. 
An in-house Perl script was used to joined the RNA-seq and Drosophila Genome 
2.0 Array two data sets together. A total of 9953 genes was included in this data 
set from the two platforms. Two values were produced for each gene, namely 
the median affy log2 (signal intensity) and log2 (RPKM). Figure 3-7 shows the 
scatter plot drawn by Partek. 
 
Figure 3-7 Scatter plot of whole flies technical replicate samples of RNA-seq compared with 
Drosophila expression microarrays.   
The expression microarrays log2 (signal intensity) compared with 76bp Illumina log2 (RPKM). The 
scatter plot showed strong but nonlinear correlation between the two measurements with Pearson 
correlation coefficient 0.860854 and Spearman rank correlation at 0.923115. Genes with only one 
transcript, with unique mapped reads, and the unequivocal annotation were chosen for both 
platforms. The colour of the spots indicates the expression value of both platforms; the value range 
from low (<8) to high (>8), the colour changes from blue to red. Data values at the far bottom left 
quadrant for arrays signify genes highly expressed in Drosophila Genome 2.0 Array but 
undetectable by RNA-seq. The low end of RNA-seq corresponding to RNA-seq log2 (RPKM) in the 
range from 2-10 and Dros 2 log2 (signal intensity) <2.3 signifies the genes that were absent in 
Drosophila Genome 2 Array but some genes were detected by RNA-seq. These spots indicate the 
main different expressed genes between the two platforms. 
The scatter plot in Figure 3-7 shows the technical replicate samples comparison 
between Dros 2 and RNA-seq. The correlation is better than a previous report 
which had a Spearman rank correlation 0.73 (Marioni et al., 2008); our data had 
Pearson correlation coefficient 0.86054 and Spearman rank correlation 0.923115. 
Pearson correlation=0.860854 
Spearman rank correlation=0.923115 
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The main reasons are that the samples were technical replicate samples, the 
genes were single transcript genes, RNA-seq used the unique reads, and both 
platforms chose the unequivocal annotation genes. These steps increased the 
correlation between the two platforms. However, there were still a group of 
genes at the low end on arrays that were highly expressed in Dros 2 but were 
undetectable by RNA-seq (left corner of Figure 3-7). Another group of genes 
located on the low end of the RNA-seq (bottom spots of RNA-seq of Figure 3-7) 
showed lowly expressed genes (the absent calls) in Dros 2 but most of them 
could be detected by RNA-seq. Some of the values were quite high, for example 
some genes Log2 (RPKM) could reach to 5 to10. These genes would be further 
investigated in the RNA-seq and Drosophila expression microarrays comparison of 
the biological replicate samples. 
3.4.1.2 Technical replicate samples of RNA-seq versus Drosophila tiling 
microarrays 
The scatter plot shows that tiling microarrays and RNA-seq are reasonably 
correlated with a Pearson correlation coefficient of 0.66397 and Spearman rank 
correlation 0.756478 (Figure 3-8). 
  
Figure 3-8 Scatter plot of whole flies technical replicate samples of RNA-seq compared with 
Drosophila tiling microarrays.  
Pearson correlation =0.66397 
Spearman rank correlation=0.756478 
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The scatter plot of technical replicate samples 76bp single-end RNA-seq log2 (RPKM) compared 
with Drosophila Tiling 2.0 Array. The scatter plot shows good nonlinear correlation between the two 
measurements with Pearson correlation coefficient 0.66397 and Spearman rank correlation 
0.756478. Genes with only one transcript, and the unequivocal annotation were chosen for both 
platforms. The colour of the spots denote the expression values from both platforms, the value 
ranging from low (<8) to high (>8), the colour changed from blue to red respectively. The bottom 
left quadrant of tiling microarrays and RNA-seq were genes that were expressed in tiling 
microarrays and were undetectable by RNA-seq showed the high false-positive rates of tiling 
microarrays compared to RNA-seq. Genes cannot detect by both platforms (far bottom left 
quadrant) indicated most noise are from the lowly expressed genes from two platforms. The 
compressed signals at the top of tiling microarrays indicated the saturation signals and the low 
dynamic range of tiling microarrays. 
Highly expressed genes are closely correlated than the genes at low expression 
levels. The genes at bottom left quadrant of RNA-seq and tiling microarrays are 
those genes which highly expressed in tiling microarrays but were undetectable 
by RNA-seq. These genes likely represent cross-hybridization of the microarrays 
which causes the high-false positive signals in tiling microarrays (Agarwal et al., 
2010). Signals at the top of the range were compressed in the tiling microarrays 
indicating saturation of the signals caused by the scanner. 
3.4.1.3 Technical replicate samples of Drosophila expression microarrays 
versus Drosophila tiling microarrays 
Three technical replicate samples of whole fly were started from 7µg RNA 
according to the GeneChip Whole Transcript (WT) Double-Stranded Target Assay 
Manual from Affymetrix, as detailed in section 2.7.2. CEL files of the samples 
were imported into Partek Genomic Suite, and normalized by GCRMA in Partek 
(version 6.6) according to the Partek manual. 
For Partek analysis, a tiling microarray signal is first defined as an intensity 
value for each probe. The PM minus MM values are computed for all replicates, 
and the replicates’ signals of genes are cut into segments where the segments 
contain a minimum of nine probes in a region; The P-value threshold for testing 
the difference in intensity level between the test segments and neighbouring 
segments was 0.01; signal is higher than noise at least by 10%. The signal-to-
noise threshold was set at 0.1 as default). Secondly, the segments were assigned 
to genes based on the annotation of Drosophila tiling microarrays allowing for 
100bp extension of both ends of genes by a developed in-house script. Thirdly, 
those genes with only one transcript and an unequivocal annotation were 
chosen. The median value was chosen for the segments for one gene as an 
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expression value. The tiling microarrays results were joined together with the 
Dros 2 and RNA-seq results in Partek giving a total of 9616 genes. The scatter 
plot showing the technical replicate samples comparison of Drosophila Genome 
2.0 Array versus Drosophila Tiling 2.0R Array is shown in Figure 3-9. 
 
Figure 3-9 Scatter plot of whole flies technical replicate samples of Drosophila expression 
microarrays compared with Drosophila tiling microarrays.  
Drosophila Genome 2.0 Array log2 (signal intensity) compared with Drosophila tiling 2.0R Array log2 
(signal intensity). The scatter plot shows good nonlinear correlation between the two 
measurements with Pearson correlation coefficient 0.740396 and Spearman rank correlation 
0.736118. Genes with only one transcript, and unequivocal annotation were chosen for both 
platforms. The colour of the spots vary according to the expression values from both platforms, the 
range from low (<8) to high (>8), indicated by the colour changing from blue to red. The bottom 
quadrant of tiling microarrays are genes expressed in tiling microarrays that were undetectable by 
Dros 2 array suggested the high-positive rates of tiling microarrays, and genes can’t detect by both 
platforms (far bottom left quadrant) suggested that both platforms have low ability to detect the 
lowly expressed genes.  
The scatter plot showing technical replicate samples for whole flies tiling 
microarrays and Dros 2 were reasonably correlated with a Pearson correlation of 
0.740396 and Spearman rank correlation of 0.736118. However they were not 
correlated as well as the correlation of Dros 2 and RNA-seq, especially when 
measuring the low expression genes. However, Dros 2 and tiling microarrays data  
generally agreed at high expression levels. For the low expressed genes, both 
Pearson correlation =0.740396 
Spearman rank correlation=0.736118 
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platforms suffered from hybridization background noise, making it difficult to 
detect the low expressed genes. 
3.4.1.4 Biological replicate samples of RNA-seq versus Drosophila 
expression microarrays  
Whole fly biological replicate samples in RNA-seq were compared with whole fly 
Drosophila Genome 2.0 Array, and with whole fly Drosophila Tiling 2.0R Array by 
using different batches of Drosophila Canton S flies with the same conditions. 
Four whole fly biological samples were used for Drosophila Genome 2.0 Array 
and two whole fly biological samples for single-end 54bp Illumina GAIIx RNA-seq. 
Using the same methods which had been used with the whole fly technical 
replicate samples comparison, Drosophila Genome 2.0 Array was compared with 
RNA-seq to generate the joined Drosophila Genome 2.0 Array, RNA-seq and tiling 
microarrays expression data. This data was recorded in a Microsoft Excel sheet 
with gene ID indexes. The scatter plots were produced by Partek Genomic Suite. 
The scatter plot of biological replicate samples of Drosophila expression 
microarrays compared with RNA-seq was shown in Figure 3-10. 
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Figure 3-10 Scatter plot of whole fly biological replicate samples of RNA-seq compared with 
Drosophila expression microarrays.  
The scatter plot of whole fly Drosophila Genome 2.0 Array log2 (signal intensity) compared with 
76bp single-end Illumina GAIIx log2 (RPKM) showed strong but nonlinear correlation between the 
two measurements with a Pearson correlation coefficient 0.82924 and Spearman rank correlation 
0.901678. Genes with only one transcript, with unique mapped reads, and the unequivocal 
annotation were chosen for both platforms. The dynamic range (ratio of largest observable value to 
apparent background value) of the RNA-seq data is clearly larger than that of microarray data. The 
microarray data appears to be slight compression at the top. The colour of the spots denote the 
expression value of both platforms, the value ranging from low (<8) to high (>8), the colour 
changed from blue to red respectively. The far left signals (arrow A) of RNA-seq were genes that 
were highly expressed in Dros 2 and were undetectable by RNA-seq. The low end of RNA-seq 
(arrow B) corresponds to RNA-seq log2 (RPKM) 4-10 and Dros2 log2 (signal intensity) <2 of the 
picture were the genes that were absent in Dros 2 but were detected by RNA-seq. These spots 
indicate the main difference in expressed genes between the two platforms. 
Data from the biological replicate samples of Dros 2 compared with Illumina 
signal-end, 54-bp RNA-seq showed a strong but nonlinear correlation between 
the two platforms with a Pearson correlation coefficient 0.82942 and Spearman 
rank correlation 0.901678. This correlation was, however, not as good as the 
technical replicates. The dynamic range (ratio of largest observable value to 
apparent background value) of the RNA-seq data is clearly larger than that of 
the microarray data. The microarray data showed slightly compressed at the 
top, which meant that the microarray data was saturated when measuring the 
high signals. The main noise came from the highly expressed genes on Dros 2 but 
Pearson correlation=0.82942 
Spearman correlation=0.901678 
A 
B 
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were undetectable by RNA-seq (arrow A of Figure 3-10) and from the absent 
genes on Dros2 but could be detected by RNA-seq (arrow B of Figure 3-10)  
3.4.1.5 Investigation of transcripts unique to particular platforms 
Further investigation of the transcripts unique to particular platforms was taken 
into two steps.  
Table 3-1 Example of top ten genes which highly expressed on Drosophila expression 
microarrays, but with very low expression on RNA-seq  
Gene ID Drosophila Genome 2 RNA-seq  
 
 
log2(Signal Intensity) Present Call Log2( RPKM) Reads Present 
CG31909 9.43915 P -6.64386 A 
Sdic3 7.97227 P -6.64386 A 
Lcp65Ag2 6.93959 P -6.64386 A 
Lcp65Ag3 6.57006 P -6.64386 A 
CG13068 6.46132 P -6.64386 A 
CG13705 5.88526 P -6.64386 A 
TwdlN 5.79068 P -6.64386 A 
TwdlM 5.66576 P -6.64386 A 
CG10598 5.52161 P -6.64386 A 
CG17290 5.32895 P -6.64386 A 
 
This table listed the top ten genes that were highly expressed on Affymetrix Drosophila Genome 
2.0 Array but undetectable by RNA-seq. Calls labelled “P” indicated ‘present’ on Affymetrix 
Drosophila Genome 2.0 Array, mainly indicating that the array signal intensity >5 .Reads labelled 
“A” indicated undetectable reads by RNA-seq, which were indicated by the RPKM <4 (in this 
study). 
Firstly, the RNA-seq data was sorted and 863 genes with RNA-seq log2 (RPKM) 
value-6.64 (arrow A of Figure 3-10) were selected. These were coordinated with 
the top ten genes that were highly expressed in Drosophila Genome 2.0 Array to 
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identify the gene set for further investigation. The results are listed in Table 3-
1. 
Further details regarding with the Affymetrix gene ID to search for these spots 
were obtained by using NetAffx (www.affymetrix.com) description of these 
genes. Using this search, we found the probe and probe-set sequences, and the 
cross-hybridizing informations. We were also able to deposit the sequences and 
use the blast alignment tool in Ensembl genome browser to find the probe sets-
gene match position to determine if these probes had been correctly designed by 
Affymetrix GeneChip. Problems with probes in microarrays are mainly caused by 
two reasons. One is cross-hybridization (false-positive or false-negative results); 
the other one is miss target transcripts (false-negative results) (Zhang et al., 
2005). The search focused on these two reasons. We found that four of these 
genes, which were located at the position of the gene families (Lcp65Ag2, 
Lcp65Ag3; TWDIN, TWDIM), could cross-hybridize within the gene families, and 
some genes were cross-hybridized to several other genes within the genome 
(details in discussion). 
Secondly, the Affymetrix Drosophila Genome 2.0 Array data was sorted. These 
genes with log2 (signal intensity) less than 2.3 and absent from Dros 2 were 
coordinated with the top ten highly expressed genes from RNA-seq and selected 
for further investigation as listed in Table 3-2. 
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Table 3-2 Example of ten highly expressed genes were detected by RNA-seq, but with very 
low expression in Drosophila expression microarrays. 
Gene ID Drosophila Genome 2 RNA-seq 
log2(Signal Intensity) Present call Log2(RPKM) Reads Present 
CG34212 2.10397 A 10.0681 P 
CG11042 2.235 A 7.89325 P 
CG31210 2.00192 A 7.35785 P 
CG32212 1.5825 A 5.311 P 
CG14309 2.07286 A 6.2526 P 
CG31804 2.3 A 6.41558 P 
Dro 2.5909 A 6.22008 P 
CG32212 1.5825 A 5.311 P 
vas 2.23102 A 5.70787 P 
CG3740 2.05629 A 5.13296 P 
This table lists the top ten genes that were absent on Dros 2 but highly expressed on RNA-seq. A 
present call of “A” indicates absent on Dros 2, mainly indicated by the array signal intensity <5. A 
real call “P” indicates detectable reads by RNA-seq, mainly indicated by log2 (RPKM) >2 in this 
study. 
To further investigate of the genes in Table 3-2, we blasted the probe-set 
sequences using the Ensembl (http://www.ensembl.org) to identify the probe-
gene match to determine whether the probe or probe-set targeted the genes or 
any miss target effect. Meanwhile, the RNA-seq data was inspected in the Tablet 
(version 1.12.03.26) genome brower by viewing the bam files for whole fly data 
as generated by Bowtie of to check if the Affymetrix probe-set was designed in 
the right place.  
The main reasons affecting microarray performance were missed target 
(CG14309) or part missed target (CG34212). Wrong annotation of the genes also 
affected the microarray performance (CG3212, CR31084, and CG11042). RNA-seq 
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had more ability to detect the lowly expressed genes such as vas. The cross-
hybridization affect was the major reason for false positive or false negative 
signals in the microarray platform (CG32212, CG3740). Details of the genes that 
were affected by the platform are also discussed further in section 3.5. 
3.4.1.6 Biological replicate samples of RNA-seq versus Drosophila tiling 
microarrays 
 
Figure 3-11 Scatter plot of whole fly biological replicate samples of RNA-seq compared with 
Drosophila tiling microarrays.  
The scatter plot of Drosophila Tiling 2.0R array log2 (signal intensity) compared with 76bp Illumina 
RNA-seq log2 (RPKM) data showed good nonlinear correlation between the two measurements 
with Pearson correlation coefficient 0.610132 and Spearman rank correlation 0.639341. The 
dynamic range (ratio of largest observable value to apparent background value) of the RNA-seq 
data is clearly larger than that of tiling microarray data. The microarray data appears to be slight 
compression at the top. The colour of the spots denote the expression value of both platforms, the 
value ranging from low (<8) to high (>8), the colour changed from blue to red respectively. Genes 
with only one transcript, and the unequivocal annotation were chosen for both platforms. The low 
end of tiling microarrays (the row region corresponds to Tiling 2 log2 signals in the range >4 and 
corresponds to RNA-seq log2 RPKM <4 as indicated in the red square) that are those genes 
expressed in tiling microarrays and were undetectable by RNA-seq showed the high false-positive 
rates of tiling arrays than RNA-seq, and genes could not detect by both platforms (far bottom left 
quadrant) indicated much noise are from the lowly expressed genes from two platforms. The 
compressed signal at the top of tiling microarrays indicated the saturation of the signals. 
Pearson correlation =0.610132 
Spearman rank correlation=0.639341 
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Biological replicate samples comparison of RNA-seq and tiling microarrays 
displayed the same shape as the technical replicate samples comparison but 
with more noise at the lower expression genes indicating the known issue of 
cross-hybridization and the high false-positive rates of tiling arrays. 
Table 3-3 Examples of false-positive signals in tiling microarrays but undetected by RNA-
seq with the corresponding signals from Dros 2 
Gene ID Tiling microarrays 
log2 (signal intensity) 
Expression microarrays 
Log2 (signal intensity) 
RNA-seq 
Log2 (RPKM) 
CG10102 10.95 2.1 -6.64 
PPk7 8.5 2.1 -6.64 
CG15212 7.6 4.7 -6.64 
CG5195 7.17 2.2 -0.31 
Aly 7.16 2.5 -0.87 
CG15335 7.0 2.8 -2.5 
CG32580 7.09 3.1 -5 
Hdm 6.6 2.1 -6.64 
Beat-IIIa 6.3 2.07 -0.56 
CG12964 6.19 2.1 -3.14 
 
This table lists ten genes that were highly expressed on tiling microarrays but were undetectable by 
RNA-seq and the corresponding signals of Dros 2. For Dros 2 signal intensity <5 or a log2 (signal 
intensity)<2.3 indicated that the signals were not detected. For RNA-seq, a log2 (RPKM) <2 
indicated the genes were undetected in this study. The table showed that the tiling microarrays 
detected false-positive signals that were not detected by Dros 2 and RNA-seq.. 
Ten genes were selected as examples from the low-end of tiling microarrays (red 
square) in Table 3-3 that demonstrated the high false-positive signals detected 
by tiling microarrays data but since the both the RNA-seq and Dros2 data 
disagreed with the tiling microarrays data. Figure 3-16 also revealed the low 
dynamic range of tiling microarrays since the top signals of tiling microarrays are 
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compressed. However, RNA-seq showed the wide dynamic range and less false-
positive signals, but RNA-seq may need more reads to detect the lower 
expression genes. 
3.4.1.7 Biological replicate samples of Drosophila expression microarrays 
versus Drosophila tiling microarrays 
  
Figure 3-12 Scatter plot of whole flies biological replicate samples of Drosophila expression 
microarrays compared with Drosophila tiling microarrays.  
The scatter plot showed good nonlinear correlation between the two measurements with Pearson 
correlation coefficient 0.610132 and Spearman rank correlation 0.639341. Genes with only one 
transcript, and the unequivocal annotation were chosen for both platforms. The colour of the spots 
are according the expression values from both platforms, the value from low to high, the colour 
changed from blue to red. The low end of tiling arrays and Dros 2 that were genes expressed in 
tiling arrays and were undetectable by Dros 2 array suggested the high-positive rates of tiling 
arrays,  and genes could not detect by both platforms showed both platforms  have low ability to 
detect the lowly expressed genes.  
Biological replicate samples comparison of Drosophila expression microarrays 
and Drosophila tiling microarrays displayed the same shape of technical 
replicate samples comparison but with more noise at the lower expression 
genes, indicating the known issue of cross-hybridization of microarray and the 
high false-positive rates of tiling microarrays (Figure 3-12). 
Pearson correlation =0.610132 
Spearman rank correlation=0.639341 
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3.4.2 Relative gene expression level comparison 
3.4.2.1 Biological replicate samples of Drosophila tubule/whole fly 
expression microarrays versus tubules/whole fly RNA-seq 
These comparisons are between tubule/whole fly fold changes of Drosophila 
expression microarray and tubule/whole fly fold changes of RNA-seq. Four 
biological replicate samples of whole fly and tubule from Canton S flies were put 
on the Drosophila Genome 2.0 Arrays. Tubule and whole fly of Drosophila 
Genome 2.0 Array .CEL files were imported into Partek Genomic Suite with 
annotation from Affymetrix Drosophila_2. GCRMA normalization in Partek was 
applied, and a one-way ANOVA was generated for tubule/whole fly fold changes 
with FDR<0.01. Two biological replicates samples of tubule and whole fly were 
run by Illumina GAIIx using single-end, 54bp RNA-seq which produced 6.3 million 
reads. Reads of RNA-seq samples were aligned by Bowtie, producing bam files 
that were imported into Partek Genomic Suite and normalized with annotation 
from Dm3 RefFlat. One-way ANOVA was used for differential gene expressions 
(DGEs) analysis of tubule/whole fly with FDR<0.01. An in-house Perl script was 
used to change the Affymetrix oligo ID to gene ID. Two data sheets were joined 
together in Partek Genomic suite, and a scatter plot was generated using Partek 
(Figure 3-13) for a total of 5593 genes. 
The top 30 genes from tubule/whole fly (Drosophila Genome 2.0 Array) 
compared with Drosophila RNA-seq tubules/whole fly top 30 genes are listed in 
Appendix VII. 
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Figure 3-13 Comparison of estimated log2(folds change) for Drosophila tubule/whole fly 
from RNA-seq and Drosophila expression microarrays.   
Only genes interrogated using both platforms were plotted. Genes with only one transcript, with 
unique mapped reads, and the unequivocal annotation were chosen for both platforms. The colour 
indicated the log2 (ratio) value, if log2 (ratio) from both platforms is greater than -12 and less than -
1, the colour is blue. If log2 (ratio) from both platforms is greater than -1, the colour is red. The 
tubules versus whole fly were generated by Partek analysis, using a one-way ANOVA with 
FDR<0.01 and Drosophila Genome 2.0 annotation. The tubules and whole fly RNA-seq reads were 
aligned by Bowtie, and run in Partek analysis, using one-way ANOVA with FDR<0.01 and Dm3 
RefFlat annotation. The middle red line of dots came from the very low read genes of RNA-seq 
(RPKM<4). The two platforms showed very strong correlation with a Pearson correlation coefficient 
0.885586 and Spearman rank correlation 0.84229. 
The scatter plot showed a strong but nonlinear correlation of the relative 
expression level of RNA-seq and Dros 2 with a Pearson correlation coefficient 
0.885586 and Spearman rank correlation 0.84229. The middle red line of dots 
with high fold change in RNA-seq and low fold change in Dros 2 seem to be those 
genes with fewer reads. The strongest correlation came from those genes with 
highly mapped reads and high signals from Dros 2 Arrays. 
24% of DGEs (folds change ≥ 3) were detected by both platforms from a total of 
5593 genes. 44% of DGEs were detected by RNA-seq but not by expression 
Pearson correlation =0.885586 
Spearman rank correlation=0.84229 
120 
microarrays, whilst 36% of DGEs were detected by expression microarrays but 
not by RNA-seq. RNA-seq detected more DGEs than arrays. 
3.4.2.2 Biological replicate samples of tubule/whole fly RNA-seq versus 
Drosophila tubule/whole fly tiling microarrays  
The tiling microarrays of Drosophila tubule/whole fly differential gene 
expression were analyzed in Partek Genomic Suite using a one-way ANOVA after 
the expression values were generated (see section 3.4.1.2). The corrected q-
value is less than 0.001 for a gene to be called differentially expressed. The q-
value cut is stricter than the differential expression analysis of RNA-seq and 
expression microarrays comparison because of the high false positive signals 
from tiling microarrays.  
 
Figure 3-14 Comparison of estimated log2 (folds change) Drosophila tubule/whole fly from 
RNA-seq and Drosophila tiling microarrays. 
Comparison of both platforms was performed in Partek analysis using a one-way ANOVA analysis. 
Dros 2 (q≤0.01) with total 5593 genes and Tiling 2 (q≤0.001) with 3483 genes were applied for the 
analysis. The scatter plot showed a strong and linear correlation between the two platforms. The 
colour indicates the value of expression from both platforms. Higher values are shown in red, lower 
values are in blue. The black colour indicates the genes were present in one platform but absent in 
another platform because of the different cutting criteria in the comparisons. 
Pearson correlation =0.864585 
Spearman rank correlation=0.84229 
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The differential gene expression lists of RNA-seq (5593 differential expression 
genes) and tiling microarrays (3483 differential expression genes) were joined 
together by gene ID. The scatter plot was generated (Figure 3-14). The scatter 
plot of RNA-seq and Tiling 2 differential gene expressions between Drosophila 
tubule and Drosophila whole fly showed the strong and almost linear correlation 
between the two measurements with a Pearson correlation coefficient 0.864585 
and Spearman rank correlation 0.84229 indicating that the ability for detecting 
the DGEs of the two platforms is similar but RNA-seq has a larger dynamic range 
than tiling microarrays. There was noise in the lower expression genes due to 
the cross-hybridization of tiling microarrays producing high-false positive signals. 
This also showed both platforms were limited in terms of detecting the lowly 
expressed genes. The higher expression genes were detected more by RNA-seq 
than tiling array due to the low dynamic range of tiling and saturation of the 
signal in tiling arrays. 
3.4.2.3 Biological replicate samples of Drosophila tubule/whole expression 
microarrays versus Drosophila tubule/whole fly tiling microarrays 
The tiling microarrays differential gene expression of Drosophila tubule and 
Drosophila whole fly were analyzed in Partek Genomic Suite using a one-way 
ANOVA after the expression values were generated (see section 3.4.1.2). The 
corrected q-value is less than 0.001 for a gene to be called differentially 
expressed. The q-value cut is stricter than the differential expression analysis of 
RNA-seq and Dros 2 comparison because of the high false positive signals from 
tiling microarrays. Expression microarrays tubule/whole fly fold changes were 
generated in Partek Genomic Suite (detailed in Section 3.4.2.1). An in-house 
Perl script was used to change the Affymetrix oligo ID to gene ID. Two data 
sheets of tubule/whole fly differential expression genes of tiling microarrays 
(3483  differential expression genes) and tubule/whole fly (5593 differential 
expression genes) of expression microarray were merged together in Partek 
Genomic Suite and a scatter plot was generated using Partek Genomic Suite 
(Figure 3-15).  
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Figure 3-15 Comparison of estimated log2 (folds change) Drosophila tubule/whole fly from 
Drosophila expression microarrays and Drosophila tiling microarrays. 
Comparison of both platforms was performed in Partek Genomic Suite using a one-way ANOVA 
analysis. Dros 2 (q≤0.01) with total 5593 genes and Tiling 2 (q≤0.001) with 3483 genes were 
applied for the analysis. The scatter plot showed a strong and linear correlation between the two 
platforms with a Pearson correlation 0.862351 and Spearman rank correlation 0.8455. The colour 
indicates the value of expression from both platforms with red indicating higher values and blue 
indicating lower values. The black colour indicates the genes were present in one platform but 
absent in another platform because of the different cutting criteria used in the comparisons. 
The scatter plot of Dros 2 and Tiling 2 differential genes expression between 
Drosophila tubule and Drosophila whole fly showed a strong and almost linear 
correlation between the two measurements with a Pearson correlation 
coefficient 0.862351 and Spearman rank correlation 0.8455, indicating the 
ability to detect the DGEs of the two platforms is similar. There was noise for 
the higher expression genes and lower expression genes due to the cross-
hybridization of both platforms and the signal saturation of both platforms. 
3.4.2.4 Venn diagram of Drosophila RNA-seq versus Drosophila tiling 
microarrays versus Drosophila expression microarrays 
Three differential expression genes (tubule versus whole fly) data sets from 
three platforms were imported into Partek Genomic Suite. Venn diagram was 
Pearson correlation =0.862351 
Spearman rank correlation=0.8455 
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generated for the top 1000 differentially expressed genes between Drosophila 
RNA-seq, Drosophila tiling microarrays and Drosophila expression microarrays as 
shown in Figure 3-16.  
 
Figure 3-16 Venn diagram of top 1000 folds change genes. 
Top 1000 genes were called differentially expressed by each platform (RNA-seq, Drosophila 
expression microarrays and Drosophila tiling microarrays). There was significant overlap (39.4%) 
between the three platforms, but more genes overlapped between RNA-seq and Dros 2 (73.6%) 
than between both RNA-seq and tiling arrays (40.7%), and between tiling microarrays and Dros 2 
(42.1%). This likely reflects that RNA-seq and Dros 2 were more accurate for measuring the 
differential expression genes than tiling microarrays, and RNA-seq had greater dynamic range than 
tiling microarray and Dros 2. 
The Venn diagram shows that 39.4% of those called as differentially expressed 
genes were detected by the three platforms. However, 59.3% genes of those 
called by tiling microarrays were not detected as differentially expressed genes 
by Dros 2; 57.9% of those called by tiling microarrays were not detected by RNA-
seq as differentially expressed genes. RNA-seq and Dros 2 again showed strong 
agreement for detecting the differentially expressed genes, with 73.6% genes of 
those called differentially expressed genes detected by both platforms. 
However, still 26.4 % of those called by RNA-seq were not detected as 
differentially expression by Dros 2; 26.4% of those called by Dros 2 were not 
detected as differentially expressed by RNA-seq. Tiling microarrays behaved 
differently when detecting the differentially expressed genes than the other two 
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platforms due to the high false-positive rate and the continuous probes 
measurement. 
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3.5 Discussion 
3.5.1 RNA-seq compared with Drosophila expression microarrays 
Microarrays and RNA-seq are two popular methods to measure gene expression 
at the whole transcriptome level. Both technologies have their own merits and 
drawbacks. Through the comparison of biological replicate samples of Drosophila 
Genome 2.0 Array (Dros 2, three-prime expression microarrays) versus RNA-seq, 
we found groups of genes highly expressed in Dros 2, but undetectable by RNA-
seq (table 3-1). In theory, RNA-seq is more sensitive than microarrays. 6-8 
million mapped reads of RNA-seq provide adequate coverage to accurately 
estimate roughly 80-90% of the head transcriptome in flies (Malone and Oliver, 
2011). The RNA-seq from this comparison had 6.3 million mapped reads, so it 
was enough to cover the expression of most genes. However, three-prime 
expression microarrays can demonstrate false-positive expression signals for 
several reasons.  
Firstly, nonspecific probes could cross-hybridize to multiple genes (within a gene 
family or other similar sequence genes). If a genes shared 19bp or more in 
sequence identity, multiple genes might cross-hybridize with that set of genes 
(Zhang et al., 2005). We found probe-sets of four genes were cross-hybridized to 
multiple genes within the gene family in Table 3-1. For example, gene Lcp65Ag2 
(1640975_at), the blast search for the probe-set sequences in Ensembl genome 
browser, found that part of the probe-set sequences matched to Lcp65Ag1-RA, 
Lcp65Ag3-RA, Lcp65Ae-RA, and Lcp65Af-RA within the area. Similarly for gene 
TWdIM, we found part of probe-set sequences matched to TWdIN-RA, TWdIH-RA, 
TWdIJ-RB, TWdIP-RA, TWdIB-RA, TWdIL-RB, TWdIO-RA, TWdIK-RA, and TWdIR-RA 
within these gene families. This is the typical of the cross-hybridization within 
gene families that results in detecting false-positive signals, also affecting the 
genes expression and generating a number of false-positive expression signals. 
Secondly, nonspecific probes could cross-hybridize to multiple genes across the 
genome. Genes CG13705, CG17290.CG31909, CG10598 and Sdic3 from Table 3-1 
all cross-hybridize to other genes within the genome. CG13750 (1632527_at) 
cross-hybridized to three genes1623412a_at, 1624625a _at, and 1628360_at 
(CG17150). CG17290 (1625558a_at) cross-hybridized to two other genes namely 
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CG30458-RA and CG10953. CG31909 (1638603_at) cross-hybridized to CG31909-
RB, CG31909-RC, CG43800-RA and CG43800-RB. CG10598 (1633409a_at) cross-
hybridized to CG14191-RA. In fact, CG14191-RA was highly expressed in whole 
flies but RNA-seq only detected CG10598, which was not expressed in whole 
flies. Sdic3 (1635695_at) cross-hybridized to 40 transcripts of which the main 
ones are 1632213a _at, 1628129a_at and 1631477a _at. 
Thirdly, the unmatched annotation files between microarray and RNA-seq are 
another reason for the signal mismatch between the two measurements. 
Drosophila Genome 2.0 Array was designed in 2006 using the annotation from 
FlyBase version 5.3, RNA-seq used the annotation from FlyBase version 5.34. For 
the top 10 genes in Table 3-1, there was no case of unmatched gene annotation 
between the two platforms. 
Taken together, Affymetrix three-prime expression microarrays contain 
thousands of redundant probe sets that interrogate different regions of the same 
genes, which can lead to inaccurate inference about overall gene expression (Cui 
and Loraine, 2009). Cross-hybridization is also very common in three-prime 
expression microarrays; extra filtering may be needed to get the right 
information about the gene expression for this type arrays. 
 
RNA-seq has a wider dynamic range to measure the gene expression than 
microarrays. RNA-seq and three-prime expression microarrays are correlated 
very well. However, we still found a group of genes that have high signals in 
RNA-seq but were undetected by microarrays in Figure 3-13 (low end of RNA-seq) 
and Table 3-2. There are multiple reasons for this: 
The first of these reasons is, missing the target transcript sequences on the 
Affymetrix GeneChip (Zhang et al., 2005). This is mainly caused by inaccuracy in 
annotation when the GeneChips were designed. In addition, there is a three-
prime design bias for Affymetrix expression microarrays. For example in Table 3-
2, probes sequences of CG31084 (1627438_at) was blasted in Ensembl, and these 
probes were matched to Chr3R 22253684-22253881 and Chr3R 22253974-
22254091. Viewing CG31084 in RNA-seq, we found the reads were mapped to 
Chr3R 22251024-22251483. Therefore, the Affymetrix expression microarrays 
probes for CG31084 missed the target due to the wrong annotation of this gene. 
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Gene CG34212 (1631103_at), provides another example where half probe missed 
the gene target. The Affymetrix probes of CG34212 matched two places of the 
genome Chr2R 1938179-1938515 and Chr2R 1937519-1937724. Only a small part 
of the probe Chr2R 1937519-1937724 mapped the gene CG34212. In RNA-seq, the 
reads mapped to Chr2R 1937431-1937645. The partial probes of arrays measured 
the gene expression, which caused the low signals of arrays. In a third example, 
gene CG14309 (1631866_at), the probes were designed on arrays missing the 
gene target. The probes of CG14309 were designed between Chr3R 14206882-
14207393, but the huge reads detected by RNA-seq were between Chr3R 
14207636-14210725. The tiling microarrays also detected the high signal for the 
gene CG14309 as log2 (signal intensity) 7.16421, further confirming that Dros 2 
has a three-prime bias design. The probes on the arrays for this gene completely 
missed the transcribed region as a result of no expression being detected by 
arrays. These are typical examples of three-prime bias of three-prime	  expression 
arrays. For RNA-sequence however, mapping the genome doesn’t depend on the 
annotation, and also RNA-seq has the potential ability to reannotate the genes 
structure to instruct accurate design of the probes for microarrays in the future. 
The new generation of gene arrays tried to make probes across the whole exons 
of the genes avoiding the three-prime bias, however these types of arrays are 
only currently available for human, mouse, rat and Arabidopsis but not for 
Drosophila. 
Secondly, cross-hybridization problems in arrays affect the expression signals. 
Cross-hybridization can generate both false-positive expression signals and false-
negative expression signals. Some probes on GeneChip were designed according 
to ESTs information, where by one gene maybe represented by several ESTs. 
Therefore two or more different probe sets are sometimes assumed to target the 
same genes or transcripts, leading to another cause of cross-hybridization 
(Bellis, 2013; Cui et al., 2010; Cui and Loraine, 2009). For example, gene 
CG32212 (1641330-at) was cross-hybridized to 18 transcripts. One of the 
transcripts CR42842-RA was a pseudogene, and CG32212 also cross-hybridized to 
CG12519-RA, CG12519-RB, 825-Oak-RB and CG18294-RA. Another example, 
CG3740 (1624552_at) was cross-hybridized to the gene “dor” (1623139_at).  
Thirdly, the wrong annotation maybe continued in FlyBase. Gene CG31210 
(1628546_at) and CG11042 (1641149_at) had been withdrawn from the FlyBase 
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5.54. This might be another reason contributing to two measurements not being 
matched. 
Fourthly, RNA-seq supports a wider dynamic range than microarrays for 
measuring genes at low and high expression levels. Microarrays have a more 
limited dynamic range in terms of gene expression level (Malone and Oliver, 
2011; Marioni et al., 2008). For genes at low expression, microarrays suffered 
from background noise that affected the detection of capability. For highly 
expressed genes, microarrays suffered from signal saturation of the scanner. For 
example, the gene Vas (1624413_at) was a lowly expressed gene which was not 
detected by microarrays but was detected by RNA-seq. 
Lastly, microarray probes were designed at the gene level, which was not 
suitable to measure the individual transcript expression (Bellis, 2013) whereas 
RNA-seq measured all transcripts and the averaged signals at the gene level. So 
the difference in measurement will cause the different gene expression level for 
some genes. 
Taken together, RNA-seq has a number of advantages over microarrays. RNA-seq 
doesn’t require the genome information, and supports detection at the gene 
expression at a single-base resolution (Wilhelm et al., 2008); RNA-seq has a 
wider dynamic range to detect gene expression from low to high levels; RNA-seq 
can detect alternative splicing and novel transcripts (Wang et al., 2009; Young 
et al., 2012). Nevertheless, microarrays still remain useful and complementary 
(Kogenaru et al., 2012; Malone and Oliver, 2011) to RNA-seq to measure the 
gene expression at the transcriptome level. 
3.5.2 RNA-seq compared with Drosophila tiling microarrays 
Both RNA-seq and tiling microarrays are unbiased, high-throughput analytical 
tools for identifying novel RNAs, discerning alternative splicing isoforms, and 
determining gene expression level (Agarwal et al., 2010). From the comparison 
of RNA-seq and tiling microarrays Figure 3-14, the correlation between the two 
platforms is reasonably good. However, RNA-seq has distinct advantages over 
tiling microarrays for detecting the highly and lowly expressed genes. 
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Firstly, tiling microarrays suffered from cross-hybridization problems and 
hybridization background noise; it is not a suitable tool to detect genes at low 
expression levels. However, Figure 3-14 and Table 3-3 showed a group of signals 
that were highly expressed on tiling microarrays but were poorly expressed by 
RNA-seq. This is a problem in the cross-hybridization that is a known issue in 
tiling microarrays producing a lot of false-positive signals. Tiling microarrays 
have a higher false-positive rate than any other microarrays. This is the case 
because firstly, there are a number of pseudogenes within the genome. 
Duplicated pseudogenes arise when a genomic region containing a gene is copied 
and a copy is subsequently disabled. However, although pseudogenes are not 
transcribed, the pseudogenes and their parents have high sequence similarity 
(Agarwal et al., 2010). Furthermore, a number of probes on tiling microarrays 
that are highly similar to their nearest neighbours tend to be called as expressed 
by tiling microarrays and not detected by RNA-seq, providing strong evidence of 
cross-hybridization (Agarwal et al., 2010). Tiling microarrays also considerably 
overestimated the proportion of “dark matter” transcripts over RNA-seq due to 
the high false-positive rate in the detection of expression (van Bakel et al., 
2010). 
Secondly, RNA-seq has a wider dynamic range of detection than tiling 
microarrays which suffered from signal saturation by the scanner. That is 
illustrated, for example in Figure 3-14, where the top signals of tiling 
microarrays are compressed. 
Thirdly, RNA-seq can detect the exon boundaries; therefore RNA-seq can clearly 
detect the alternative splicing signals. By comparing, tiling microarrays can 
detect the novel genes but have difficulty in detecting the fine structure of the 
genes. The novel genes that were found by tiling microarrays were difficult to 
confirm, as discussed for example in section 3.4.3.2. 
Taken together, the comparison of RNA-seq and tiling microarrays demonstrated 
that most gene expression levels are well correlated between RNA-seq and tiling 
microarrays. RNA-seq clearly has advantages over tiling microarrays in detect 
exon boundaries, detecting alternatively splicing, and also has a wider dynamic 
range for measuring gene expression with a low false-positive rate. However, 
tiling microarrays remain cost effective for many species, and perform 
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reasonably well with respect to expression levels (Agarwal et al., 2010), and can 
function as a tool to verify the RNA-seq results at the global level. 
3.5.3 Drosophila expression microarrays compared with 
Drosophila tiling microarrays   
Tiling microarrays and three-prime expression arrays are reasonable correlated 
when measuring the gene expression. However, the two data are fundamentally 
different. The tiling microarrays data are continuous whilst the three-prime 
expression microarrays data are discrete. This made the comparison a 
challenging task (Sasidharan et al., 2009), and may also result in the comparison 
not reflecting the real gene expression due to the basis for measurement. 
Figure 3-15 showed the both platforms are not correlated for the highly and 
lowly expressed genes. There may be multiple reasons for this. Firstly, both 
platforms suffered from the hybridization background and the cross-
hybridization affect. Secondly, both platforms suffered from signal saturation 
when measuring the highly expressed signals. Thirdly, tiling microarrays included 
probes for unannotated genes while three-prime expression arrays are only for 
detecting annotated genes. 
Taken together, the comparison of tiling microarrays and three-prime expression 
microarrays demonstrated that most gene expression levels are well correlated. 
Three-prime expression arrays have advantages in detecting expression of known 
gene and tiling microarrays can detect novel genes and the transcription of 
“dark matters” (van Bakel et al., 2010) in the genome. 
This thesis first demonstrated the three-way comparison of RNA-seq, tiling 
microarrays, expression microarrays that will be a valuable guide for the 
researcher in choosing suitable platforms for detecting gene expression in the 
future. 
 
  
131 
3.6 Conclusions 
RNA-seq, expression microarrays and tiling microarrays are three popular 
methods to measure gene expression at the high-throughput whole 
transcriptome level. RNA-seq has more agreement with expression arrays than 
tiling microarrays. RNA-seq has a number of advantanges over microarrays; RNA-
seq can measure gene expression without the genome reference; RNA-seq can 
detect the exon boundaries and detect the novel alternative splicing isoforms; 
RNA-seq can discover novel genes; RNA-seq has a wider dynamic range to for the 
measurement of gene expression. Expression arrays are still valuable for 
detecting the expression of known gene, and can be used to complement RNA-
seq. Tiling microarrays are also a gene discovery tool but suffered from high 
false-positive rates. Data from tiling microarrays must be strictly cut in order to 
reduce the false-positive expression during the analysis, and so the data must be 
interpreted with cautions. Therefore, RNA-seq will be chosen as a tool to search 
the novel genes in Drosophila tubules in this thesis. 
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4. RNA-seq and directional RNA-seq for novel 
gene discovery in the transcriptome of 
Drosophila tubules  
Summary 
The next generation sequencing is a recently developed high-throughput 
method, which overcomes the limitations of previous sequencing methods and 
has the ability to produce an enormous volume of data cheaply (Franzen et al., 
2013). The RNA-seq approach of next-generation sequencing avoids the need for 
bacterial cloning, can sequence the genome to a resolution of one base, and 
measures transcript expression by counting the reads corresponding to the RNA 
from each known exon, splice event or new candidate gene (Mortazavi et al., 
2008). Thus RNA-seq method revolutionises the whole process of discovering 
novel genes and their variants at the genome level. This chapter describes the 
application of RNA-seq and strand-specific RNA-seq technologies to the discovery 
of tubule enriched novel genes in Drosophila and also confirmation of the novel 
gene by RT-PCR.  
4.1 Introduction 
4.1.1 RNA-seq and novel gene discovery 
RNA-seq is a recently developed approach to transcriptome profiling that uses 
deep-sequencing technologies. Studies using this method have revealed a far 
greater complexity of eukaryotic transcriptome than was previously appreciated 
(Graveley et al., 2011). RNA-seq also provides a more precise measurement of 
the expression levels of transcripts and their isoforms, discovering the activities 
of novel coding and noncoding genes during transcription (Wang et al., 2009; 
Wilhelm et al., 2008). 
There are two methods to produce the RNA-seq data for novel gene discovery.  
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Figure 4-1 A typical RNA-seq experiment.  
(A) Poly(A) selection for RNA-seq. mRNA is selected using oligo (dT) beads. RNA is then first 
converted into a library of cDNA fragments through either RNA or DNA fragmentation. Sequencing 
adaptors (blue) are subsequently added to each cDNA fragment and a short sequence is obtained 
from each cDNA using high-throughput sequencing technology. Picture adapted from  (Wang et al., 
2009). (B) A flowchart of rmRNA-seq protocol for SOLid. Ribosomal RNAs (coloured in orange 
and blue) are depleted with sequence-specific biotin-labelled probes and the remaining mRNA-rich 
fraction (green and violet) is fragmented with RNase III. After ligation to adaptors (red; NN stands 
for random oligonucleotide hexamers), the fragments in a size range of ~ 50 bp are collected and 
reverse-transcribed into a single-stranded cDNA library. The library is subsequently amplified, size-
selected (140 to 200 bp), and sequenced in high coverage. Picture adapted from (Cui et al., 2010). 
B 
A 
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The first of these methods, which is illustrated in Figure 4.1 A, involves poly (A) 
selection followed by random priming to convert the RNA of interest to a cDNA 
library for high-throughput deep sequencing (Graveley et al., 2011; Vidal et al., 
2013).  
The second of these methods, which is illustrated in Figure 4.1 B, involves 
ribosome reduction of the total RNA followed by random priming to convert the 
RNA of interest to a cDNA library for further deep sequencing (Liu et al., 2011b). 
The first method focuses on discovery of the novel RNAs with a poly(A) tail, such 
as coding RNA and mRNA-like non-coding RNA. The second method is suitable for 
discovery of all the coding and non-coding RNAs. However, different RNA sample 
preparations may result in significant variations in gene expression profiles (Cui 
et al., 2010; Tariq et al., 2011). 
 
RNA-seq has clear advantages over previous methods. Firstly, RNA-seq is not 
limited to detecting transcripts that correspond to existing genomic sequence.  
The de novo assembly can sequence the genome and construct the 
transcriptome (Fan et al., 2013; Torales et al., 2013). This is very attractive in 
the case of non-model organisms for which the genome sequences are not 
determined, and for which no GeneChips are available. Secondly, RNA-seq 
measurement has a higher dynamic range of expression level. RNA-seq contains 
very low background signal, so it is able to measure genes with lower expression 
levels.  RNA-seq also has no upper limit for quantification, and so can reveal the 
absolute level of gene expression (Graveley, 2008; Kogenaru et al., 2012; 
Wilhelm et al., 2008). Thirdly, RNA-seq can clearly detect the transcription 
boundaries, and so can detect both the novel junctions of novel isoforms and 
reveal completely new genes (Vidal et al., 2013; Wilhelm et al., 2008). This is a 
revolutionary tool for transcriptomics research (Mortazavi et al., 2008). 
There are, however, still a number of challenges when using this technology 
(Wang et al., 2009). The library construction method currently requires 
fragmentation and amplification, which will introduce bias and artefacts into the 
system. Bioinformatic challenges include the need to store the large amount of 
data produced, the need for algorithms to identify high-quality reads, and the 
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provision software for read mapping, read construction and expression 
quantification (Hitzemann et al., 2013). 
4.1.2 Directional RNA-seq and novel gene discovery 
Strand-specific, massively parallel cDNA sequencing (ssRNA-seq), also called 
directional RNA-seq, and is a powerful tool for transcript discovery, genome 
annotation and expression profiling (Franzen et al., 2013; Levin et al., 2010). 
The standard RNA-seq method does not provide information about which strand 
was originally transcribed, and therefore cannot distinguish overlapping 
transcription from two strands. Strand-specific RNA-seq is uniquely suited for 
novel gene discovery, especially for noncoding RNA discovery (Yassour et al., 
2010; Zhu et al., 2013b). Studies reveal that most antisense transcripts may 
result from promiscuous bi-directional transcription in a dense genome, so 
strand-specific RNA-seq provides the opportunity to discover, for example, the 
long noncoding antisense RNAs that may not be detected using previous methods 
(Young et al., 2012). 
Methods to construct the strand-specific RNA-seq libraries can be categorized 
into many classes. Methods in the first class rely on attaching different adaptors 
in a known orientation relative to the 5’ and 3’ ends of the RNA transcripts as 
illustrated in Figure 4.2 A. Methods in the second class as illustrated in Figure 
4.2 B, rely on making one strand by chemical modification, either on RNA itself 
by bisulfite treatment or during second-strand cDNA synthesis followed by 
degradation of the unmarked strand (Levin et al., 2010). The experimental 
protocol used for the work reported in this thesis applies the first method 
according to the recommended protocol from Illumina. 
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Figure 4-2 Strand-specific RNA-Seq. 
Strand-specific RNA-seq showing differential adaptor methods (A) and differential marking 
methods (B) mRNA is shown in grey, and cDNA in black. For differential adaptor methods, 5’ 
adaptors are shown in blue, and 3’ adaptors in red (Levin et al., 2010). 
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4.1.3 Advantages and disadvantages of RNA-seq compared to 
directional RNA-seq 
RNA-seq allows analysis of all expressed transcripts, with three key goals in 
terms of structure annotation, expression quantification, and characterizing 
alternative splicing. Strand-specific RNA-seq offers improvements on standard 
RNA-seq with respect to these three goals as highlighted in Table 4-1, but incurs 
higher costs. 
Table 4-1 Comparison of RNA-seq and strand-specific RNA-seq 
 RNA-seq Strand-specific RNA-seq 
 
Advantages 
Annotating the structures of all 
transcribed genes including their 5′ and 3′ 
ends and all splice junctions 
Accurately identifying antisense 
transcripts 
Quantifying expression of each transcript Determining the transcribed 
strand of non-coding RNAs  
(lincRNAs) 
 Measuring the extent of alternative 
splicing 
Demarcating the boundaries of 
closely situated or overlapping 
genes 
Disadvantages Cannot determine the polarity of RNA 
transcription 
Costs much more than RNA-seq 
 
4.1.4 Units of expression measurement 
Quantifying the results of RNA-seq is much more complicated than doing so for 
microarrays. The sensitivity of RNA-seq will be a function of both molar 
concentration and transcript length. To take this into account, the unit measure 
of read density reflects the molar concentration of a transcript in the starting 
sample by normalizing for RNA length and for the total read number in the 
measurement (Mortazavi et al., 2008). The normalization method will facilitate 
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transparent comparison of transcript levels both within and between samples 
(Mortazavi et al., 2008). 
Two specific measures of reads density that are commonly used are RPKM and 
FPKM. RPKM indicates the Reads Per Kilobase of exon model per Million mapped 
reads. For example, a 1kb transcript with 1000 alignments in a sample of 10 
million reads (out of which 8 million reads can be mapped) will have a 
RPKM=1000/ (1*8) =125. FPKM is used for pair-end sequencing, and indicates the 
Fragments Per Kilobase of exon per Million fragments mapped. A pair of reads 
constitutes one fragment. 
4.1.5 Analysis tools for RNA-seq 
A range of software analysis tools are available for use with RNA-seq data. The 
main software used for RNA-seq analysis is: 
• CLC Genomic workbench (CLC bio), which can be used to discover the 
novel exons but offers limited functionality for discovering novel 
alternative splicing. 
• Partek Genomics Suite, which can discover ‘unexpected regions’ including 
the novel genes, 3’and 5’ extensions and the splicing variants between 
the tissues. However this software offers limited functionality for 
discovery of the novel alternative splicing isoforms and transcripts 
discovery. 
• TopHat and Cufflinks is freely available public domain software. This 
software can be used to generate pipelines that represent the best option 
for novel gene and novel alternative splicing discovery. 
Many mapping tools have been developed since the introduction of RNA-seq, 
with the TopHat being among the most popular ones. TopHat aligns RNA-seq 
reads using the ultra high-throughput short reads aligner Bowtie, and then 
analyses the mapping results to identify known and novel splice junctions 
between exons as illustrated in Figure 4.3 A (Trapnell et al., 2009). For 
transcriptome reconstruction, the most commonly used tools are Cufflinks 
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(Trapnell et al., 2010) and Scripture (Guttman et al., 2010), both of which 
reconstruct a set of transcripts using reads mapped with TopHat. As shown in 
Figure 4.3 B, the Cufflinks package makes use of the components Cuffcompare 
and Cuffdiff for different gene expression detection and discovering novel genes  
(Trapnell et al., 2012; Trapnell et al., 2010). 
Although other mappers, such as GSNAP (Wu and Nacu, 2010), have been 
described as more accurate than TopHat, they have never been used in 
combination with the transcriptome reconstruction tools. It is these 
transcriptome reconstruction tools that not only assemble the transcripts and 
estimate their abundances, but also search for the difference between 
assemblies and references  in order to discover novel genes and test for 
differential expression and regulation in RNA-seq samples as mentioned 
previously (Palmieri et al., 2012). In this sense, the TopHat and Cufflinks 
pipeline is the only pipeline so far that performs all the analysis together. 
However, TopHat and Cufflinks do not address all applications of RNA-seq, nor 
they are only tools for RNA-seq analysis. TopHat and Cufflinks require a 
sequenced genome reference. The software has been designed for use 
specifically with data formatted from either Illumina or SOLiD sequencing 
machines. In addition, it can be difficult to distinguish full-length novel 
transcripts from partial fragments using RNA-seq alone. As a consequence, the 
results obtained need to be validated by traditional cloning and PCR-based 
techniques, or validation of transcript ends by rapid amplification of cDNA ends 
(RACE) to rule out incomplete reconstruction due to gaps in sequencing coverage 
(Trapnell et al., 2012). 
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The simple TopHat and Cufflinks pipeline of RNA-seq analysis by. 
 
Figure 4-3 The TopHat and Cufflinks pipeline. 
(A) The TopHat pipeline. RNA-Seq reads are mapped against the whole reference genome, and 
those reads that do not map are set aside. An initial consensus of mapped regions is computed by 
Maq. Sequences flanking potential donor/acceptor splice sites within neighbouring regions are 
joined to form potential splice junctions. Picture adapted from (Trapnell et al., 2009) (B) The 
TopHat and Cufflinks pipeline. TopHat uses Bowtie to align the reads and TopHat discovers 
splice sites. Cufflinks assembles the transcripts. CummeRbund views the image. Picture adapted 
from (Trapnell et al., 2012). (C) A simple TopHat and Cufflinks workflow for RNA-seq analysis. 
A B 
C 
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4.1.6 RNA-seq in Drosophila research 
The rapid development of RNA-seq has led to several research groups using this 
technology to investigate the transcriptome of Drosophila. Whilst this has 
included looking for the novel transcripts, novel alternative splicing but most 
research focused on development in Drosophila. 
One of the key research projects at present is the National Human Genome 
Research Institute (NHGRI) model organism ENCyclopedia Of DNA Elements 
(modENCODE). A principal goal of this project is to go beyond the annotations 
and identify previously unannotated transcripts in Drosophila. Two papers have 
been published recently by modENCODE. One of these papers investigated the 
transcriptome of 27 distinct stages of development of Drosophila melanogaster. 
This project identified 1,938 new transcribed regions not linked to any 
annotated gene model (Graveley et al., 2011). The second paper reported on an 
investigation into transcriptional diversity in 25 Drosophila cell lines.	  This second 
project identified 1,405 novel transcribed regions; 684 of these appear to be 
new exons of neighbouring, often distant, genes. Another  Drosophila  RNA-seq 
research project investigated 10 Drosophila developmental stages by using 
paired-end RNA sequencing (Daines et al., 2011). In this study, a total of 319 
novel transcripts were identified, representing a 2% increase over the current 
level of annotation. Yet another group reanalysed modENCODE data by 
redeveloping the TopHat program, subsequently identifying 1,119 lincRNA loci in 
the Drosophila melanogaster genome (Young et al., 2012). 
Given their distinct focus on development rather than differentiated adult 
tissues, these recently publications can form a useful complement to the work 
presented in this thesis. Our research principally focuses on the discovery of 
novel transcripts, genes, exons and alternative splicing in specific adult tissues 
of Drosophila melanogaster. We have generated the RNA-seq data from heads, 
testes, whole flies and tubules. In particular, my project is concerned mainly 
with studies of tubules. We can use the data from modENCODE to help us 
confirm our results, and our results in turn can be integrated with those of the 
modENCODE project for the benefit of the wider research community. 
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4.2 RNA-seq and Strand –specific RNA-seq (ssRNA-seq) 
experiment design 
The aim of this experiment using RNA-seq analysis was to identify novel genes in 
Drosophila tubules. Four biological replicates of whole flies (Canton S), three 
biological replicates of tubules, three biological replicates of heads, three 
biological replicates of testes of Canton S flies were sequenced by the Illumina 
Genome Analysis System (GAIIx) using RNA-seq technology in order to obtain the 
fold-change of tubule/whole flies, testes/whole flies and heads/whole flies and 
find out the tubule-enriched, testes-enriched and head-enriched novel genes of 
Drosophila melanogaster. Because the RNA-seq was just started when this 
project was set up, so the ‘pilot’ experiment was from one sample of each tissue 
(whole flies, testes, tubules and heads) generated by single-end reads of 54bp. 
Further replicates of the four tissues were generated by single-end reads of 76bp 
as technology developed between the two experiments. 
The aim of the experiment using strand-specific RNA-seq was to identify the 
direction of novel transcripts and thereby increase confidence in the findings of 
the RNA-seq results. Due to the disadvantages of RNA-seq which can’t identify 
the direction of the strand, however the information of the strand is important 
to identify novel genes and this project focused on searching novel genes in 
tubules, so one sample of tubule (Canton S flies) was analyzed by the strand-
specific RNA-seq technology to help verifying the novel tubule-enriched genes 
which found by RNA-seq technology. 
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4.3 Results 
4.3.1 Transcript Classification Scheme in Cufflinks 
The ‘class_code’ is a classification alphabet designed for Cufflinks pipeline to 
represent the status of transcripts compared with the reference genome. The 
set of class_codes and their representation in Cufflinks is listed in table 4-2. 
These classifications were used in the analysis pipeline developed for this 
project. 
Table 4-2 Class_code and its representation in Cufflinks 
Priority Code Description 
1 = Complete match of intron chain 
2 c Contained  
3 j Potentially novel isoform (fragment): at least one splice junction is shared with a reference 
transcript 
 
4 e Single exon transfrag overlapping a reference exon and at least 10 bp of a reference intron, 
indicating a possible pre-mRNA fragment. 
 
5 i A transfrag falling entirely within a reference intron  
6 o Generic exonic overlap with a reference transcript  
7 p Possible polymerase run-on fragment (within 2Kbases of a reference transcript)  
8 r Repeat. Currently determined by looking at the soft-masked reference sequence and applied 
to transcripts where at least 50% of the bases are lower case 
 
9 u Unknown, intergenic transcript  
10 x Exonic overlap with reference on the opposite strand  
11 s An intron of the transfrag overlaps a reference intron on the opposite strand (likely due to 
read mapping errors) 
 
12 . (.tracking file only, indicates multiple classifications) 
 
Table adapted from the online Cufflinks user manual available at 
http://cufflinks.cbcb.umd.edu/manual.html. Each ‘class_code’ is characterized in terms of its 
priority meaning the ordering used to assign class codes in the case when multiple classifications 
are possible (low number indicate higher priority), its assigned code symbol, and a textual 
description. 
Novel tissue-enriched genes were identified using the data analysis pipeline 
described in Figure 4-4. 
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4.3.2 Analysis pipeline to find tissue-enriched genes 
The single-end 54bp (one replicate) and 76bp (two-replicates) sequence samples 
from the Illumina GAIIx were cleaned using scripts developed in-house to remove 
the adaptors, then the FASTQ files were exported for analysis in TopHat. TopHat 
aligned the reads to the genome using Bowtie (Langmead et al., 2009), and 
TopHat (Trapnell et al., 2009) also generated a database of the possible splicing 
junctions, and then mapped the reads against these junctions to confirm them. 
Next, the unmapped reads were splitted and remapped to the database of the 
splicing junctions. The known splicing junctions and novel splicing junctions 
were found. 
Cufflinks was used to assemble all the possible transcripts and build new 
combined annotations. Cuffcompare was then used to compare the resulting 
combined annotations with the FlyBase reference annotation to identify the 
novel isoforms (class_code ‘j’) and novel gene (class_code ‘u’). 
Cuffmerge was used to merge all the transcripts involved in the comparison in 
the project. Cuffcompare could also take the entire merged file to compare the 
reference annotation files to find all the novel genes and isoforms in the entire 
merged files. 
Cuffdiff was run to perform a comparison across the merged files to find the 
enriched genes in specific tissues that met the criteria of a fold change greater 
than 3 and p-value less than 0.05, and a false positive rate value (q value) less 
than 0.05 (statistic as detailed in Section 4.3.7.1). The types of tissue-specific 
enriched genes were indicated by different class codes. The Venn diagram 
helped to identify the overlapped genes in heads, testes and tubules, and then 
find the possible tissue specific novel genes. 
In order to eliminate potential for genomic contamination, those candidates in 
the tissue-specific novel gene list that have a single exon were not considered as 
novel genes unless they were conserved in other species. The candidate novel 
genes with two exons are more likely to be novel genes and not genomic 
contamination. In addition, the entire candidate novel genes had to be 
supported by strand-specific RNA-seq results (ssRNA-seq) to make the final list of 
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novel genes due to the fact that the RNA-seq was not direction-aware, and the 
information from RNA-seq came from both forward and reverse strands. Some of 
this information may be inaccurate, especially in the case of two genes 
overlapped from different directions or partially overlapped genes from both 
strands. 
The process of how to select tissue-specific novel genes using TopHat and 
Cufflinks pipeline was also listed in Figure 4-4. 
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Figure 4-4 The analysis pipeline using TopHat and Cufflinks to find novel tissue enriched 
genes.  
Tubules, testes, heads and whole fly single-end 54bp and 76bp RNA-seq results imported into 
TopHat. TopHat aligned the reads to exons and splice junctions using Bowtie. TopHat results were 
assembled into transcripts by Cufflinks. Cuffcompare used cufflinks results to compare with 
FlyBase annotation to find new isoforms (76,640), new genes located intergenic regions (2,568). 
Cuffdiff used Cufflinks results to find the novel tissue enriched genes (1,144 in testes, 71 in tubules, 
and 119 in heads), the filter was also applied as  gene expression level RPKM>1, folds-change ≥3, 
p value<0.05, q value <0.05. Venn diagram to choose the nonoverlapping tissue specific novel 
genes (1,124 in testes, 55 in tubules, 103 in heads) with more than two exons were considered 
novel genes (10 genes), 22 single exons may be possible novel genes, they are conserved in 
Drosophila species. Note that new isoforms are assigned the class_code ‘j’, and new genes are 
assigned the class_code ‘u’. 
4.3.3 Filtering of reads produced by Illumina GAIIx  
The samples were run on Illumina GAIIx, and then the proprietary software 
within GAIIx was used to filter out high quality reads. A script was developed in 
house to remove the adaptors, clean the reads producing Fastq files suitable for 
importing into TopHat. 
Table 4-3 Filtered reads produced by Illumina GAIIx 
Flow cell Lane sample Read length  
Number of 
PF reads 
Number of 
Clean reads % clean 
FC058 
FC058 
FC006 
 
FC058 
FC058 
FC006 
 
FC063 
FC055 
FC006 
 
FC058 
FC058 
FC006 
FC015 
 
FC053 
 
S2 
S3 
S1 
 
S4 
S5 
S4 
 
S7 
S4 
S3 
 
S6 
S7 
S2 
S4 
 
S5 
Tb1 
Tb2 
Tb3 
 
Hd1 
Hd2 
Hd3 
 
Ts1 
Ts2 
Ts3 
 
Wf1 
Wf2 
Wf3 
Wf4 
 
Tb3 direct 
76 
76 
54 
 
76 
76 
54 
 
76 
76 
54  
 
76 
76 
54 
76 
 
76 
32,553,488 
26,528,842 
5,473,207 
 
29,509,968 
30,700,445 
6,092,923 
 
29,486,131 
30,146,737 
6,017,042 
 
30,299,951 
30,395,145 
63,155,32 
13,687,600 
 
27,076,624 
 
32,057,244 
26,232,304 
5,449,066 
 
29,026,152 
30,346,171 
6,077,917 
 
29,406,000 
29,951,494 
5,988,635 
 
29,908,345 
30,054,672 
6,177,362 
13,567,308 
 
26,928,326 
98.48 
98.88 
99.56 
 
98.36 
98.85 
99.75 
 
99.73 
99.35 
99.53 
 
98.71 
98.88 
97.81 
99.12 
 
99.45 
Tb tubules Hd heads Wf whole flies Ts testes Tb direct tubules strand-specific RNA-seq. Flow 
cell tells which flow cell the samples amplified on. Lane indicates the position of the samples on 
the flow cell. Read length indicates the sequence length. Number of PF reads means the number 
of the reads past the filter of GAIIx proprietary software. Number of cleaned reads means the 
reads generated by house-made script after removed the adaptors. % clean the percentage of the 
clean to pass filter reads. 
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Table 4-3 lists the set of filtered reads produced by the Illumina GAIIx for 
samples used in this project. 
4.3.4 Checking quality of RNA-seq data using FastQC 
 
 
 
Figure 4-5 FastQC quality control of RNA-seq samples.  
The central red line represents the median value. The yellow box represents the inter-quartile 
range (25-75%). The upper and lower whiskers represent the 10% and 90% points. The blue line 
represents the mean quality. The y-axis on the graph shows the quality scores also called the 
Phred quality scores. The background of the graph is divided along the y axis into very good quality 
calls (green), calls of reasonable quality (orange), and calls of poor quality (red). (A) (B) (D) Tubule 
and whole fly sequences of read length 76bp. From base 1 to 76, the mean Phred quality score is 
above 28 indicating probability of an incorrect base call is 1 in 1000. The base call accuracy is 
99.9%. Graph showed most base calls are very good quality (in green) (C) Tubule sequences of 
read length 54bp. From base 1 to 40, the mean Phred quality score is above 28 indicating the 
probability of an incorrect base call is 1 in 1000. The base call accuracy is 99.9% and calls are very 
good quality (green), from base 42 to 54, the mean Phred quality score drops to 24 indicating the 
probability of an incorrect base call is 1 in 100. The base call accuracy is 99 % and calls are of 
reasonable quality (orange). 
A. Tubules1 
 
C.Tubules3 D. Whole flies 
B. Tubules2 
149 
FastQC offers a simple quality control checks aimed at providing a QC report 
that can spot problems which originated either in the sequencer, or in the 
starting library material. 
The FastQC analysis was performed by a series of analysis modules. Figure 4.5 
presents the results of the Per Base Sequence Quality mode. This view shows the 
range of quality values across all bases at each position in the FastQ file using a 
Box Whisker type of plot. 
The quality scores also called Phred quality scores which were originally 
developed by the program Phred to help in the automation of DNA sequencing in 
the Human Genome Project (Ewing and Green, 1998; Ewing et al., 1998). Phred 
quality scores have become widely accepted to characterize the quality of DNA 
sequences, and can be used to compare the efficacy of different sequencing 
methods. Phred quality can be used to automatically determine accurate, 
quality-based consensus sequences. Higher Phred scores indicate better base call 
as listed in Table 4-4. The maximum Phred quality is 40 in Illumina. 
Table 4-4  Phred quality scores and their interpretation 
 Phred Quality Score Probability of incorrect base call Base call accuracy 
10 1 in 10 90% 
20 1 in 100 99% 
30 1 in 1000 99.9% 
99.99% 40 1 in 10000 
50 1 in 100000 99.999% 
 
Phred quality scores are logarithmically linked to error probabilities. Phred quality score 10 
indicates of an incorrect base call is 1 in 10 and the base call accuracy is 90%. Phred quality score 
20 indicates of an incorrect base call is 1 in 100 and the base call accuracy is 99%. Phred quality 
score 30 indicates of an incorrect base call is 1 in 1000 and the base call accuracy is 99.9%. Phred 
quality score 40 indicates of an incorrect base call is 1 in 10000 and the base call accuracy is 
99.99%. Phred quality score 50 indicates of an incorrect base call is 1 in 100000 and the base call 
accuracy is 99.999%. The higher score indicates the better quality of the sequence. 
The background of the graph shown in Figure 4-5 divided along y axis in order to 
highlight very good quality calls (green), calls of reasonable quality (orange), 
and calls of poor quality (red). The quality of calls on most platforms degrades 
as the run progresses, so it was common to see base calls falling into the orange 
area towards the end of a read. 
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4.3.5 Aligning reads using TopHat and Bowtie 
The Glasgow University Polyomics built TopHat and Cufflinks pipeline was used 
in this analysis. 
TopHat (version 1.3.0) was firstly to use the clean Fastq reads files (from Table 
4-3 Number of clean reads) to align the reads to the exons using Bowtie which 
assigned at least 12bp bases on each side of the junction by this project. Table 
4-5 summarizes the results of this alignment. 
Table 4-5 Reads mapped to exons and junctions, produced by TopHat 
Sample Reads processed Reads mapped to the exons Reads mapped to the 
junction 
Tb1 
Tb2 
Tb3 
 
Hd1 
Hd2 
Hd3 
 
Ts1 
Ts2 
Ts3 
 
Wf1 
Wf2 
Wf3 
Wf4 
32,006,864 
26,194,960 
5,445,631 
 
28,973,336 
30,297,540 
6,075,507 
 
29,124,920 
29,926,559 
5,984,409 
 
29,867,435 
30,003,785 
6,173,774 
13,508,858 
25,247,267 
20,676,854 
4,5694,00 
22,811,201 
23,889,196 
5,099,139 
 
22,072,809 
22,863,205 
5,050,273 
 
24,185,549 
24,162,772 
5,089,657 
90,118,51 
 
3,191,986 
2,831,559 
401,047 
3,205,868 
3,150,896  
466,779 
 
2,636,754 
2,768,407 
355,182 
 
2,601,356 
2,844,382 
401,047 
1,341,704 
 
 
Tb tubules Hd heads   Wf whole flies Ts testes. Reads processed were the clean reads from 
GAIIx after being filtered. Reads mapped to the exons were the reads mapped to exons by 
TopHat. Reads mapped to the junctions were total reads mapped to the known and putative 
junctions 
The unmapped reads were put aside. TopHat was next used to build the index of 
all possible spliced junctions including all the known and putative junctions 
recoded in the annotated data from Flybase 5.36 (www.flybase.org) by using the 
aligned exons. TopHat used all the discarded reads to map this newly built 
junction database (see Table 4-5 Reads mapped to the junctions), and then the 
novel junctions could then be found by a process of comparison after subtracting 
the known junctions. The final output of TopHat is an alignment file in BAM 
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format (accept_hits.bam) and lists of splice junctions and indels in BED format 
ready for visualization in a genome brower. 
 
4.3.6 Discovering tissue-specific novel genes using Cufflinks  
Cufflinks (version 1.0.3) was run for each sample separately. Transcripts were 
assembled based on the TopHat alignment files (accepted_hits.bam), using 
existing genome annotations recodes in FlyBase 5.36 but also allowing for novel 
transcripts. Output: transcripts.gtf (Cufflinks assembled isoforms); 
Isoforms.fpkm_ tracking (isoform level expression value RPKM); genes.fpkm_ 
tracking (gene level expression value RPKM). This produced a list of all the 
generated transcripts.gtf which was stored in the file ‘assemblies.txt’ for every 
sample. 
Cuffmerge was used to convert the input from files gtf to sam format and then 
merged Cufflinks generated transcripts .gtf files (also specified in the list as 
‘assemblies.txt’ for each tissue) into a single merged.gtf file. The output files 
were: transcripts.gtf; isoform.fpkm_tracking; genes.fpkm_tracking for all tissue 
samples. 
The transcripts.gtf file was compared against the reference genome annotation 
file by Cuffcompare and the final merged.gtf file was generated (examples of 
merged_gtf file is shown in Table 4-6). This merged file contained newly built 
gene_id (XLOC_...), transcript_id (TCONS_...), exon start and end point, and 
transcript class_codes indicating the possible type of the transcripts. 
Cuffcompare was used to discover the novel genes or transcripts in merged.gtf 
file that were located in intergenic regions (class_code “u”) or fell into the 
intronic regions (class_code “i”). However, the novel genes discovered were not 
necessarily tissue-specific. Cuffdiff allowed the identification of tissue-specific 
novel genes. The example of a merged.gtf file with class_code is shown in Table 
4-6. The summary of all the class_codes of the entire tissues is listed in Table 4-
7. 
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Table 4-6 Example of an excerpt from a merged.gtf file with the reported class_code 
 
Note that this is only an excerpt from merge.gtf file (the original file is too big to include in whole in 
the thesis). This file contains all the tissue samples. It shows the chromosome position, the gene 
prediction source (Cufflinks or FlyBase), gene identification number (XLOC_), transcripts 
identification number (TCONS_), exon numbers in the transcripts, and class_code. tss_id is the ID 
of this transcript's inferred start site. Determines which primary transcript this processed transcript 
is believed to come from. 
  
chr2L Cufflinks gene_id	  "XLOC_000001";	  transcript_id	  "TCONS_00000001";	  exon_number	  "1";	  class_code	  "j";	  tss_id	  "TSS1";
chr2L Cufflinks gene_id	  "XLOC_000001";	  transcript_id	  "TCONS_00000001";	  exon_number	  "2"";	  class_code	  "j";	  tss_id	  "TSS1";
chr2L Cufflinks gene_id	  "XLOC_000001";	  transcript_id	  "TCONS_00000001";	  exon_number	  "3";	  class_code	  "j";	  tss_id	  "TSS1";
chr2L FlyBase gene_id	  "XLOC_000001";	  transcript_id	  "TCONS_00000003";	  exon_number	  "1";	  class_code	  "=";	  tss_id	  "TSS1";
chr2L FlyBase gene_id	  "XLOC_000001";	  transcript_id	  "TCONS_00000003";	  exon_number	  "2"	  class_code	  "=";	  tss_id	  "TSS1";
chr2L Cufflinks gene_id	  "XLOC_000002";	  transcript_id	  "TCONS_00000004";	  exon_number	  "1"	  class_code	  "s";	  tss_id	  "TSS2";
chr2L Cufflinks gene_id	  "XLOC_000002";	  transcript_id	  "TCONS_00000004";	  exon_number	  "2"	  class_code	  "s";	  tss_id	  "TSS2";
chr2L Cufflinks gene_id	  "XLOC_000014";	  transcript_id	  "TCONS_00000051";	  exon_number	  "1";	  	  class_code	  "x";
chr2L Cufflinks gene_id	  "XLOC_000015";	  transcript_id	  "TCONS_00000052";	  exon_number	  "1";	  class_code	  "o";
chr2L Cufflinks gene_id	  "XLOC_000806";	  transcript_id	  "TCONS_00001671";	  exon_number	  "1";	  	  class_code	  "u";	  tss_id	  "TSS984";
chr2L Cufflinks gene_id	  "XLOC_000806";	  transcript_id	  "TCONS_00001671";	  exon_number	  "2";	  	  class_code	  "u";	  tss_id	  "TSS984";
chr2L Cufflinks gene_id	  "XLOC_000831";	  transcript_id	  "TCONS_00001706";	  exon_number	  "1";	  class_code	  "x";	  tss_id	  "TSS1008";
chr2L Cufflinks gene_id	  "XLOC_000857";	  transcript_id	  "TCONS_00001767";	  class_code	  "u";	  tss_id	  "TSS1049";
chr2L Cufflinks gene_id	  "XLOC_000857";	  transcript_id	  "TCONS_00001767";	  exon_number	  "2";	  ;	  class_code	  "u";	  tss_id	  "TSS1049";
chr2L Cufflinks gene_id	  "XLOC_000857";	  transcript_id	  "TCONS_00001767";	  exon_number	  "3";	  class_code	  "u";	  tss_id	  "TSS1049";
chr2L Cufflinks gene_id	  "XLOC_000867";	  transcript_id	  "TCONS_00001805";	  exon_number	  "1";	  class_code	  "u";	  tss_id	  "TSS1068";
chr2L Cufflinks gene_id	  "XLOC_000867";	  transcript_id	  "TCONS_00001805";	  exon_number	  "2";	  	  class_code	  "u";	  tss_id	  "TSS1068";
chr2L Cufflinks gene_id	  "XLOC_000886";	  transcript_id	  "TCONS_00001843";	  exon_number	  "1";	  class_code	  "x";
chr2L Cufflinks gene_id	  "XLOC_000887";	  transcript_id	  "TCONS_00001844";	  exon_number	  "1";	  	  class_code	  "j";	  tss_id	  "TSS1091";
chr2L Cufflinks gene_id	  "XLOC_000887";	  transcript_id	  "TCONS_00001844";	  exon_number	  "2";	  class_code	  "j";	  tss_id	  "TSS1091";
chr2L Cufflinks gene_id	  "XLOC_000887";	  transcript_id	  "TCONS_00001844";	  exon_number	  "3";	  class_code	  "j";	  tss_id	  "TSS1091";
chr2L Cufflinks gene_id	  "XLOC_000887";	  transcript_id	  "TCONS_00001844";	  exon_number	  "4";	  	  ;	  class_code	  "j";	  tss_id	  "TSS1091";
chr2L FlyBase gene_id	  "XLOC_000901";	  transcript_id	  "TCONS_00001877";	  exon_number	  "1";	  class_code	  "=";
chr2L Cufflinks gene_id	  "XLOC_000902";	  transcript_id	  "TCONS_00001878";	  exon_number	  "1";	  class_code	  "x";
chr2R Cufflinks gene_id	  "XLOC_003782";	  transcript_id	  "TCONS_00007807";	  exon_number	  "1";	  class_code	  "x";	  tss_id	  "TSS4243";
chr2R Cufflinks gene_id	  "XLOC_003782";	  transcript_id	  "TCONS_00007807";	  exon_number	  "2";	  class_code	  "x";	  tss_id	  "TSS4243";
chr2R FlyBase gene_id	  "XLOC_003783";	  transcript_id	  "TCONS_00007808";	  exon_number	  "1";	  class_code	  "=";	  tss_id	  "TSS4244";
chr2R Cufflinks gene_id	  "XLOC_003784";	  transcript_id	  "TCONS_00007810";	  exon_number	  "1";	  class_code	  "j";	  tss_id	  "TSS4246";
chr2R Cufflinks gene_id	  "XLOC_003784";	  transcript_id	  "TCONS_00007810";	  exon_number	  "2";	  class_code	  "j";	  tss_id	  "TSS4246";
chr2R Cufflinks gene_id	  "XLOC_003784";	  transcript_id	  "TCONS_00007810";	  exon_number	  "3";	  class_code	  "j";	  tss_id	  "TSS4246";
chr2R Cufflinks gene_id	  "XLOC_003784";	  transcript_id	  "TCONS_00007810";	  exon_number	  "4";	  class_code	  "j";	  tss_id	  "TSS4246";
chr2R Cufflinks gene_id	  "XLOC_004549";	  transcript_id	  "TCONS_00009527";	  exon_number	  "1";;	  class_code	  "u";	  tss_id	  "TSS5130";
chr2R Cufflinks gene_id	  "XLOC_004549";	  transcript_id	  "TCONS_00009527";	  exon_number	  "2";	  ;	  class_code	  "u";	  tss_id	  "TSS5130";
chr2R Cufflinks gene_id	  "XLOC_004550";	  transcript_id	  "TCONS_00009528";	  exon_number	  "1";	  class_code	  "u";	  tss_id	  "TSS5131";
chr2R Cufflinks gene_id	  "XLOC_004550";	  transcript_id	  "TCONS_00009528";	  exon_number	  "2";	  class_code	  "u";	  tss_id	  "TSS5131";
chr3L Cufflinks gene_id	  "XLOC_006483";	  transcript_id	  "TCONS_00013701";	  exon_number	  "1";	  class_code	  "j";	  tss_id	  "TSS7243";
chr3L Cufflinks gene_id	  "XLOC_006483";	  transcript_id	  "TCONS_00013701";	  exon_number	  "2";	  ;	  class_code	  "j";	  tss_id	  "TSS7243";
chr3L Cufflinks gene_id	  "XLOC_006483";	  transcript_id	  "TCONS_00013701";	  exon_number	  "3";	  class_code	  "j";	  tss_id	  "TSS7243";
chr3L Cufflinks gene_id	  "XLOC_007340";	  transcript_id	  "TCONS_00015452";	  exon_number	  "1";	  class_code	  "u";	  tss_id	  "TSS8255";
chr3L Cufflinks gene_id	  "XLOC_007340";	  transcript_id	  "TCONS_00015452";	  exon_number	  "2";	  ;	  class_code	  "u";	  tss_id	  "TSS8255";
chr3L Cufflinks gene_id	  "XLOC_007340";	  transcript_id	  "TCONS_00015453";	  exon_number	  "1";	  	  class_code	  "u";	  tss_id	  "TSS8255";
chr3L Cufflinks gene_id	  "XLOC_007340";	  transcript_id	  "TCONS_00015453";	  exon_number	  "2";	  	  class_code	  "u";	  tss_id	  "TSS8255";
chr3L Cufflinks gene_id	  "XLOC_007340";	  transcript_id	  "TCONS_00015453";	  exon_number	  "3";	  class_code	  "u";	  tss_id	  "TSS8255";
chr3R Cufflinks gene_id	  "XLOC_011674";	  transcript_id	  "TCONS_00024666";	  exon_number	  "1";	  class_code	  "u";	  tss_id	  "TSS13385";
chr3R Cufflinks gene_id	  "XLOC_011674";	  transcript_id	  "TCONS_00024666";	  exon_number	  "2";	  ;	  class_code	  "u";	  tss_id	  "TSS13385";
chr3R Cufflinks gene_id	  "XLOC_011675";	  transcript_id	  "TCONS_00024667";	  exon_number	  "1";	  class_code	  "x";	  tss_id	  "TSS13386";
chr3R Cufflinks gene_id	  "XLOC_011675";	  transcript_id	  "TCONS_00024667";	  exon_number	  "2";	  class_code	  "x";	  tss_id	  "TSS13386";
chr3R Cufflinks gene_id	  "XLOC_011676";	  transcript_id	  "TCONS_00024668";	  exon_number	  "1";	  	  class_code	  "=";	  tss_id	  "TSS13387";
chr3R Cufflinks gene_id	  "XLOC_011676";	  transcript_id	  "TCONS_00024668";	  exon_number	  "2";	  class_code	  "=";	  tss_id	  "TSS13387";
chr3R Cufflinks gene_id	  "XLOC_011676";	  transcript_id	  "TCONS_00024668";	  exon_number	  "3";	  class_code	  "=";	  tss_id	  "TSS13387";
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Table 4-7 Summary of classified transcripts in the merged.gtf file for all tissues 
Class_code id Description Total number of 
transcripts 
= Complete match of intron chain 114761 
u Unknown, intergenic transcript 2568 
o Generic exonic overlap with a reference transcript 1114 
j Potentially novel isoform (fragment): at least one 
splice junction is shared with a reference transcript 
76460 
x Exonic overlap with reference on the opposite strand 1071 
s An intron of the transfrag overlaps a reference intron 
on the opposite strand (likely due to read mapping 
errors) 
205 
p Possible polymerase run-on fragment (within 2Kbases 
of a reference transcript) 
0 
r 
 
Repeat. Currently determined by looking at the soft-
masked reference sequence and applied to transcripts 
where at least 50% of the bases are lower case. 
0 
e 
 
Single exon transfrag overlapping a reference exon and 
at least 10 bp of a reference intron, indicating a 
possible pre-mRNA fragment. 
0 
i A transfrag falling entirely within a reference intron 0 
c 
 
Contained 0 
Total 196179 
Note that this is the summary of all classified transcripts in the merged file produced by Cufflinks for 
heads, testes, tubules and whole flies. The class_code id is defined by Cufflinks. 
 
4.3.7 Calculating differential gene expression using Cuffdiff 
4.3.7.1 Differential expression in all tissues 
Cuffdiff was run using the merged.gtf as input to find the differential expression 
in genes and isoforms so identifying tissue-enriched gene expression. The output 
files produced by this data analysis were gene_exp.diff including differential 
gene expression of tubules versus whole flies (Tb-Wf), heads versus whole flies 
(Hd-W), and testes versus whole flies (Ts-Wf) and isoform_exp.diff including 
transcript differential expression of tubules versus whole flies (Tb-Wf), heads 
versus whole flies (Hd-wf), and testes versus whole flies (Ts-Wf). From the data 
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in isoform_exp.diff, entries with an undefined class_code marked as “_” 
corresponded to the class_code “u” in the merged.gtf file had been found. No 
class_code “i” had been found in the merged files. Selection criteria was applied 
to the resulting data to select the subset class_code which marked “u” in the 
isoform_exp.diff data and with p<0.05, q<0.05, fold change≥3 and RPKM≥1 in 
order to find the tubule-enriched genes. For the statistical testing, Cuffdiff fits a 
model of fragment count variance across replicates of each sample. The 
variance is estimated using either the negative binomial distribution when a 
gene has a single isoform, or the beta negative binomial distribution when a 
gene has multiple isoforms (Anders and Huber, 2010; Trapnell et al., 2013). For 
each gene, the log2-fold change between the FPKM values in two experimental 
conditions and their estimated variances produce a variable that is 
approximately normally distributed to which standard statistics can be applied 
(student’s t test, two-tailed); p-values are then adjusted for multiple testing 
using Benjamini-Hochberg correction (Benjamini et al., 2001; Benjamini and 
Hochberg, 1995) and are reported as q-values (Bullard et al., 2010; Storey, 
2003). Cuffdiff performs only pair-wise comparison for differential expression, so 
the comparisons were between tubules/whole flies, testes/whole flies and 
heads/wholes flies. To enhance accuracy of differential analysis, upper quantile 
normalization (--upper-quantile-norm”) and multi-mapped read correction (“--
multi-read-correction”) were applied (Bullard et al., 2010; Dillies et al., 2013; 
Mortazavi et al., 2008). A summary of the novel exons and novel genes in 
different tissues (tubules, heads, testes and whole flies) generated by Cuffdiff is 
listed in Table 4-8. 
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Table 4-8 Summaries of novel single exons, multiexons (genes) in tubules, heads, testes 
and whole flies.  
Tissue Number of exons 
1 exon 2 exons      3 exons 4 exons 5 exons 6 exons Total 
Testes 
Tubules 
Heads 
Wholes flies 
906 
143 
228 
 
381 
33 
35 
71 
3 
10 
19 
0 
5 
1 
0 
0 
0 
0 
2 
1378 
179 
208 
2568 
 
Note these are the results from Cuffdiff combined with merge.gtf results (RPKM≥1).  In this study, 
we only consider multiexon or single exon which are conserved in multiple tissues as novel genes 
(Cabili et al., 2011; Graveley et al., 2011; Roberts et al., 2011). 
 
Table 4-9 Summary of tissue-enriched novel exons and gene numbers. 
Tissue Class_code Tissue vs whole flies Total number of novel 
isoforms 
Tubules 
Testes 
Heads 
u 
u 
u 
P<0.05, q<0.05,RPKM≥1, fold 
change≥3 
 
P<0.05, q<0.05,RPKM≥1, fold 
change≥3 
 
P<0.05, q<0.05,RPKM≥1, fold 
change≥3 
71 
1144 
119 
Note that this is the result from Cuffdiff combined with merge.gtf results (p<0.05, q<0.05, RPKM≥1, 
fold change≥3). The total number of novel isoforms including novel single exon and multiple exons 
isoforms (novel genes). 
A summary of the tissue-enriched genes of tubules, testes, and heads from the 
Cuffdiff and merge.gtf results is shown in Table 4-9. 
4.3.7.2 Differential expression of tubule-specific genes 
The set of tubule-enriched genes in the annotated Drosophila genome contains 
more coding genes than noncoding genes (Figure 4-6). However, in the novel 
tubule-enriched gene list (Table 4-10 as generated by Cuffdiff); there are many 
more noncoding genes than coding genes. Most of the novel genes are more 
likely to be noncoding genes (Figure 4-6). 
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Coding genes are normally more highly expressed than noncoding genes. On 
analysing long noncoding RNA genes in D. melanogaster at 30 developmental 
time points using modENCODE whole transcriptome (RNA-seq) data, Daines and 
his colleague found that across the different samples, the total gene model 
expression was, on average, 253-fold higher than for long noncoding RNA loci. 
(Daines et al., 2011; Young et al., 2012). EST, SAGE and Tiling array technologies 
are mainly more biased towards the highly expressed genes (Alba et al., 2004; 
Graveley, 2008), so more coding genes were discovered than noncoding genes in 
the past. 
Novel noncoding genes are often expressed in stage and/or sex-specific patterns 
(Young et al., 2012), some novel noncoding gene are expressed in tissue-specific 
patterns. As a consequence, these genes may be difficult to discover until the 
specific tissues or stages and/or sex are studied (Daines et al., 2011; Wang et 
al., 2004). 
 
 
 
 
 
  
 
Figure 4-6 Tubule-enriched genes from the Cuffdiff. 
Tubule-enriched genes list from Cuffdiff (tubules compared with whole flies, p<0.05, q<0.05, 
RPKM≥1, fold change≥3). (A)The canonical genes list (genes which annotated by FlyBase) 
indicated that there were more coding genes than noncoding genes in the annotated genes group. 
(B) The noncanonical genes list (novel gene lists generated from Table 4-10) indicated that there 
were more noncoding genes than coding genes in the novel gene group.  
 
  
A 
B 
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Table 4-10 Tubule-enriched novel exons and genes by Cuff_diff.  
 
  
  
This table is the differential expression analysis result of tubules versus whole flies from Cuffdiff 
(RPKM≥1, P<0.05, q<0.05 Fold Change≥3), showing Test_id (transcript id), Locus (chromosome 
position), fold-change (tubule versus whole fly ratio), q value (FDR adjusted p value). Class-
_code “u” novel genes. The list was ranked by fold change enrichment in tubules. For row 1-12 
transcripts have “0” RPKM in whole flies, and so are assigned an arbitrary enrichment of 1000000x 
 
test_id locus whole	  flies	  RPKM tubules	  RPKM fold-­‐change p_value q_value class_code
TCONS_00006099 chr2L:13095624-­‐13109468 0 7.42818 100000 0.005959 0.014623 u
TCONS_00006179 chr2L:19079233-­‐19108108 0 2.69345 100000 0.020138 0.040711 u
TCONS_00006202 chr2L:21995616-­‐21996517 0 1.5216 100000 0.005914 0.014529 u
TCONS_00006003 chr2L:3269436-­‐3319912 0 2.15575 100000 0.000441 0.001518 u
TCONS_00012999 chr2R:18966948-­‐18967217 0 21.2493 100000 0.001206 0.003687 u
TCONS_00012860 chr2R:2534767-­‐2535342 0 2.17334 100000 0.009734 0.022123 u
TCONS_00027429 chr3R:1098380-­‐1176536 0 0.175369 100000 0 0 u
TCONS_00027668 chr3R:16908757-­‐16923621 0 0.020921 100000 5.04E-­‐46 1.11E-­‐44 u
TCONS_00027669 chr3R:17139066-­‐17139474 0 2.75282 100000 0.02308 0.045647 u
TCONS_00027581 chr3R:6943963-­‐6965634 0 0.024942 100000 0 0 u
TCONS_00034144 chrX:19217991-­‐19218262 0 18.5448 100000 0.002074 0.005909 u
TCONS_00016194 chr3L:23777293-­‐23780611 0.612365 86.539 141.319 0 0 u
TCONS_00027722 chr3R:23310324-­‐23312528 0.213081 27.7166 130.0748 0 0 u
TCONS_00027738 chr3R:24393801-­‐24396268 0.06886 7.21746 104.8132 3.56E-­‐11 4.03E-­‐10 u
TCONS_00034129 chrX:17350216-­‐17425171 0.018634 1.81233 97.25827 0 0 u
TCONS_00027692 chr3R:18990380-­‐18991802 0.057033 3.93441 68.98437 3.72E-­‐05 0.000166 u
TCONS_00008658 chr2R:16189454-­‐16190517 1.40763 76.2053 54.13712 8.88E-­‐16 1.74E-­‐14 u
TCONS_00001177 chr2L:8490771-­‐8491444 0.109924 5.07965 46.21064 0.000216 0.000804 u
TCONS_00034123 chrX:16720640-­‐16730794 0.166643 7.61787 45.71379 0 0 u
TCONS_00006097 chr2L:13095624-­‐13109468 0.054874 1.82877 33.32707 5.22E-­‐07 3.24E-­‐06 u
TCONS_00020479 chr3R:5951869-­‐5965492 0.158627 4.81691 30.3662 0.000555 0.001866 u
TCONS_00019349 chr3L:4852862-­‐4853889 0.510701 15.0029 29.37723 8.36E-­‐09 6.79E-­‐08 u
TCONS_00027207 chr3R:26230174-­‐26231091 0.118323 3.37127 28.4919 0.000275 0.001 u
TCONS_00027577 chr3R:6943963-­‐6965634 0.174966 4.86959 27.83154 1.14E-­‐05 5.59E-­‐05 u
TCONS_00006065 chr2L:10048688-­‐10049223 0.34109 9.19548 26.95908 0.000128 0.000503 u
TCONS_00027656 chr3R:15425392-­‐15426143 0.135954 3.19778 23.52091 0.002792 0.007632 u
TCONS_00034121 chrX:16298524-­‐16298875 0.52414 8.99951 17.17011 0.007586 0.017925 u
TCONS_00009515 chr2R:184503-­‐184996 1.03831 17.7604 17.10516 5.84E-­‐05 0.000249 u
TCONS_00027672 chr3R:17141001-­‐17142046 0.134378 2.25207 16.75924 0.00136 0.004095 u
TCONS_00013882 chr3L:4629603-­‐4687354 1.48425 23.9035 16.10484 3.76E-­‐06 2.03E-­‐05 u
TCONS_00006094 chr2L:13094768-­‐13095402 0.24743 3.75432 15.17319 0.002173 0.006154 u
TCONS_00006027 chr2L:5339022-­‐5365039 0.767296 11.4185 14.88152 2.11E-­‐08 1.61E-­‐07 u
TCONS_00004375 chr2L:9669700-­‐9670824 0.175688 2.5663 14.60713 0.000551 0.001853 u
TCONS_00027315 chr3R:26956519-­‐26957324 0.195563 2.83968 14.52048 0.004472 0.011489 u
TCONS_00022965 chr3R:24411661-­‐24417150 0.18552 2.64739 14.27001 0.000729 0.002374 u
TCONS_00006095 chr2L:13095624-­‐13109468 0.253019 3.60268 14.23879 0.001076 0.003337 u
TCONS_00012944 chr2R:14692364-­‐14693007 0.150399 1.98069 13.16958 0.017534 0.036256 u
TCONS_00028338 chr4:77917-­‐83616 0.101055 1.28196 12.68563 1.26E-­‐06 7.36E-­‐06 u
TCONS_00006096 chr2L:13095624-­‐13109468 0.24878 3.14448 12.63954 0.003364 0.008989 u
TCONS_00034089 chrX:9474619-­‐9475098 0.260195 3.15075 12.10925 0.020975 0.042118 u
TCONS_00006105 chr2L:13801919-­‐13802826 0.236262 2.80555 11.8747 0.000738 0.002398 u
TCONS_00012972 chr2R:17369423-­‐17385431 0.034267 0.392436 11.45241 0 0 u
TCONS_00027486 chr3R:6689076-­‐6696542 42.3827 469.477 11.0771 5.12E-­‐10 4.99E-­‐09 u
TCONS_00001105 chr2L:8258615-­‐8301072 0.102267 1.12577 11.00808 6.39E-­‐05 0.000271 u
TCONS_00006092 chr2L:13092399-­‐13093841 0.215135 2.32892 10.82534 0.001311 0.003971 u
TCONS_00006093 chr2L:13093910-­‐13094690 0.158768 1.70519 10.74016 0.015536 0.032785 u
TCONS_00017431 chr3L:8569749-­‐8571158 0.379966 3.99535 10.51508 7.15E-­‐05 0.000299 u
TCONS_00012976 chr2R:17593556-­‐17594031 0.300066 3.13174 10.43682 0.023019 0.045545 u
TCONS_00029066 chrX:3405353-­‐3434285 0.272267 2.83816 10.4242 1.40E-­‐06 8.11E-­‐06 u
TCONS_00006008 chr2L:3608199-­‐3608809 0.47313 4.90378 10.36454 0.003641 0.009635 u
TCONS_00027647 chr3R:14627098-­‐14628610 0.345958 3.50511 10.13161 7.38E-­‐05 0.000307 u
TCONS_00012938 chr2R:13365159-­‐13365645 0.352813 3.45851 9.802623 0.016383 0.034253 u
TCONS_00013119 chr2RHet:198175-­‐339379 6.82228 65.5755 9.611978 0.002614 0.007212 u
TCONS_00012877 chr2R:5378104-­‐5378330 15.0949 143.12 9.481286 0.000199 0.00075 u
TCONS_00019659 chr3LHet:1181132-­‐1430621 0.265998 2.40408 9.038019 0.001088 0.003368 u
TCONS_00006080 chr2L:12024039-­‐12025463 0.350991 2.90838 8.286188 0.001364 0.004107 u
TCONS_00034124 chrX:16787650-­‐16787877 3.24521 26.5153 8.170581 0.013434 0.029034 u
TCONS_00027646 chr3R:14624986-­‐14627033 0.55695 4.50366 8.08629 4.22E-­‐05 0.000186 u
TCONS_00012882 chr2R:6153841-­‐6154026 7.97046 61.1122 7.667342 0.011247 0.024977 u
TCONS_00006098 chr2L:13095624-­‐13109468 0.468943 3.52219 7.510935 9.14E-­‐05 0.000371 u
TCONS_00002881 chr2L:21864959-­‐21867977 0.024901 0.17567 7.054883 0.004542 0.011638 u
TCONS_00027621 chr3R:11833945-­‐11834363 0.688453 4.71228 6.844737 0.019567 0.03974 u
TCONS_00006090 chr2L:13089866-­‐13090523 1.36471 8.64992 6.338296 0.001616 0.004754 u
TCONS_00034071 chrX:3434369-­‐3435823 0.413719 2.57905 6.233824 0.002858 0.007792 u
TCONS_00012858 chr2R:2324027-­‐2325796 0.213649 1.26312 5.912094 0.007303 0.017365 u
TCONS_00027461 chr3R:3746122-­‐3793296 0.707098 2.87983 4.072756 0.000871 0.002776 u
TCONS_00027673 chr3R:17142111-­‐17143622 1.68963 6.72888 3.982461 0.003061 0.008276 u
TCONS_00023626 chr3R:1095875-­‐1098297 4.99077 19.0402 3.815074 0.002094 0.00596 u
TCONS_00019387 chr3L:8685535-­‐8686379 1.36052 5.03268 3.699065 0.01746 0.036118 u
TCONS_00019394 chr3L:9094737-­‐9123692 27.4831 88.4202 3.21726 0.007442 0.017645 u
TCONS_00019393 chr3L:9094737-­‐9123692 17.0489 52.8883 3.102164 0.010293 0.02316 u
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4.3.8 Illustrating tissue specificity of novel genes using Venn 
diagram. 
Most of novel genes of Drosophila are found in testes and heads; so a Venn 
diagram was run between tubules, testes and heads in order to eliminate the 
overlap of novel gene between tissues and found the possible tissue specific 
novel genes. Using the differential expression genes list which was generated by 
Cuffdiff, the Venn diagram shows 1125 testes specific novel genes, 103 heads 
specific novel genes and 55 tubules specific novel genes, and that are listed in 
Table 4-11. 
 
 
Figure 4-7 Identification of tissue-specific novel genes by Venn diagram.  
The diagram is showing the number of novel genes in each subset corresponding to the 
intersection of tissue types. The total tissue-specific novel genes produced by Cuffdiff are 1144 in 
testes, 119 in heads, and 71 genes in tubules. The overlap between testes and heads are 11 
genes, between heads and tubules are 8 genes, and between tubules and testes are 11 genes. 
This produced 55 tubule-specific genes, 1125 testes-specific genes and 119 heads-specific genes. 
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Table 4-11 55 Novel exons and genes in tubules generated by Venn diagram 
 
Note this is the novel tubule-specific gene list generated by Cuff_diff and Venn diagram. Test_id 
(transcript id), Locus (chromosome position), fold-change (tubule vs whole fly ratio), q_value 
(FDR adjusted p value). class-code “u” novel genes. The list was ranked by fold change enriched 
in tubules. For row 1-7 transcripts have “0” RPKM in whole flies, and so are assigned an arbitrary 
enriched of 1000000x 
Tubule-specific genes lists generated from RNA-seq need to be confirmed by 
strand-specific RNA-seq data. The polarity of the transcript is important for 
test_id locus whole	  fly	  	  RPKM tubules	  RPKM fold-­‐change p_value q_value class_code
TCONS_00006003 chr2L:3269436-­‐3319912 0 2.15575 100000 0.000441 0.001518 u
TCONS_00006179 chr2L:19079233-­‐19108108 0 2.69345 100000 0.020138 0.040711 u
TCONS_00006202 chr2L:21995616-­‐21996517 0 1.5216 100000 0.005914 0.014529 u
TCONS_00012860 chr2R:2534767-­‐2535342 0 2.17334 100000 0.009734 0.022123 u
TCONS_00012999 chr2R:18966948-­‐18967217 0 21.2493 100000 0.001206 0.003687 u
TCONS_00027669 chr3R:17139066-­‐17139474 0 2.75282 100000 0.02308 0.045647 u
TCONS_00034144 chrX:19217991-­‐19218262 0 18.5448 100000 0.002074 0.005909 u
TCONS_00016194 chr3L:23777293-­‐23780611 0.612365 86.539 141.319 0 0 u
TCONS_00027722 chr3R:23310324-­‐23312528 0.213081 27.7166 130.075 0 0 u
TCONS_00027738 chr3R:24393801-­‐24396268 0.06886 7.21746 104.813 3.56E-­‐11 4.03E-­‐10 u
TCONS_00027692 chr3R:18990380-­‐18991802 0.057033 3.93441 68.9844 3.72E-­‐05 0.000166 u
TCONS_00008658 chr2R:16189454-­‐16190517 1.40763 76.2053 54.1371 8.88E-­‐16 1.74E-­‐14 u
TCONS_00034123 chrX:16720640-­‐16730794 0.166643 7.61787 45.7138 0 0 u
TCONS_00020479 chr3R:5951869-­‐5965492 0.158627 4.81691 30.3662 0.000555 0.001866 u
TCONS_00019349 chr3L:4852862-­‐4853889 0.510701 15.0029 29.3772 8.36E-­‐09 6.79E-­‐08 u
TCONS_00027207 chr3R:26230174-­‐26231091 0.118323 3.37127 28.4919 0.000275 0.001 u
TCONS_00006065 chr2L:10048688-­‐10049223 0.34109 9.19548 26.9591 0.000128 0.000503 u
TCONS_00027656 chr3R:15425392-­‐15426143 0.135954 3.19778 23.5209 0.002792 0.007632 u
TCONS_00034121 chrX:16298524-­‐16298875 0.52414 8.99951 17.1701 0.007586 0.017925 u
TCONS_00009515 chr2R:184503-­‐184996 1.03831 17.7604 17.1052 5.84E-­‐05 0.000249 u
TCONS_00013882 chr3L:4629603-­‐4687354 1.48425 23.9035 16.1048 3.76E-­‐06 2.03E-­‐05 u
TCONS_00006094 chr2L:13094768-­‐13095402 0.24743 3.75432 15.1732 0.002173 0.006154 u
TCONS_00006027 chr2L:5339022-­‐5365039 0.767296 11.4185 14.8815 2.11E-­‐08 1.61E-­‐07 u
TCONS_00004375 chr2L:9669700-­‐9670824 0.175688 2.5663 14.6071 0.000551 0.001853 u
TCONS_00027315 chr3R:26956519-­‐26957324 0.195563 2.83968 14.5205 0.004472 0.011489 u
TCONS_00022965 chr3R:24411661-­‐24417150 0.18552 2.64739 14.27 0.000729 0.002374 u
TCONS_00006095 chr2L:13095624-­‐13109468 0.253019 3.60268 14.2388 0.001076 0.003337 u
TCONS_00012944 chr2R:14692364-­‐14693007 0.150399 1.98069 13.1696 0.017534 0.036256 u
TCONS_00006096 chr2L:13095624-­‐13109468 0.24878 3.14448 12.6395 0.003364 0.008989 u
TCONS_00034089 chrX:9474619-­‐9475098 0.260195 3.15075 12.1092 0.020975 0.042118 u
TCONS_00006105 chr2L:13801919-­‐13802826 0.236262 2.80555 11.8747 0.000738 0.002398 u
TCONS_00027486 chr3R:6689076-­‐6696542 42.3827 469.477 11.0771 5.12E-­‐10 4.99E-­‐09 u
TCONS_00006092 chr2L:13092399-­‐13093841 0.215135 2.32892 10.8253 0.001311 0.003971 u
TCONS_00006093 chr2L:13093910-­‐13094690 0.158768 1.70519 10.7402 0.015536 0.032785 u
TCONS_00017431 chr3L:8569749-­‐8571158 0.379966 3.99535 10.5151 7.15E-­‐05 0.000299 u
TCONS_00012976 chr2R:17593556-­‐17594031 0.300066 3.13174 10.4368 0.023019 0.045545 u
TCONS_00029066 chrX:3405353-­‐3434285 0.272267 2.83816 10.4242 1.40E-­‐06 8.11E-­‐06 u
TCONS_00006008 chr2L:3608199-­‐3608809 0.47313 4.90378 10.3645 0.003641 0.009635 u
TCONS_00012938 chr2R:13365159-­‐13365645 0.352813 3.45851 9.80262 0.016383 0.034253 u
TCONS_00013119 chr2RHet:198175-­‐339379 6.82228 65.5755 9.61198 0.002614 0.007212 u
TCONS_00012877 chr2R:5378104-­‐5378330 15.0949 143.12 9.48129 0.000199 0.00075 u
TCONS_00019659 chr3LHet:1181132-­‐1430621 0.265998 2.40408 9.03802 0.001088 0.003368 u
TCONS_00006080 chr2L:12024039-­‐12025463 0.350991 2.90838 8.28619 0.001364 0.004107 u
TCONS_00034124 chrX:16787650-­‐16787877 3.24521 26.5153 8.17058 0.013434 0.029034 u
TCONS_00012882 chr2R:6153841-­‐6154026 7.97046 61.1122 7.66734 0.011247 0.024977 u
TCONS_00006098 chr2L:13095624-­‐13109468 0.468943 3.52219 7.51093 9.14E-­‐05 0.000371 u
TCONS_00027621 chr3R:11833945-­‐11834363 0.688453 4.71228 6.84474 0.019567 0.03974 u
TCONS_00006090 chr2L:13089866-­‐13090523 1.36471 8.64992 6.3383 0.001616 0.004754 u
TCONS_00034071 chrX:3434369-­‐3435823 0.413719 2.57905 6.23382 0.002858 0.007792 u
TCONS_00027461 chr3R:3746122-­‐3793296 0.707098 2.87983 4.07276 0.000871 0.002776 u
TCONS_00027673 chr3R:17142111-­‐17143622 1.68963 6.72888 3.98246 0.003061 0.008276 u
TCONS_00023626 chr3R:1095875-­‐1098297 4.99077 19.0402 3.81507 0.002094 0.00596 u
TCONS_00019387 chr3L:8685535-­‐8686379 1.36052 5.03268 3.69907 0.01746 0.036118 u
TCONS_00019394 chr3L:9094737-­‐9123692 27.4831 88.4202 3.21726 0.007442 0.017645 u
TCONS_00019393 chr3L:9094737-­‐9123692 17.0489 52.8883 3.10216 0.010293 0.02316 u
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correct annotation of novel genes, because it provides essential information 
about the possible function of a gene (Parkhomchuk et al., 2009). RNA-seq from 
Illumina GAIIx can facilitate the discovery of novel transcripts, but most studies 
have not distinguished the transcribed strand (Nagalakshmi et al., 2008; Yassour 
et al., 2009). The transcripts detected by RNA-seq may be from both forward 
and reverse strands that were overlapped or partially overlapped.  The antisense 
transcripts, which play an important role in gene regulation from bacteria to 
human, may be underestimated if only the RNA-seq method is used (Yassour et 
al., 2010). Most of the novel genes we detected may be noncoding genes which 
from the antisense strand our results suggest. It is necessary to use strand-
specific tubule data to indentify every novel gene which is discovered by RNA-
seq. Table 4-12 shows the RNA-seq data which has confirmation from strand-
specific RNA-seq data. The genes were confirmed by RT-PCR (section 4.3.10) 
which informed using the RNA-seq data combined with tubule strand-specific 
RNA-seq data. 
Table 4-12 Summary of 55 tubule-specific novel genes in the list 
 
Exons of  Transcripts number conservation Supported by ssRNA-seq 
I exon 
2 exons 
45 
10 
1 conserved 
5 conserved 
22 
7 
 Note this table is the 55 tubules-specific novel genes that supported by ss-RNA-seq. 55 novel 
genes and exons checked manually by corresponding genes of ss-RNA-seq data in Tablet. 
Conservation means the novel genes or exons exist in multiple tissues. 
 
4.3.9 Finalizing the list of tubule-specific genes  
To ensure the results are not affected by genomic contamination in cDNA 
library, the novel genes are only considered such if the transcripts are longer 
than 200bp and have multiexons or single exons that are conserved in different 
species (Cabili et al., 2011; Graveley et al., 2011; Young et al., 2012). We also 
manually checked the novel transcripts with the ssRNA-seq data in Tablet (RNA-
seq viewer version 1.12.03.26) to avoid false positive products. The final novel 
tubule-specific genes list only includes transcripts with multiexons longer than 
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200 bp and which are also supported by ssRNA-seq data (see Table 4-13). The 
RNA type was defined by CPC (coding potential calculator) which assess the 
protein-coding potential of a transcript based on six biologically meaningful 
sequence features (Kong et al., 2007) CPC is a user-friendly web-based interface 
of CPC at http://cpc.cbi.pku.edu.cn. 
Table 4-13 Final tubule-specific gene list (only count multiexons) 
Test_id Locus Whole flies 
RPKM 
Tubules 
RPKM 
Fold-
change 
RNA type Conservation 
in Drosophila  
TCONS_00016194 chr3L:2377729
3-23780611 
0.612365 86.539 141.319 coding  conserved 
TCONS_00008658 chr2R:1618945
4-16190517 
1.40763 76.2053 54.1371 noncoding conserved 
TCONS_00023626 chr3R:1095875
-1098297 
4.99077 19.0402 3.81507 noncoding Not conserved 
TCONS_00009515 chr2R:184503-
184996 
1.03831 17.7604 17.1052 noncoding conserved 
TCONS_00020479 chr3R:5951869
-5965492 
0.158627 4.81691 30.3662 noncoding conserved 
TCONS_00022965 chr3R:2441166
1-24417150 
0.18552 2.64739 14.27 mRNA-like 
noncoding 
conserved 
TCONS_00004375 chr2L: 
9670824-
9669700 
0.175688 2.5663 14.6071 noncoding Not conserved 
This table is chosen from the Table 4-11 that is only considered transcripts have multiexons (all of 
these transcripts in Table 4-13 have two exons) and also supported by strand-specific RNA-seq 
data.  Test_id is identification number defined by Cufflinks. Whole flies value (RPKM), tubules 
value (RPKM), RNA type from CPC (coding potential calculator) prediction score, Conservation 
from blastN search. The gene which is highlighted in red will be further investigated in Chapter 4. 
The RNA used in this table is from Canton S whole flies and Canton S tubules. 
4.3.10 RT-PCR validation of tubule-specific novel genes 
predicted by RNA-seq and supported by ssRNA-seq 
RT-PCR was performed on these predicted novel transcripts in order to confirm 
that these novel transcripts were real. Because all of these predicted novel 
transcripts contained two exons. The primers were designed on the two exons 
that the cDNA of PCR products would span an intron. If the predictions were 
correct, the PCR amplified genomic DNA and cDNA would result in two different 
sizes band, and the difference would be the spliced intron. Then the novel genes 
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would be confirmed, and also genomic contamination would be eliminated. If 
the PCR amplified genomic DNA size is the same as the PCR amplified cDNA size 
indicating that the PCR amplified cDNA product may be genomic contamination, 
and in this case the Superscript minus control of cDNA will help to confirm if the 
amplified cDNA product is genomic contamination. If the PCR amplified 
Superscript minus control of cDNA has the same size band as PCR amplified cDNA 
that will confirm the transcript is not real, and only a genomic contamination. 
RT-PCR products and primers for novel genes are detailed in Appendix VI. 
A Chr3L 23777293-23780611         B Chr2R 16189454-16190517                                       C Chr2R 184503-184996 
        1KB cDNA gDNA cDNA-           1KB ladder   cDNA   gDNA       cDNA-                           1KB      cDNA   gDNA   cDNA- 
                                     
 
   D  Chr3R 1096703-1095876                                                    E Chr3R 5951869-5965492             
 
 1KB        cDNA   gDNA      cDNA-superscriptII-                       1KB ladder    cDNA  gDNA  cDNA-superscriptII-                    
                             
  
cDNA 
gDNA 
cDNA 
gDNA,cDN
A 
gDNA,cDNA 
cDNA  
gDNA,cDNA 
gDNA 
cDNA 
cDNA 
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F Chr2L 9670824-9669700                                             G Chr3R 24411661-24417150             
 
1KB ladder   cDNA   gDNA     cDNA-                                     1KB ladder    cDNA  gDNA  cDNA- 
                                       
Figure 4-8 RT-PCR validations of tubule-specific novel genes predicted by RNA-seq. 
  
(A) Chr3L 23777293-23780611 is a predicted novel coding transcript. PCR primers were 
designed to amplify a 241bp product from genomic DNA. The expected splice junction associated 
with this transcript, 3L: 23777433-23777506 (73bp) results in a 178bp RT-PCR product when 
amplified from tubule cDNA. (B) Chr2R 16189454-16190517 is a predicted novel noncoding 
transcript (mlncRNA). PCR primers were designed to amplify a 243bp product from genomic 
DNA. The expected splice junction associated with this transcript, 2R: 16190080-16190140 (60bp), 
results in a 183bp RT-PCR product and 243bp RT-PCR products indicating this transcript has two 
isoforms (246bp and 195bp). (C) Chr2R 184996-194503 is a predicted noncoding transcript on 
minus strand. PCR primers were designed to amplify a 161bp product from genomic DNA. The 
expected splice junction is Chr2R 184862-184775 (87bp). The PCR results show a 151bp and 
64bp RT-PCR products from cDNA indicating this transcript has two isoforms. (D) Chr3R 1096703-
1095876 is a predicted novel noncoding transcript on reverse strand. PCR primers were 
designed to amplify a 346bp product from genomic DNA. The expected splice junction associated 
with this transcript, 3R: 1096660-1096607 (53bp). The cDNA RT-PCR product is not detected for 
this junction but shows this transcript. (E) Chr3R 5951869-5965492 is a predicted noncoding 
transcript on minus strand. PCR primers were designed to amplify a 5870bp product from 
genomic DNA but this gDNA is only 3kb. The expected splice junction is Chr3R 5957141-5962859 
(5718bp). The PCR results in a 152bp RT-PCR product (cDNA lower band) (F) Chr2L 9669700-
9670824 is a predicted novel noncoding transcript on reverse strand. PCR primers were 
designed to amplify a 835bp product from genomic DNA. The expected splice junction associated 
with this transcript, 3R: 9670824-9669700 (113bp). No transcribed product has been detected with 
cDNA. (G) Chr3R 24411661-24417150 is a predicted novel noncoding genes. PCR primers 
were designed to amplify 428bp products from genomic DNA. Splice junction associated with this 
product is 3R 24416577-24416669 (92bp). No transcribed product has been detected with cDNA. 
The prediction may be wrong or the primer design may not be correct. 
From Figure 4-8 (A) to (G), five out of seven (71%) novel genes which were 
supported by ssRNA-seq have also been confirmed by RT-PCR. (A) (B) (C) (E) 
showed the PCR products of genomic DNA and cDNA had different sizes 
indicating that the transcripts were spliced during the reverse transcription and 
the introns had been spliced out. The size difference between genomic DNA and 
cDNA were the spliced introns, and also the superscript minus corresponding 
gDNA 
gDNA 
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cDNA control didn’t show any band indicating there was no genomic 
contamination in the RNA samples and the transcripts were real. So Figure 4-8 
(A) (B) (C) (E) had confirmed the splice junctions. These novel genes are more 
likely real. (D) Only confirmed a transcriptional expression not the splice 
junction. Because the genomic DNA and cDNA had the same size, but the cDNA 
superscript minus control was no amplified product. (F) and (G) did not detect 
PCR amplified product may be the expression was too low to be detected or the 
problems with primers design were not sure. 
4.3.11 Tubules specific novel transcripts predicted by RNA-
seq but not supported by ssRNA-seq 
Table 4-14 were chosen from Table 4-11 which were the list of 55 predicted 
novel genes of tubules. All of these transcripts have two exons; however these 
transcripts were not shown on strand-specific RNA-seq data. We further 
investigated these novel transcripts by RT-PCR. 
Table 4-14 Tubules specific novel transcripts predicted by RNA-seq but not supported by 
ssRNA-seq 
test_id Locus Whole 
flies 
Tubules Fold-
change 
RNA type Conservation 
TCONS_00017431 chr3L:8569749-
8571158 
0.379966 3.99535 10.5151 noncoding Not conserved 
TCONS_00027207 chr3R:26230174
-26231091 
0.118323 3.37127 28.4919 noncoding Not conserved 
TCONS_00027315 
 
chr3R:26956519
-26957324 
0.195563 
 
2.83968 
 
14.5205 
 
noncoding Not conserved 
 
This table is chosen from the Table 4-11 that only considers transcripts with multiexons (all of these 
transcripts in Table 4-14 have two exons) but were not supported by strand-specific RNA-seq data. 
Test_id is identification number defined by Cufflinks. Whole flies value (RPKM), tubules value 
(RPKM), RNA type from CPC (coding potential calculator) prediction score, Conservation from 
blastN search. 
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RT-PCR for two samples 
A Chr3L 8569749-8671158                 B Chr3R 26230174-26231091 
  1KB     cDNA gDNA cDNA-                    1KB ladder   cDNA gDNA cDNA-  
             
Figure 4-9 Examples by validating the novel genes predicated by RNA-seq but not 
supported by ssRNA-seq 
(A) Chr3L 8571158-8569749 and (B) Chr3R 26230714-26231091 are predicted novel 
noncoding genes, PCP primers were designed to amplify 580bp and 213bp products from 
genomic DNA. Splice junctions associated with these two products are 3L: 8569846-8569784 
(62bp); 3R26231050-26230965 (85bp). No transcribed products have been detected with cDNA. 
The prediction may be wrong because the transcripts were not supported by ssRNA-seq data. 
Two of thee transcripts could not be validated by qPCR. So the prediction may 
be wrong, due give no support from strand-specific RNA-seq data. 
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4.4 Discussion 
RNA-sequencing (RNA-seq) is a powerful method for discovering, annotating, and 
quantifying RNA transcripts in different organisms at the whole transcriptome 
level. RNA-seq can be used for discovery applications such as identifying 
alternative splicing events, gene fusions, allele-specific expression, and rare and 
novel transcripts. 
RNA-seq is a robust technology for transcriptome profiling including the 
characterization of gene models. However, not all annotated genes are well 
represented by RNA-seq reads. Some genes are under represented by RNA-seq. 
This may have multiple causes. Firstly, a lack of gene coverage may result due 
to some reads not uniquely mapping to the reference sequence or no reads 
originating from the genes in question. Some read mapping methodologies cause 
problems for splice junction mapping or multimapping (Cherbas et al., 2011).  
One study changed the mapping methods to reanalyse the results reported in 
other papers and found more novel lincRNA than the original paper (Roberts et 
al., 2011; Young et al., 2012). Secondly, library preparation methods can 
produce different transcriptome profiles (such as polyA selection or ribosome 
reduction method) as discussed later in this subsection. Thirdly, some tissue- or 
cell- specific type expression may not be observed due to their restricted 
expression pattern. We may need to choose the specific tissue or cell type to 
study (Cabili et al., 2011; Chintapalli et al., 2007; Wang et al., 2004) and also 
consider changing to a different approach for size selection of library 
preparation. Fourthly, the very low expression genes (RPKM<4) may not be 
detected due to the sequence coverage (see chapter 3). RNA-seq can’t detect 
the direction; it is difficult to recognize the transcripts if the reads come from 
reverse and forward strands at the same position of the chromosome (Yassour et 
al., 2010). In this case, directional RNA-seq may help to distinguish the read 
direction. For this study, the greater the level of support available for 
transcripts from directional RNA-seq, the easier it was to confirm the results (as 
shown in Tables 4-13 and Table 4-14). Hence library preparation and the read 
mapping methodologies employed will be the main reasons for genes being under 
represented by RNA-seq, but other reasons still play roles in the novel genes 
discovery. 
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There are two methods to prepare RNA-seq samples, ribo-minus RNA-sequencing 
(rmRNA-seq), and polyA-selected RNA-sequencing (mRNA-seq or poly(A) 
selection).  For novel transcript discovery, the poly(A) selection method, which 
would be enriched for coding transcripts is suitable for discovering those 
transcripts which have the poly(A) tail such as coding RNA and the mRNA-like 
noncoding RNA, but is not suitable for discovering the noncoding RNA which do 
not have poly(A) tail. However, the polyA+ selection did not fully exclude RNAs 
that are not polyadenylated. Alternatively, some of these may be 
polyadenylated under normal condition, or they could correspond to degradation 
intermediates (van Bakel et al., 2010). The other method is ribosome reduction. 
This process minimizes ribosomal contamination and maximizes the percentage 
of uniquely mapped reads covering both mRNA and a broad range of noncoding 
RNA species of interest including long intergenic noncoding RNA (lincRNA), small 
nuclear RNA (snRNA), and small nucleolar RNA (snoRNA)(Cui et al., 2010). 
However during the ribosome reduction, the mRNA transcription may change. 
This method may contribute bias to the coding gene expression. 
The unpolyadenylated transcripts such as miRNA and snoRNA are not likely to be 
observed since the poly(A) selection method was used in this study (Daines et 
al., 2011). The novel coding RNA or noncoding RNA with poly(A), and some other 
noncoding RNAs would be found in this project. So the novel gene list we found 
including one coding RNA and six noncoding RNAs for which the size are longer 
than 200bp could be mRNA-like noncoding RNAs (mlncRNA) (Table 4-13) (Hiller 
et al., 2009; Soshnev et al., 2011). The one coding RNA within the list was 
confirmed by RT-PCR.  The noncoding RNAs, either are mRNA-like noncoding RNA 
or contamination with genomic DNA or secondary structures of RNA that may 
come from the beads during the samples cleaned up. PCR confirmed the second, 
the third and fourth noncoding RNAs have two exons and were spliced so it could 
be mlncRNA. The results supported by directional RNA-seq will have more power 
on the data. 
The novel genes that were identified and defined in this study as transcripts 
have single to multiple exons which appeared in multiple tissues, and the 
transcripts did not overlap in FlyBase gene models. If the transcripts lacked 
evidence of significant protein coding ability and were longer than 200bp, they 
were defined as lincRNA. Furthermore, the transcripts with the protein coding 
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ability were defined as novel coding genes. During the novel gene search, we 
found a number of novel exons in the novel genes list (Table 4-11). However, 
these were not considered as novel genes themselves as previous studies 
revealed most of novel exons are novel exons of known genes (neighbouring, 
often distant, genes). These exons are located at the 5’ or 3’ ends of a gene, 
and some are within a gene (Cabili et al., 2011; Cherbas et al., 2011). We 
observed similar case to the above where we found 5’ or 3’ alternative novel 
exons. Thus we don’t consider the single novel exons as novel genes. In addition, 
some single exons may come from the genomic DNA contamination, we can’t 
confirm them by PCR due to genomic DNA and cDNA will have the same size if 
they are not the products of splicing. In this study, multiexonic transcripts are 
easier to confirm from different sizes of cDNA and genomic DNA when using 
primers that span the introns. The RNA-seq is supported by strand-specific RNA-
seq; the results will be less false positive. Strand-specific RNA-seq has more 
power to detect the noncoding genes that are located in the reverse strand. Five 
out of seven novel genes (71%) supported by ssRNA-seq were and further 
confirmed by RT-PCR in this study, which is better than ~60% reported by 
another study (Daines et al., 2011). Novel transcripts Chr3R 24411661-24417150 
and  Chr2L9670824-9669700 are supported by ssRNA-seq but the expression level 
on ssRNA-seq was very low. This may be the reason for the transcripts to be 
undetected by RT-PCR. Novel transcripts that were detected by RNA-seq but not 
supported by ssRNA-seq proved more likely to fail in the RT-PCR detection 
(Table 4-14. Figure 4-9). 
The results agree with other studies that novel genes had specific characters as 
follows. Novel genes would be expected to be expressed at low levels. RNA-seq 
has more power to detect the lowly expressed genes and allows strand-specific 
expression detection in contrast to the Affymetrix microarrays for example. The 
majority of novel transcripts contain only two exons (Daines et al., 2011). All the 
novel genes in this study have two exons, but they could have multiple exons in 
other tissues. Novel noncoding genes are often expressed in a tissue-specific 
manner than coding genes. One study revealed that lincRNAs are associated with 
specific diseases (Cabili et al., 2011). This study revealed testes have more novel 
genes than other tissues. Novel genes have more noncoding genes than coding 
genes especially in specific tissues (Daines et al., 2011). These noncoding genes 
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may play special regulatory roles in gene transcription (Daines et al., 2011; 
Ponting et al., 2009), cellular function and influence alternative splicing 
(Tripathi et al., 2010). This study revealed more coding genes than noncoding 
genes for the noncanonical list of tubule-specific genes. However, it has much 
noncoding genes than coding genes in the canonical tubule-specific genes list 
(shown in Figure 4-6 A and B). These results support the evidence that novel 
genes are more likely to be noncoding genes. 
Evidence of lincRNA functionality will be most compelling if disruption of loci 
frequently results in reproducible cellular or organismal phenotypes (Young et 
al., 2012).  This may be easier to achieve in Drosophila than with other 
organisms. Novel gene discovery will have more impact with Drosophila as a 
model organism. 
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4.5 Conclusions 
RNA-seq is a cutting-edge technology searching for novel genes. This technology 
overcomes the limitations of previous technologies, has become the most 
popular technology for novel gene discovery. The novel genes found by the RNA-
seq poly(A) selection method are more likely to be coding genes and mRNA-like 
noncoding genes. Most of these genes have two exons, non abundant, belong to 
noncoding genes and expressed in a tissue-specific manner. Strand-specific RNA-
seq has more power to verify the noncoding genes or overlapping genes. The 
RNA-seq ribosome reduction method may have more power for discovering all 
novel noncoding RNAs than the poly(A) selection method. 
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5. Functional studies of Drosophila novel gene 
Chr3L 23777200-23781000 using reverse 
genetics 
Summary 
This chapter describes a reverse genetics approach employed in order to assess 
the functional role of the Drosophila tubule-enriched novel gene, at Chr3L 
23777200-237810001, which was identified by RNA-seq method from chapter 4. 
Multiple RNAi knockdown constructs in the pRISE vector were generated for 
Chr3L 23777200-23781000, and RNA overexpression constructs in the PTW and 
PTWV vectors were generated for Chr3L 23777200-23781000 through Invitrogen 
Gateway recombination technology in which the RNAi or RNA overexpression 
constructs were placed under UAS control. The PTW overexpression construct 
was to overexpress wild-type RNA and the PTWV construct was to generate YFP 
(Venus) fusion. Transgenic animals bearing the above UAS constructs were 
generated using Drosophila germline transformation technology. 
The RNAi and RNA overexpression fly lines were analyzed in this chapter using a 
combination of genetic and molecular cellular biology tools including genetic 
crossing, qPCR and confocal microscopy. Crossing the Chr3L 23777200-23782000-
RNAi line to the c42 GAL4 driver allowed expression of RNAi construct in 
Malpighian tubules principal cell only; crossing RNAi construct to c724 GAL4 
driver allowed expression of RNAi construct in tubules stellate cell only. 
Quantitative expression measurement by qPCR with the c42-chr3L 23777200-
23781000-RNAi and c724-chr3L 23777200-23781000-RNAi lines together with their 
respective control parental lines confirmed the location of the gene in tubule 
principal cells. Secretion assay with these two lines compared with parental 
lines suggested the phenotype of this gene and potential function of this gene. 
Ubiquitous GAL4 driver, Actin-GAL4/CyO crossed with Chr3L 23777000-2378100 
YFP fusion line also indicated the localization of the novel gene Chr3L 23777200-
                                         
1 This gene was later named in Flybase as CG43968. 
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23781000. As demonstrated by this chapter, reverse genetic approach proved 
particularly useful for searching of novel gene functions. 
5.1 Introduction 
5.1.1 GAL4/UAS system in Drosophila 
The GAL4-UAS system which is the second generation of enhancer trapping is 
unique in Drosophila to achieve cell-specific inactivation of virtually any gene 
(Hardy et al., 2010). The reporter gene is the yeast transcription factor GAL4 
which is expressed in a cell and tissue specific manner. It is capable of driving 
transgenes under control of the yeast UASG promoter, the upstream activation 
sequence that is bound by GAL4 (Dow and Davies, 2003; Duffy, 2002). Cell-
specific expression of the transgene is achieved in the progeny of a cross 
between the transgenic fly and the appropriate ‘driver’, a fly expressing GAL4 in 
the desired cell type detailed in Figure 5-1.  
 
Figure 5-1 GAL4/UAS system.  
GAL4 is a transcriptional activator from yeast, which is expressed in a tissue-specific manner. UAS 
(Upstream Activation Sequence), an enhancer to which Gal4 specifically binds to activate gene 
transcription. Picture adapted from (Elliott and Brand, 2008) 
So, the cell specific inactivation of any virtual gene is achieved by GAL4-UAS 
system in fly (Hardy et al., 2010). There are now a number of GAL4 (harbouring) 
fly lines, RNAi fly lines in the fly stock centres around the world (e.g. 
Bloomington Stock Centre), and also a number of RNAi vectors in Drosophila 
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Genomic resource centre for (https://dgrc.cgb.indiana.edu) researcher use to 
achieve nearly any gene knockdown in specific tissue. 
5.1.2 Drosophila as a model for novel gene discovery 
Drosophila melanogaster has been used in genetics studies for almost a century. 
Drosophila is small, easy and cheap to raise with short developmental life cycle. 
These factors make it an ideal model organism to study homologous gene 
functions. It has a small genome around 180 Mb with around approximately 
14000 protein coding genes. About 75% of known human disease genes have a 
recognizable match in the genome of fruit flies (Reiter et al., 2001) and 50% of 
fly protein sequences have mammalian homologs, so Drosophila is increasingly 
used as a translation model for human development, homeostasis and disease 
(Graveley et al., 2011; Spradling, 2006). Genetic markers are commonly used in 
Drosophila research, for example Genetic markers in combinations with P-
element inserts, easily allow one to identify transgenic animals from non-
transgenic animals. Major advantages of Drosophila over other organisms are the 
relative ease of genetic manipulation, and the worldwide Drosophila stock 
centres that produce RNAi line against every gene. GAL4-UAS system is used in 
Drosophila to achieve the inactivation of genes in tissue specific manner (Dow, 
2007). UAS fly lines can be made in less than 3 months for a few 100 dollars, and 
different vectors are available for Drosophila that can achieve the function of 
RNAi or RNA overexpression so reverse genetics can be easily applied in 
Drosophila to search the functions of novel genes including novel noncoding gene 
(Roberts et al., 2011). 
Germline transformation of Drosophila with engineered P-element represents 
one of the most powerful methods with which study the functions of genes 
(Rubin and Spradling, 1982; Spradling and Rubin, 1982). P-elements can be 
engineered to carry the transgene of interest, as well as a marker gene, allowing 
the flies with insertion to be identified with genetic markers. A number of 
vectors engineered with P-element, marker gene, UAS sequence to make UAS 
transgene flies, such as pRISE, are available for applying to the Drosophila 
unique GAL4-UAS system. Microinjection with the P-element constructs will 
integrate into the genome and be inherited stably in the progeny of transformed 
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individuals by the maker selection. The germline transformation scheme is 
outlined in Figure 5-2. 
 
Figure 5-2 Germline transformation of Drosophila embryos 
Embryos from strain w1118 are co-injected with P-element with the gene of interest, marker gene 
and with the helper P-element plasmid that produces the functional transposase. Survival adults 
that potentially have the insertion will be back crossed with w1118 . The progeny of this cross will be 
screened and the flies chosen with the insertion by selecting the white+ marker gene with P-
element (red eyes). The progeny will be back crossed with w1118 and then successive generations 
will establish the transgene line containing the insertion, either in homogenous or heterozygous 
manner. Picture adapted from (Guo, 1996). 
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Drosophila is a common model organism for development (Graveley et al., 2011) 
and behaviour (Kaun et al., 2011) studies,  but it is also a very useful model for 
physiology experiments because it is easy dissected and easy to use to make a 
physiology model (Dow and Davies, 2003). More recently, a number of innovative 
physiological techniques can be brought to bear on the transport or signalling 
process by using Drosophila tubules (Davies et al., 2012). These physiology 
technologies can help reverse genetics close the ‘phenotype gap’ by searching 
for the novel gene functions. The use of Drosophila as a model organism is also 
presented in chapter 1.3.1. 
5.1.3 FlyBase annotation  
FlyBase (http://flybase.org) is an online bioinformatics database and the 
primary resource for molecular and genetic information on the Drosophila 
including 12 Drosophila species that had been sequenced. 
Information in FlyBase originates from a variety of sources ranging from large-
scale genome projects to the primary research literature. Data-types include 
sequence-level gene models, molecular classification of gene product functions, 
mutant phenotypes, mutant lesions and chromosome aberrations, gene 
expression patterns, transgene insertions, and anatomical images. FlyBase 
contains a complete annotation of the Drosophila melanogaster genome that is 
updated several times per year (Drysdale, 2008). 
The database servers researchers of diverse backgrounds and interests, and 
offers several different query tools to provide efficient access to the data 
available and facilitate the discovery of significant relationships within the 
database (Wilson et al., 2008). Query tools, including the simple search tools 
QuickSearch and Jump to Gene are designed to help users navigate to a report 
page where information related to the object is presented, Other tools, such as 
GBrowse and the new Interactions Browser, highlight relationships between 
objects through a graphical interface, while QueryBuilder provides users with 
the ability to perform complex multi-step queries across all fields and different 
data sets. FlyBase also includes the recent availability of genome-wide data from 
the modENCODE project, next generation sequencing data (McQuilton et al., 
2012). 
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5.1.4 Structure and functions of Drosophila Malpighian Tubules  
 
Figure 5-3 Tubules of Drosophila melanogaster. 
Drosophila has two pairs of tubules, namely anterior and posterior tubules that ramify anteriorly and 
posteriorly in the body respectively. Morphologically and functionally distinct domains are labelled 
for anterior tubules; their posterior counterparts have the equivalent domains except that they don’t 
have the enlarged initial segment. Left picture [Adapted from (Wessing A, 1978)]. 
Malpighian tubules domains as identified from enhancer trap analysis. The numbers of principal 
and stellate cells in each region are shown, as deduced from ethidium bromide staining. Standard 
errors are <1 in each case. Right picture [Adapted from (Sozen et al., 1997)]. 
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Figure 5-4 Two major cell types of tubules. 
The larger, principal cells and smaller, stellate cells are joined together with septate junctions. 
These two cells surround the tubule lumen, thus separating the lumen from hemolymph. Details 
about the transport and signalling pathways are given in the texts. Picture [Adapted from (Dow and 
Romero, 2010)]. 
The two anterior Malpighian tubules are classically described as comprising a 
distal initial segment and a proximal main segment, joined by a narrow 
transitional segment; the two posterior tubules, in contrast, were thought to 
consist solely of a main segment. Contemporary studies, using enhancer trap 
lines, which place reporter genes under the control of tissue specific enhancers, 
confirm this viewpoint and thus the nomenclature "initial," "transitional”, "main", 
and “lower tubule” segments has been adopted to describe these genetically 
deduced domains (Sözen, 1997) (Figure 5-3). 
It has been reported that the initial segment of Drosophila anterior tubule does 
not secrete detectable fluid, that the lower third of the tubule is reabsorptive, 
and that only the main segment is responsible for fluid production. 
The initial segment is unique to anterior Malpighian tubules. Although the cells 
of the initial domain are thin and do not display prominent structural 
adaptations for ion transport, this region is	  excreting calcium at extremely high 
rates (Chintapalli et al., 2012; Dube et al., 2000). and a peroxisome-targeted 
isoform of SpoCk (Southall et al., 2006) on initial segment vesicles was 
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confirmed by direct recording of peroxisomal calcium showing that the major 
peroxisomal calcium pool in tubules was in initial segment (Chintapalli et al., 
2012). The homothorax/dorsotonals transcription factors are expressed 
exclusively in the initial segment of the right-hand tubules (Chintapalli et al., 
2012; Wang et al., 2004). 
The middle region of tubule, which is referred to as the main segment, 
generates the primary urine and plays a key role in excretion and 
osmoregulation. Two special cell types are involved, metabolically active 
principal (type I) and smaller intercalated secondary or stellate (type II) (Dow 
and Davies, 2003), which are joined together with septate junctions (Figure 5-3). 
Four classes of transporters dominate the metabolically active principal cell: a 
basolateral Na+- K+-ATPase (Torrie et al., 2004) and basolateral inward-rectifier 
K+ channels (Evans et al., 2005), which secrete K+ into the lumen, and apically, a 
plasma membrane V-ATPase (Davies et al., 1996), which is a vital proton pump, 
and an alkali-metal/proton exchanger of the NHA (Day et al., 2008). This 
provides the first evidence that cation transport into the lumen of Malpighian 
tubules may be a unique property of principal, rather than type II cells. 
The Basolateral Na+-K+- ATPase is an ouabain-sensitive, electrogentic ion pump 
responsible for maintaining the balance of sodium and potassium ions. It highly 
expressed in Drosophila tubule and only a single gene appears to encode the 𝛼-
subunit of the Na+-K+- ATPase in Drosophila (ATPalpha) (Lebovitz et al., 1989). A 
further reported two genes are present in the Drosophila genome that are 
similar to the α and β subunits of Na+/K+-ATPase (Okamura et al., 2003). The 
Dow/Davies group first reported using microarray technology, that there are at 
least two genes to encode the α-subunit and five genes to encode the β-subunit. 
Na+/K+-ATPase may be an important part of models of tubule function. 
An apical plasma membrane V-ATpase is an energizing plasma membrane proton 
pump. It is a large holoenzyme of at least thirteen subunits, encoded by thirty-
one Drosophila genes. V-ATPase energizes animal plasma membrane for 
secretion and absorption of ion and fluid by imposing a transmembrane H+ 
(proton) (Harvey and Wieczorek, 1997; Wieczorek et al., 2003). It has been 
recognized as the main energized pump in Drosophila tubules. 
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The basolateral inward-rectifier K+ channel is an actively pumped in tubules, 
and the main basolateral entry step is via barium-sensitive potassium channel, 
both in tubule and in other V-ATPase driven insect epithelia. 
An apical plasma membrane NHA is an alkali-metal/proton exchanger, co-
expressed with ATPase genes in apical plasma membrane. Their expression level 
affects epithelial transport of both Na+ and K+, one gene preferring Na+ and the 
other gene preferring K+  (Day et al., 2008). 
The smaller stellate cells of tubule (type II cells) are distributed evenly 
throughout the initial, transitional and main segments of posterior tubules and 
within the main segment of anterior tubules. The main segments have 
hormonally-regulated chloride conductance pathways. There are three CLC-type 
chloride channels in the Drosophila tubules. A water flux pathway is also 
localized in tubule stellate cells (Dow and Davies, 2003). In addition to secretion 
of urine, Drosophila tubules are also involved in calcium excretion (Chintapalli 
et al., 2012), in immunity (Davies et al., 2012), in metabolism (Bratty et al., 
2012) and detoxification of both endogenous solute and xenobiotics (Yang et al., 
2007). 
The tight (in insects, septate) junctions, which are between principal cell and 
stellate cells, may also contribute to the leak pathway for chloride movement 
(Dow and Romero, 2010) (Figure 5-4). 
Secretion by Malpighian tubules is under hormonal control, including the insect 
kinins (e.g., leucokinin), corticotropin-releasing factor (CRF)-related diuretic 
hormones (CRF_related DH), calcitonin-like diuretic hormones (CT-like DH) and 
capa peptides. Capa peptide action is diuretic; via elevation of nitric oxide, 
cGMP and calcium in the principal cells of the Malpighian tubules. 
Capa peptides were first identified as cardioacceleratory peptides (CAPs) CAP1 
and 2 by Tublitz and Truman from the ventral nerve cord of Manduca sexta 
(Tublitz and Truman, 1985a, b, c). CAP2b, a cardioacceleratory peptide, is 
present in Drosophila and stimulates Malpighian tubule fluid secretion via cGMP, 
which in turn stimulates the nitric oxide signalling pathway (Davies et al., 2013; 
Terhzaz et al., 2013). Liquid chromatography analysis of adult Drosophila reveals 
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the presence of a CAP2b-like peptide, which coelutes with Manduca sexta 
CAP2b, and synthetic CAP2b and that has CAP2b-like effects on the M. sexta 
heart. CAP2b stimulation elevates tubule cGMP levels but not those of cAMP. 
Both CAP2b and cGMP increase the transepithelial potential difference, 
suggesting that stimulation of vacuolar ATP action underlies the corresponding 
increases in fluid secretion (Davies, 1995). 
Other hormones likely to be involved in Malpighian tubule function are the 
leucokinins, a group of widespread insect hormones. In tubules, their major 
action is to raise chloride permeability through stellate cells by binding to 
receptors on the basolateral membrane, and so ultimately to enhance fluid 
secretion. The action of Leucokinin is additive to both cAMP and cGMP but not to 
thapsigargin, suggesting that leucokinin acts by elevation of intracellular calcium 
(Dow, 2012; Kerr et al., 2004). 
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5.1.5 Experimental plan 
 
Figure 5-5 Experiment plan for searching for the function of novel genes by the reverse 
genetics method. 
Figure 5.5 illustrates the reverse genetic experimental plan to verify the 
function of the novel gene that we found by RNA-seq analysis. It is an example 
of applying the reverse genetic technique to search the novel gene function. The 
overall plan is that knockdown and overexpression this gene to search for the 
phenotype, with in situ hybridization to search for the location. The details of 
this plan are: 
1. Cloning of the novel Drosophila gene Chr3L 23777200-2378100 to RNAi 
vector (pRISE) and gene overexpression vector (PTW and PTWV) for in 
vitro (S2 cells) and in vivo (fruit flies) functional analysis. 
2. Transfection of S2 cells with YFP fusion of Chr3L 23777200-23781000 
constructs (PTWV) for fluorescent localisation within the cell. This would 
distinguish plasma membrane form endosomal (e.g., peroxisome, 
182 
mitochondria, ER, Golgi and others) localisation. This also would check if 
the overexpression construct has worked in order to further generate the 
overexpression transgenic flies. 
3. Validation of overexpression and RNAi fly lines using qPCR, by crossing 
them with several GAL4 drivers (tubule principal cell, stellate cell specific 
etc). This shows if the mRNA levels are affected in the overexpression and 
RNAi flies driven using ubiquitous GAL4 lines. The ‘cell-specific 
knockdown or overexpression’ validations show in which cells this new 
gene is expressed. 
4. Assessment of the phenotypic characters (including survival, structural, 
morphological defects, assay fluid secretion rates of Malpighian tubules). 
The percentage of survival rate would indicate if this gene is lethal and 
affects which developmental stage. The observation of structures and 
morphological characters would show if the novel gene plays a role in any 
developmental and morphological defects. The assay of the fluid 
secretion rates is to see whether knockdown or overexpression causes any 
impairment. This would suggest if this gene functioned in tubule 
secretion. If the secretion rate changes, on addition of the neuropeptides 
capa and leucokinin, this would suggest this change is caused by principal 
cell (cationic pathway) or stellate cell (anionic pathway) pathway. 
5. In vivo localisation of YFP tagged novel gene, using different GAL4 drivers 
to see the cellular location of these proteins in different tissues of the fly 
and in specific cells of an individual tissue. 
6. Western blot using the anti-GFP antibody, to see if the gene encodes a 
protein and the size of the protein. Because the novel gene encodes 
protein fused by YFP, the protein size should be the YFP plus the novel 
gene-encoded protein size. 
7. In situ hybridization will show in vivo the localisation of this novel gene in 
tissue. 
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The results aim to use reverse genetic method to present the location and 
phenotype of the novel gene, then we will draw the possible function of 
this gene from it. 
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5.2 Results 
5.2.1 Cufflinks result of novel gene Chr3L 23777200-23781000 
The Cufflinks report from the merged.gtf file and Cuffdiff report from isoform-
_exp.diff show that the novel gene Chr3L 23777200-23781000 has two exons: 
Chr3L Cufflinks Exon 1 23777294-23777433, and Exon 2 23777506-23780611. The 
RPKM expression level of this isoform for whole flies  is 0.612365, and for tubules 
is 86.539. The tubules/whole flies fold change is 141.319. The class _code of this 
gene is “u” (novel gene). Of the novel genes discovered by this project using 
RNA-seq with the TopHat and Cufflinks pipeline, this gene had the highest fold 
change. This gene had no annotation in FlyBase 5.34, and was subsequently 
named as CG43968. This gene was chosen for further study in this project 
because all the results indicated that this gene showed tubule-enriched 
expression with two isoforms, which were not previously annotated and are 
located in an intergenic region of the Drosophila genome. The ORF search (see 
5.5.4) indicated that this gene is a protein coding gene which is easy to use 
reverse genetic method to search gene function. Figure 5-6 shows the 
merged.gtf file generated by Cufflinks as viewed in the Integrated Genome 
Browser (IGB), and depicts region Chr3L 23777200-23781000 indicating the novel 
transcript structure predicted by Cufflinks. 
 
Figure 5-6 The novel transcript structure predicted by Cufflinks as viewed in IGB. 
This figure shows the novel transcript in region Chr3L 23777200-23781000 has two exons. The 
small red bar on the left indicates a small exon, and the large red bar on the right indicates a 
second large exon. The gap in the middle between these two red bars indicates the intron. The 
scale along the bottom of the figure shows the region within chromosome 3L. 
Strand-specific RNA-seq tubules data from the file transcript.gtf generated using 
Cufflinks were viewed using Tablet (version 1.12.03.26), and showed the 
predicted transcript and its direction (Figure 5-7). Figure 5-7 indicates that this 
transcript is on the sense strand and has two exons. 
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Figure 5-7 Chr3L 23777200-23781000 as viewed in Tablet. 
This figure of the Tablet visualization shows the novel transcript has two exons (Exon1 and Exon 2) 
and is on the sense strand of chromosome 3L. Part A shows an overview of a region of 
chromosome 3L (23772200-23797199, 25KB). The subregion of interest (23777200-237810000) is 
highlighted using the red box. Part B shows a more detailed view of CG43968 between 23777200-
23781000 of chromosome 3L. This detailed view shows the reads obtained for the exons in the 
small region at the beginning and the large region at the end of CG43968. No reads are shown in 
the region in between these two indicating an intron. Part C presents a schematic view of the gene 
structure, identifying the region of the first, small exon and the second, large exon. 
5.2.2 FlyBase annotation of novel gene Chr3L 23777200-23781000 
FlyBase 5.34 (http://flybase.org) has no annotation for this gene (Figure 5-8).  
 
Figure 5-8 FlyBase 5.34 showing no gene model in region 23777200-23781000.  
This is a visualization of Chromosome 3L (region 23777200-237810000) for FlyBase 5.34. An 
overview of Chromosome 3L is shown in the top part of the figure, with the subregion of interest 
highlighted by the red line. A more detailed view of the region is shown in the bottom part of the 
figure. There is no gene model is indicated under this gene region.  
However recent modENCODE RNA-seq trace in FlyBase 5.36 showed the novel 
exon junction has been found by TopHat in Drosophila (Figure 5-9). This 
indicates a potential transcript in this region with two exons so there must be a 
gene here that is not annotated yet in this version.  
Exon1 Exon 2 
Start Chromosome 3L 23777200 
End Chromosome 3L 23781000 
A 
B 
Exon1 Exon 2 
C 
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Figure 5-9 FlyBase 5.36, modECODE RNA-seq data.  
The RNA-seq Drosophila data shows there is a novel splice junction (the lower pink bar) in region 
23777200-23781000 (the upper region bar) highlighted by RNA-seq Drosophila data, indicating  
that there is a potential transcript in this area.  
Very recently (16/08/2012), this gene has been annotated in FlyBase 5.48 with 
the symbol Dmel\CG43968 (FBgn0264699), but no further data are provided. It is 
a protein-coding gene from Drosophila melanogaster. Gene sequence location is 
3L: 23777331-23780505 (http://flybase.org). The transcript is displayed in 
FlyBase Gbrowser as shown in Figure 5-10. 
 
Figure 5-10 Novel gene CG43968 in FlyBase 5.48. 
Part A shows an overview of chromosome 3L with the region of interest indicated by the red bar. 
Part B shows a more detailed view of chromosome 3L in the region of interest. Part C shows the 
gene model for CG43968 from FlyBase 5.48 using the blue bar, and the transcript CG43968-RA 
using the pink bar. 
5.2.3 Drosophila Tiling microarrays analysis result 
Drosophila tubule Tiling 2.0R Array results were analysed by Tiling Array analysis 
Software (TAS). Berkeley Drosophila Genome Project version 5 (BDGP) was used 
as reference genome. The tubule.bed file is generated by using the parameters 
bandwidth of 60, default value for threshold of 4, maximum gap of 80 and 
minimum run of 40. The tubule.bed file is viewed in the Integrated Genome 
Browser (IGB) with reference genome from BDGP version 5. The position of the 
novel gene Chr3L 23777200-23781000 is shown in Figure 5-11. The novel 
transfragment of gene CG43968, which is indicated by the blue bar, was only 
showing as part of one exon, corresponding to the more highly expressed part of 
CG43968. This is because the background noise in tiling arrays due to cross 
hybridization affects the calculation of the gene expression. The lower 
expression exon of CG43968 was cut with the background. 
A 
B 
C 
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Figure 5-11 Drosophila tubule tiling microarray result from TAS as viewed using IGB. 
Part A of this figure shows that the Drosophila tubule tiling microarray results as analyzed in TAS 
only indicate part of  the transfragment highlighted by the blue bar of Chr3L 23777400-23781000 
(CG43968). Only those expression levels above the background noise can be detected and so not 
all exons and introns for  the transfragment can be distinguished. The middle of the figure shows 
that refseq has no gene model at this region. The scale bar at the bottom of the figure indicates the 
region of chromosome 3L. Part B shows the non-overlapping probe design of Drosophila Tiling 
Array 2.0 (resolution 39bp). The probes indicated within the red brackets correspond to the 
detected region of expression of the transfragment as indicated by the blue bar in Part A of this 
figure. Note, however, that this is only part of CG43968. The real transcript is much larger. 
The result indicated the transfragment had been found in Drosophila tiling 
microarray but tiling microarray could not detect the splicing junction, so we 
cannot see the two exons in this transfragement. However RNA-seq can detect 
the boundary of the gene and the splicing junction, which is one of the 
advantages of RNA-seq over tiling microarray. 
So the evidence is that D. melanogaster has a novel gene in this region. The rest 
of the chapter describes work to characterize this novel gene. 
5.2.4 Blast analysis of novel gene CG43968 
Is the gene unique to D. melanogaster, or is it found in other species? The BLAST 
analysis would increase our confidence in the gene assignment. 
Translation BLAST (blastx), search protein databases using a translated 
nucleotide query. In order to find the predicted protein for novel gene Chr3L 
23777200-23781000 (CG43968), blastx was performed using the nucleotide 
sequence of gene CG43968 to search the NCBI database to determine if the gene 
A 
B 
23777400 23781000 
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codes for a protein that is found in other organisms (Figure 5-13). The search 
took a DNA sequence and determined the sequence of six reading frames from 
both strand of DNA then used these sequences to search the protein database. 
Six frame searches found six possible open reading frames (ORF) for this gene 
(Figure 5-12). Because the strand-specific RNA-seq result indicated the novel 
gene CG43968 was on sense strand, so the top ORF possibility had more chance. 
 
Figure 5-12 Open reading frame search results for novel gene CG43968.  
The results show the protein sequence similarity between novel genes and other species. The 
protein from the novel gene matched very well to ‘known’ genes in other Drosophila species such 
as Drosophila mojavensis and Drosophila willistoni. In addition, there were good similarities to 
other mosquito and beetle proteins. Six possible open reading frames of this gene had been found. 
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Figure 5-13 Blastx search for the novel gene CG43968.  
The blastx search found the similar protein sequence for the novel gene CG43968 in Drosophila 
mojavensis and Drosophila willistoni. 
Although no conserved domains were found in D. melanogaster sequence, a 
reciprocal BLAST with the D. willistoni sequence identified possible domains. 
Reciprocal BLAST is a common computational method for predicting putative 
orthologues. 
 
Figure 5-14 Reciprocal Blast with the D.willistoni sequence identified the GPS domain. 
GPS domain (G-protein-coupled receptor proteolytic site domain) had been 
found from the reciprocal BLAST using D.willistoni sequence (Figure 5-14). GPS 
Domain presents in latrophilin/CL-1, sea urchin REJ and polycystin. Polycystin is 
a protein that in humans is encoded by the PKD1 gene Polycystic (Glücksmann-
Kuis and Schneider, 1995; Hughes et al., 1995). PKD1 is a kidney gene in humans! 
Polycystin-1 is a glycoprotein, which contains a large N-terminal extracellular 
region, multiple transmembrane domains and a cytoplasmic C-tail (Figure 5-15). 
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Figure 5-15 Illustration of PKD1 and PKD2  proteins.  
The PKD1 (Polycystin-1) and PKD2 (Polycystin-2) proteins are at the cell membrane. The PKD1 
(Polycystin-1) contains a large N-terminal extracellular region, and seven- transmembrane receptor 
(Secretin family) of the G-protein-coupled receptors (GCPRs). Picture derived from 
http://www.bio.davidson.edu/Courses/Molbio/MolStudents/spring2003/MaloneyH/Polycystins.html  
From Blastx (Figure 5-13, the front half of the protein CG43968 is less well 
conserved, but the back half is more conserved in other species. The shape of 
the protein can be explained by the fact that the front half of the protein 
Polycystin-1 has a long extracellular N-terminus, and the back end has a 
conserved seven-transmembrane (7TM) receptor of the G-protein-coupled 
receptors (GCPRs). Polycystin-1 may modulate intracellular calcium 
homoeostasis and other signal-transduction pathways. It plays a role in renal 
tubular development as well. 
5.2.5 Protein localization prediction  
5.2.5.1 PSORT II program for protein subcellular localization prediction 
PSORT (http://psort.hgc.jp/form2.html) is a free web-based tool used for the 
prediction of protein localisation sites in cells. It receives the information of an 
amino acid sequence and its taxon of origin (e.g. Gram-negative bacteria) as 
inputs. Then it analyzes the input sequence by applying the stored rules for 
various sequence features of known protein sorting signals. Finally, it reports the 
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possibility for the input protein to be localized at each candidate site with 
additional information. PSORT was developed in 1990 and is applicable to 
bacterial and plant sequences. Although this technique is suited to integrating 
various kinds of information on protein sorting, the program requires manual 
adjustment of many numeric parameters. To overcome this difficulty, a new 
version, PSORT II was development in 1997 and is applicable to animal and yeast 
sequences; the k-nearest-neighbour method algorithm is used (Nakai and Horton, 
1999). From the blastx search, the ORF sequence of novel gene CG43968 was 
obtained. The result of a subsequent enquiry by PSORT II is as follow:  
PSORT II Prediction 
30.4 %: cytoplasmic 
17.4 %: vesicles of secretory system 
13.0 %: nuclear 
13.0 %: mitochondrial  
8.7 %: Golgi 
8.7 %: plasma membrane 
4.3 %: endoplasmic reticulum 
4.3 %: vacuolar 
 
The PSORT II results provide support for the protein of novel CG43968 being 
located in cytoplasm of the cell. 
5.2.5.2 WoLF PSORT program for protein subcellular Localization prediction  
WoLF PSORT (http://wolfpsort.org) is an extension of the PSORT II program for 
protein subcellular location prediction and is applicable to fungi, animal, and 
plant sequences. WoLF PSORT converts protein amino acid sequences into 
numerical localization features; these features are based on sorting signals, 
amino acid composition and functional motifs such as DNA-binding motifs. After 
conversion, a simple k-nearest neighbour classifier is used for prediction. The 
evidence for each prediction is shown in two ways. Firstly, a list of proteins of 
known location is compared with the most similar localization feature to the 
query. Secondly, a table is provided of the values of each localization feature 
for the query and its neighbours (Horton et al., 2007). This subcellular prediction 
of the protein location will supply important information of the function of the 
protein. Unlike older programs such as PSORT and PSORTII that use one 
dimensional amino acid sequences of proteins, the WoLF POST uses feature 
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selection and a flexible scoring model to increase accuracy and handle multiply 
localized proteins. 
The ORF sequence of novel gene CG43968 is obtained from a blastx search. The 
result of a subsequent enquiry by WoLF POST is as follow: 
Cytoplasm: 24.0%, mitochondrial: 4.0%, mito_peroxisome: 4.0%, peroxisome: 
2.0%. 
The result lends greater support to cytoplasmic localisation of protein for the 
novel gene CG43968. 
5.2.6 In situ hybridization to search for the location of novel gene 
CG43968 
PCR products derived from 3’UTR end of novel gene were cloned into TOPO® 
pCRII vectors with Sp6 and T7 dual promoter (details described in 2.19). The 
orientation of the PCR product was established using PCR. The T7 and Sp6 
promoters of the pCR™II vector allowed in vitro transcription of the insert to 
produce sense or anti-sense products. The anti-sense probes then hybridized to 
mRNA within the tissue, and then the signal indicated the in vivo location of the 
gene within the tissue. The sense probes performed as a control to show the 
background to make sure the in situ hybridization signals were real (Figure 5-
16). 
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Figure 5-16 In situ hybridization images of novel gene Chr3L 23777200-23781000 
This figure shows the images obtained from in situ hybridization analysis using 3H, 4H antisense 
and sense riboprobes for novel gene CG43968. A, B are different probes for the same gene only 
from the different PCR products at 3’UTR of novel gene CG43968, with the images showing strong 
expression in the main segment of the Malpighian tubule (MT). D, E were negative controls; sense 
probes corresponding to the antisense probes of CG43968 showed no stain in tubules. C, F all 
acted as controls to show the signal affected by antibody or the other factors during the in situ 
hybridization procedure, with the images showing no staining. 
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The main segments of tubules contain principal cells and stellate cells. The in 
situ hybridization could not distinguish the signals from the two cell types in the 
main segments. Principal cells are responsible for cation and organic metabolites 
secretion, and stellate cells are responsible for water and chloride secretion. 
Because the in situ hybridization could not clearly identify the gene expression 
in specific cells types, cell specific gene knockdown and qPCR was used to 
identify the location of novel gene expression in the next experiment. 
5.2.7 Loss-of-function analysis (dsRNA knockdown analysis 
using pRISE vector for CG43968)  
5.2.7.1 RT-PCR, pENTR/D-TOPO® vectors and sequencing 
RT-PCR primer design was performed using Invitrogen Primer design tool-perfect 
primer ™ designer (http://tools.lifetechnologies.com) and Snap Dragon dsRNA 
design (http://www.flyrnai.org). Invitrogen Primers designed two primers on 
different exons and spanning an intron. SnapDragon designed primers on the 3’ 
end of the gene. The novel gene CG43968 sequence was obtained from Download 
Sequence Region (Drosophila melanogaster release 5.30, 
http://www.ncbi.nlm.nih.gov/projects/mapview/seq_reg). Four amplified 
fragments in this region were cloned into the pENTRY/D-TOPO (Invitrogen) 
vector using the Gateway technology. Details of the method are presented in 
section 2.15.3. 
Construct 1: Primer design uses Invitrogen software. See Table 5-1 for details. 
RT-PCR used primers designed on the two exons, so the transcript spanned an 
intron. This method also confirmed that this novel transcript was a real 
transcript not a genomic contamination. Result is shown in Figure 5-17. The PCR 
program used 94oC 2mins then 94oC 30s, 55oC 30s, 72oC 30s for 30 cycles, 72oC 5 
mins. The construct-1 was sequenced (Figure 5-18), and the splicing junction 
was confirmed. 
 
  
195 
  
 
Figure 5-17 RT-PCR of novel gene CG43968. 
RT-PCR used primers which spanned an intron showing two bands, cDNA (178bp) and Genomic 
DNA (241bp). It also confirmed that the intron was spliced out in the transcript. The superscript 
minus control indicated the cDNA samples did not have genomic contamination. 
 
 
  
 
       
Figure 5-18 Sequence of CG43968 of pENTR/D-TOPO vector. 
The intron (73bp) was confirmed of RNA-seq prediction after the CG43968 construct of pENTR/D-
TOPO® vector was sequenced. The two black arrows show the sequence of the intron that was 
spliced out during reverse transcription. 
The other three constructs (2,3,4) of pENTR/D-TOPO® vectors were made for 
the same gene CG43968 primers designed at the 3’ end of the gene by Snap 
Dragon, as detailed in Table 5-1. 
GTATGAAAAGTTTGAGTAGTTTTAGGTCAAATTTCAAA 
TAAGTAGAATAATTTACGAATTAATATATTTTA  
cDNA Genomic DNA Superscript- 1kb plus ladder 
241bp 
178bp 
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Table 5-1 Primers of CG43968 for pRISE constructs. 
pRISE 
construct 
Primer Primer sequence Primer 
location 
cDNA 
product 
(bp) 
Genomic DNA 
product (bp) 
Construct 1 Forward 
Reverse 
GTAGCATTTATGTGCCTATTGC 
GATGGTTAGACTTAAGGCACA 
Exon1 
Exon2 
173 241 
Construct 2 Forward 
Reverse 
 
CCTTGCAAGCTTCAACCAAT   
AAACGCCTTAAACGGCATAG 
Exon2 
Exon2 
310 310 
Construct 3 Forward 
Reverse 
TTTGTTCATGGCGCATATTG 
TGTTGCGTTTAGCTCAGCAG 
Exon2 
Exon2 
369 369 
Construct 4 Forward 
Reverse 
AGTTTCAAGCTATCGCACCG 
AATCCAAAACACAACGCACA 
Exon2 
Exon2 
304 304 
Summarizing the primers for Drosophila tubule-enriched novel gene CG43968 that were designed 
in SnapDragon, and used to generate pRISE constructs. 
Sequences have been confirmed for these four constructs. 
5.2.7.2 Destination vector pRISE to generate UAS-RNAi line 
The four trigger sequences for the same gene from the pENTRY/D-TOPO vector 
using Gateway technology could be transferred easily to pRISE by an in vitro 
reaction mediated by LR Clonase. The RNAi constructs generated were based on 
the protocol by Kondo T et al. (Kondo et al., 2006) with the generation of 
construct containing inverted repeats the attR1-ccdB-attR2 cassette. This was 
achieved by cloning two identical fragments of the gene of interest into the 
vector of the Gateway cassette in the opposite orientation separated by a 
hairpin loop (intron), under UAS control that acted as dsRNAi into the tissue. 
Since pRISE carries a pentamer of UASGAL4 in the promoter region, RNA silencing 
can be controlled by selecting appropriate ‘driver’ GAL4 transgenes (Duffy, 
2002). Further functional analysis was performed when the RNAi transgenes flies 
were generated. Details of this method are presented are in section 2.15.3 
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5.2.7.3 Making the transgenic fly lines and validation 
The pRISE plasmid was purified by columns. Insert size and direction of pRISE 
vectors were checked. 50 µg plasmid with concentration at least 0.5 µg/µl was 
sent to BestGene Inc (thebestgene.com) for microinjection to make transgene 
flies. The process is illustrated in Figure 1-6. The Gateway™ destination vector 
pRISE consists of a P-element, UAS sequence and mini-white marker for genomic 
integration, and coinjected with a helper P-element plasmid that produces a 
functional transposase in Drosophila germline, allowing insertion of the genetic 
payload. Using the mini-white+ marker, the transformants were selected. The 
transgenic lines were made either homozygous or heterozygous (with balancer). 
Then, the essential process of validating the fly lines using GAL4/UAS bipartite 
system was performed by driving the transgene CG43968-RNAi expression using a 
variety of cell- or tissue-specific GAL4s or using a ubiquitous GAL4 such as 
Tubulin-GAL4 UAS Dicer-2/TM3, Sb; or Actin-GAL4/CyO. A schematic diagram of 
the cross scheme is shown in Figure 5-19.  
 
Figure 5-19 A schematic diagram of the RNAi knockdown cross scheme.  
CG43968-RNAi crossed with ubiquitous GAL4 driver Tubulin-GAL4 UAS Dicer-2/TM3, Sb obtained 
CG43968-RNAi knockdown in adult whole flies. Four genotypes were produced (Tubulin-Gal4 UAS 
Dcr-2/CG43968-RNAi; Tubulin-Gal4 UAS Dcr2/TM3, Sb; CG43968-RNAi/TM3 Sb; TM3Sb/TM3, 
Sb). The number in the bracket indicated the survival numbers of the F1 progeny. The survival rate 
of each genotype is 1:1:1:0. The novel gene CG43968 is not lethal. 
CG43968-RNAi was knocked down by using ubiquitous Tubulin-Gal4 UAS 
Dcr2/TM3, Sb driver in adult whole flies. The F1 progeny were also counted for 
the four genotypes to check the survival rate that confirmed the novel CG43968 
was not lethal when after knockdown. 
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Figure 5-20 Screen of the UAS-CG43968 constructs. 
The UAS-CG43968-RNAi (3a) achieved over 77% knockdown over control. The comparison of the 
knockdown efficiency of four fly lines was obtained from three UAS-RNAi constructs of novel gene 
CG43968 by using the ubiquitous driver GAL4. The percentage knockdown was 38% (1a), 77% 
(3a), 4% (4a), and 70% (5a) respectively. UAS-CG43968- RNAi (3a) achieved the most efficient 
knockdown. 
qPCR performed gene expression comparison between the siblings of progeny to 
determine the efficiency of the knockdown as shown in Figure 5-20. RNAi (1a) 
was from CG43968 construct 1; RNAi (3a), RNAi (4a) were from construct 2, RNAi 
(5a) was from construct 4. The absolute percentage of knockdown for UAS-RNAi 
(1a), driven by Tubulin-GAL4, was 38% (t-test, P < 0.01) to its heterozygous 
siblings control. The absolute percentage of knockdown for UAS-RNAi (3a), 
driven by Tubulin-GAL4 UAS Dcr2, was 77% (t-test, P < 0.05) to its heterozygous 
siblings control. The absolute percentage of knockdown for UAS-RNAi (4a), 
driven by Tubulin-GAL4, was 4 % (t-test, P >0.5) to its heterozygous siblings 
control, 4a was not knocked down. The absolute percentage of knockdown for 
UAS-RNAi (3a), driven by Tubulin-GAL4, was 70% (t-test, P < 0.05) to its 
heterozygous siblings control. The four transgene fly lines showed only three 
lines contained the knockdown. UAS-RNAi (3a) and (5a) were more efficiently 
knocked down than UAS-RNAi (1a). UAS-RNAi (4a) was not knocked down. 
Consequently, at least one RNA line [UAS-CG43968-RNAi (3a)] produced a good 
knockdown (>75%). 
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5.2.7.4 Effect of principal cell-specific knockdown of CG43968 
The following procedure was used to create the c42-GAL4/UAS-CG43968-RNAi 
(3a) line in fly tubule principal cells. The c42-GAL4 is a specific tubule principal 
cell driver. c42 was crossed with UAS-CG43968-RNAi/TM3, Sb. The progeny was 
c42/UAS-CG43968-RNAi, c42/TM3, Sb. The survival rate of F1 progeny is 1:1 for 
the two genotypes, so this gene was not lethal in principal cell. 
 
In order to produce reliable comparison to see where this gene was expressed 
and to control the genetic background effect, we needed to create a single copy 
of the heterozygous parental line for the control. To achieve this, virgin females 
c42 were crossed with males UAS-CG43968-RNAi/TM3, Sb; virgin females c42 
were crossed with male Canton S; virgin females Canton S were crossed with 
UAS-CG43968-RNAi/TM3, Sb. The F1 progeny were selected as c42-GAL4/UAS-
CG43968-RNAi (normal hair), c42/Canton S, Canton S/UAS-CG43968-RNAi (normal 
hair). 
The entire cross was set up at 26 ºC and 70-80% relative humidity (Duffy, 2002; 
Haley et al., 2003), three females and six males in one vial, allowed to mate for 
48 hours and laid eggs. After 48 hours, the flies were transferred to new vials, 
and this was repeated another two times. The F1 progeny were selected 
according to the marker, for example, normal hair or short hair. The F1 progeny 
were transferred to fresh vial in every two days over seven days. The seven days 
flies were selected according to the marker, and equal numbers of females and 
males (3 males and 3 females) were flash frozen in liquid nitrogen then stored at 
-80 ºC.  
5.2.7.5 Effect of stellate cell-specific knockdown of CG43968 
The following procedure was used to create the c724-GAL4/UAS-CG43968-RNAi 
(3a) line in fly tubule stellate cells. The c724-GAL4 is a specific tubule stellate 
cell driver. c724 was crossed with UAS-CG43968-RNAi/TM3, Sb. The F1 progeny 
was c724-Gal4/UAS-CG43968-RNAi, c724-Gal4/TM3, Sb. The survival rate of the 
progeny was 1:1 for the two genotypes, so this gene was not lethal in stellate 
cell. 
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In order to produce reliable comparison to see where this gene existed and to 
control the genetic background effect, we needed to create a single copy of the 
heterozygous parental line for the control. So virgin females c724 were crossed 
with males UAS-CG43968-RNAi/TM3, Sb; virgin females c724 were crossed with 
males Canton S; virgin females Canton S were crossed with males UAS-CG43968-
RNAi/TM3, Sb. The F1 progeny were selected as c724-GAL4/UAS-CG43968-RNAi 
(normal hair), c724/Canton S, Canton S/UAS-CG43968-RNAi (normal hair). The F1 
progeny were transferred to fresh vials every two days over seven days. The 
seven days F1 progeny flies were selected according to the marker, and equal 
numbers of females and males (3 males and 3 females) were flash frozen in 
liquid nitrogen then stored at -80 ºC. 
5.2.7.6 Where is CG43968 expressed? 
RNA extraction was performed using Qiagen Micro kit (see methods section 
2.5.1) for c42-Gal4 crossed samples and c724 crossed samples. The quantity was 
checked by Nanodrop, and quality was checked by Agilent bioanalyzer (2.5.2). 
Relative standard qPCR were performed not only between c42-Gal4/UAS-
CG43968-RNAi line with parental lines but also between c724-Gal4/UAS-
CG43968-RNAi line with parental line and between c42-Gal4 crossed fly and 
c724-Gal4 crossed fly in order to find the location of the novel gene CG43968 
(Figure 5-20). 
In the comparison between c42-GAL4/UAS-CG43968-RNAi, c42-GAL4/Canton S, 
Canton S/UAS-CG43968-RNAi, significantly less expression of c42-GAL4/UAS-
CG43968-RNAi than parental line c42-GAL4/Canton S and Canton S/UAS-
CG43968-RNAi line was shown.  This result confirmed that CG43968 was knocked 
down in c42-Gal4/UAS-CG43968-RNAi line. The comparison between c42-
GAL4/UAS-CG43968-RNAi with sibling line c42-GAL4/TM3, Sb also confirmed 
CG43968 was knocked down in c42-GAL4/UAS-CG43968-RNAi line (Figure 5-20). 
In the comparison between c724-GAL4/UAS-CG43968-RNAi, c724-GAL4/Canton S, 
Canton S/UAS-CG43968-RNAi, the same expression level of c724-GAL4/UAS-
CG43968-RNAi with parental line c724-GAL4/Canton S and Canton S/UAS-
CG43968-RNAi line was shown confirming that there was no knockdown in the 
c724-Gal4 crossed fly. The comparison between c724-GAL4/UAS-CG43968-RNAi 
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with sibling line c724-GAL4/TM3, Sb also confirmed the novel gene was not 
knocked down in c724-GAL4/UAS-CG43968-RNAi line (Figure 5-21). 
Further comparisons were performed between c724-GAL4/UAS-CG43968-RNAi, 
c724-GAL4/Canton S, Canton S/UAS-CG43968-RNAi along with c42-GAL4/UAS-
CG43968-RNAi, c42-GAL4/Canton S, and Canton S/UAS-CG43968-RNAi. The 
c42/TM3 Sb and c724/TM3, Sb also in the same plate showed the comparison 
between the knockdown line and siblings in order to determine the efficiency of 
the knockdown. The results are shown in Figure 5-20. The absolute percentage 
of knockdown for UAS-CG43968-RNAi, driven by c42-GAL4, was 80% (t-test, P < 
0.05) to its heterozygous sibling c42/TM3, Sb control. The absolute percentage 
of knockdown for UAS-CG43968-RNAi, driven by c42-GAL4, was 70% (t-test, P < 
0.01) to its heterozygous c42/Canton S parental control, indicating that CG43968 
was knocked down in principal cells. The comparisons between c724 lines 
showed no change, indicating this gene was not knocked down in stellate cells. 
The absolute percentage of knockdown for UAS-CG43968-RNAi, driven by c42-
GAL4, was 70% (t-test, P < 0.01) compared to c724/Canton S control indicating 
CG43968 is in principal cells but not in stellate cells of tubules. c42-GAL4/UAS-
CG43968-RNAi compared to parental line Canton S/UAS-CG43968-RNAi showed no 
significant change possibly due to the RNAi leakage when the crossed happened. 
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Figure 5-21 Comparative gene expression showing CG43968 is expressed mainly in 
principal cell.  
Relative standard qPCR was performed between c42-GAL4 /UAS-CG43968-RNAi, c42/Canton S, 
Canton S/UAS-CG43968-RNAi, c42/TM3, Sb; between c724-GAL4/UAS-CG43968-RNAi, 
c724/Canton S, Canton S/UAS-CG43968-RNAi, c724/TM3, Sb; between c42 crossed lines and 
c724 crossed lines. The novel gene CG43968 was significantly less expressed in c42-GAL4/UAS-
CG43968-RNAi line than in all the other lines as shown. This indicated that CG43968 is mainly 
expressed in tubules principal cells. 
 
5.2.7.7 Secretion Assay of c42-GAL4/ UAS-CG43968-RNAi compared with 
parental line 
Secretion assay was performed between F1 progeny c42-GAL4/UAS-CG43968-
RNAi, c42/Canton S and Canton S/UAS-CG43968-RNAi from the cross scheme 
(section 5.2.7.4). This comparison was used to find out if CG43968 knockdown 
would affect the tubule secretion phenotype. If it did affect the secretion, the 
relation to principal cell or stellate cell would be checked by adding the 
neuropeptide capa or leucokinin (LK or Drosophila kinin). Capa increased the 
secretion through principal cell, whilst Leucokinins increased secretion of 
tubules through stellate cell. The mechanism of CG43968 function involved in 
secretion is summarized in Figure 5-22. 
** 
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Figure 5-22 Secretion assay for c42-Gal4/UAS-CG43968-RNAi compared with parental line. 
The secretion was significantly decreased in the c42-GAL4/UAS-CG43968-RNAi line compared to 
the parental line indicating CG43968 is involved in the tubule secretion in principal cell. (A) Tubule 
secretion assays were performed using modified Ramsay assay (section 2.21). The Ca2+ agonist 
capa was added after 30 min of basal readings every 10 min. An additional 40 min of secretion 
reading were taken every 10 min. (B) The secretion rates were averaged over the 70 mins as three 
lines and presented as a graph for statistical significance using a t-test, P-value. In c42-GAL4/UAS-
CG43968-RNAi (3a) (red), the secretion significantly reduced with a mean difference of 0.1784 ± 
0.01158 (t-test, P<0.001) (red line), it was not changed significantly in the Canton S/UAS-
CG43968-RNAi line (green line). The secretion went significantly up in the c42/Canton S after 
adding Capa 10-7M with a mean difference 0.3285 ± 0.03398 (t-test, P<0.05) (blue line). 
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The results confirmed that secretion was decreased in the c42-GAL4/UAS-
CG43968-RNAi line compared to parental lines c42/Canton S and UAS-CG43968-
RNAi/Canton S. Furthermore, the secretion of c42-GAL4 line was slightly 
increased when capa-1 (10-7 M) was added after 30 mins compared to the 
parental lines c42/Canton S where secretion was significantly increased and UAS-
CG43968-RNAi (3a)/Canton S where secretion was moderately increased. The 
secretion of Canton S/UAS-CG43968-RNAi was not significantly changed due to 
the UAS-CG43968-RNAi leakage affecting the result. Capa-1 peptide action is 
diuretic via elevation of nitric oxide, cGMP and calcium in the principal cells of 
the Malpighian tubules. The c42-GAL4/UAS-CG43968-RNAi did not respond to 
Capa as well as the parental lines, indicating the Capa pathway had been 
blocked in some part after CG43968 knockdown. So this novel gene is in tubule 
principal cell and is involved in tubule secretion. 
5.2.7.8 Secretion Assay of Actin-GAL4/ UAS-CG43968-RNAi compared with 
parental line 
The flies were crossed using the universal driver Actin-GAL4/CyO. The crosses 
were created as females Actin-GAL4/CyO x males UAS-CG43968-RNAi; females 
Actin-GAL4/CyO x males Canton S and females Canton S x males UAS-CG43968-
RNAi. The F1 progeny were chosen as Actin-GAL4/UAS-CG43968-RNAi, Actin-
GAL4/Canton S, and Canton S/UAS-CG43968-RNAi identified by the marker CyO 
(curly wing). The secretion assay was performed between F1 progeny Actin-
GAL4/UAS-CG43968-RNAi, Actin-GAL4/Canton S, and Canton S/UAS-CG43968-
RNAi. Capa 10-7M and Drosophila leucokinin 10-7M were added after 30 mins 
(Figure 5-23). 
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Figure 5-23 Secretion assay for Actin-Gal4/UAS-RNAi compared with parental line. 
The secretion decreased in the Actin-GAL4/UAS-CG43968-RNAi line compared to the parental line 
indicating CG43968 is involved in the tubule secretion in tubule principal cells but not stellate cells. 
(A) Tubule secretion assays were performed using modified Ramsay assay (section 2.21). The 
Ca2+ agonist capa-1 and Drosophila kini were added after 30 min of basal readings every 10 min. 
An additional 60 min of secretion reading were taken every 10 min. (B) The secretion rates were 
averaged over the 90 mins as three lines and presented as a graph for statistical significance using 
a t-test, P-value. In Actin-GAL4/UAS-CG43968-RNAi (red), the secretion significantly reduced with 
a mean difference of 0.1177 ± 0.03539 (t-test, P<0.001) (red line), it did not change significantly in 
the Canton S/UAS-CG43968-RNAi line (green line). The secretion went significantly up in Actin-
Gal4/Canton S after adding Capa 10-7M /Lk 10-7M with a mean difference 0.4542 ± 0.07520 (t-test, 
P<0.05) (blue line). However, Actin-Gal4/UAS-CG43968-RNAi (red) also increased more than c42-
Gal4/UAS-CG43968-RNAi after added Capa 10-7M only indicated that CG43968 was not in stellate 
cell. 
*** 
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From section 5.2.7.7, the c42-GAL4/UAS-CG43968-RNAi did not respond well to 
Capa-1. Secretion was assayed after adding Capa and Drosophila kinin to Actin-
GAL4/UAS-CG43968-RNAi, Actin-GAL4/Canton S, and Canton S/UAS-CG43968-
RNAi.The secretion rate for Actin-GAL4/UAS-CG43968-RNAi had a better 
response to Capa-1 and Drosophila kinin than just adding Capa 10-7M itself 
(Figure 5-23) but still a much less response compared to the parental line Actin-
GAL4/Canton S. 
As we know, Capa peptide acts in the principal cells of the Malpighian tubules. 
In tubules, Drosophila kinin’s major action is to raise chloride permeability 
through stellate cells by binding to receptors on the basolateral membrane, and 
so ultimately to enhance fluid secretion. The action of Drosophila kinin is 
additive to both cAMP and cGMP by elevation of intracellular calcium (Dow, 
2012; Kerr et al., 2004). The slightly increased the secretion of Actin-GAL4/UAS-
CG43968-RNAi line compared to the c42-GAL4/UAS-CG43968-RNAi line after 
adding both peptides indicated the CG43968 knockdown was not affecting 
stellate cell but only affecting principal cells. So the difference in secretion rate 
was greater between Actin-GAL4/Canton S and c42-GAL4/UAS-CG43968-RNAi. 
The Canton S/UAS-CG43968-RNAi showed no significant change due to the UAS-
CG43968-RNAi leakage affecting the result. These results supported the qPCR 
results that CG43968 gene only existed in tubule principal cell. 
5.2.8 Overexpression analysis for CG43968 
5.2.8.1 Generation of an overexpression construct by using Gateway 
destination vectors PTW and PTWV 
Two primers had been designed by using the entire ORF of Chr3L 23777200-
2378100. Primers were designed with the sequence CACC on the 5' end of the 5' 
primer for using Gateway entry clone (pENTR/D-TOPO Cloning Kit) followed by 
the gene specific sequence in the first reading frame. One primer, ORF1, 
included the stop codon taa; the other primer, ORF2, excluded the stop codon 
taa for adding tag-YFP (Table 5-2). ORF1 and ORF2 were cloned into the 
pENTRY/D-TOPO (invitrogen) vector using the Gateway technology. This trigger 
sequence could be transferred easily to Gateway destination vector PTW and 
PTWV by an in vitro reaction mediated by LR Clonase. 
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PTWV contains a C-terminal tag [Venus, improved YFP (515/528 nm)]. Venus YFP 
shows fast and efficient maturation, allowing detection of reliable fluorescent 
signals that was not previously possible (Nagai et al., 2002). 
Table 5-2 Primers for PTW and PTWV overexpression 
Constructs Primer sequence Products size 
PTW Forward: CACCATGCGGGTGTGCGATACA  
Reverse: TTACAAACGTCTAAATATGCACTTGC   
2880bp 
PTWV Forward: ATGCGGGTGTGCGATACA 
Reverse: CAAACGTCTAAATATGCACTTGC  
2877bp 
 
5.2.8.2 Verification of PTWV in Drosophila S2 cells 
In order to verify the PTWV construct worked efficiently before sending the  
construct to generate transgenic flies, a PTWV plasmid was transfected into the 
S2 cell by using Insect GeneJuice Transfection method (section 2.16.2). The 
overexpression protein in S2 cell cytoplasm by confocal microscope can be 
determined (section 2.20.2) (Figure 5-24) 
   
Figure 5-24 UAS-CG43968-PTWV25 plasmid overexpression in Drosophila S2 cell. 
UAS-CG43968-PTWV25 plasmid (containing Venus) successfully showed the fluorescent signals. 
The UAS-CG43968-PTW25 plasmid was transfected into Drosophila S2 cell using Insect 
GeneJuice Transfection method, and used to show the YFP signals in S2 cell membrane or 
cytoplasm or both. (A) The control cells were not transfected by PTWV. No fluorescent signal was 
detected. (B) Fluorescent signal (Venus) was detected in cytoplasm. The blue fluorescent signals 
were DAPI which were stained nuclei, the green fluorescnt signals were YFP of the novel gene. 
The fluorescent signal (Venus, YFP) was detected in cytoplasm of Drosophila S2 
cell indicating that the novel gene CG43968 was successfully transferred into 
PTWV vector by using Gateway system and transfected into S2 cell. So the UAS-
A B 
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CG43968-PTWV25 overexpression construct was confident to send to generate 
the transgenic fluorescent flies. PTW was sent to generate transgenic flies 
without tag in order to test the gene function without the effect of the 
fluorescent tag. 
5.2.8.3 Making and validating the overexpression transgenic flies lines 
PTW and PTWV plasmid with ORF1 and ORF2 was purified and 50 µg plasmid with 
concentration at least 0.5 µg/µl was sent to BestGene Inc (thebestgene.com) for 
microinjection to make transgene flies (Figure 5-1). 
In order to validate the overexpression constructs, UAS-24/CyO, UAS-25/Cyo 
lines were chosen to cross with Actin-GAL4/CyO universal driver in adult whole 
flies.  
The cross scheme (Figure 5-25): 
 
Figure 5-25 A schematic diagram of the RNAi overexpression cross scheme. 
Schematic diagram of using ubiquitous driver (Actin-GAL4/CyO) crossed with overexpression fly 
line UAS-CG43968-PTW24 and UAS-CG43968-PTWV25 to obtain the CG43968 overexpression in 
adult whole fly lines (Actin-GAL4/UAS-CG43968-PTW24 and Actin-GAL4/UAS-CG43968-
PTWV25) through the GAL4-UAS system. The survival numbers for each genotype are shown in 
brackets. The survival ratio for each genotype was the same 1:1:1 indicating overexpression gene 
CG43968 was not lethal. 
 
The F1 progeny were also counted (with the numbers shown in the bracket) for 
the four genotypes to check the survival rate in order to confirm the novel 
CG43968 was not lethal when overexpression was happened. 
The qPCR validation of novel gene overexpression of F1 progeny from Actin-
GAL4/CyO x UAS-CG43968-PTW24/CyO was performed relative to Actin-
GAL4/UAS-CG43968-PTW24 vs. Actin-Gal4/CyO; Actin-GAL4/CyO x UAS-CG43968-
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PTWV25 was validated relative to Actin-GAL4/UAS-CG43968-PTWV25 vs. Actin-
Gal4/CyO (Figure 5-25). The result showed no change for Actin-GAL4/UAS-
CG43968-PTW24 vs. Actin-Gal4/CyO (First two red bars); Actin-GAL4/UAS-
CG43968-PTWV25 vs. Actin-Gal4/CyO showed the expression increased by 58% 
(Figure 5-26) (the last two green bars). The UAS-CG43968-PTWV25 was chosen 
for further analysis of function.  
 
 
Figure 5-26 Screen of CG43968 overexpression constructs. 
The Actin-GAL4/UAS-CG43968-PTWV25 fly line achieved overexpression of 58% over control. 
The comparison of the overexpression efficiency of two fly lines was performed for UAS-CG43968-
PTW24, UAS-CG43968-PTWV25 constructs by using the ubiquitous driver GAL4. The percentage 
of overexpression was 58% (Actin-GAL4/UAS-CG43968-PTW25) compared to their siblings, Actin-
GAL4/UAS-CG43968-PTWV25 achieved the more efficient overexpression. Actin-GAL4/UAS-
CG43968-PTW24 showed the expression had no change compared to their siblings. 
5.2.8.4 Immunocytochemistry (ICC) for overexpression line 
Overexpression over control for the F1 progeny of Actin-GAL4/UAS-CG43968-
PTW25 from Actin-GAL4/CyO xUAS-CG43968-PTW25/CyO was confirmed by qPCR 
(Figure 5-25). UAS-CG43968-PTWV25 was analysed in fusion with YFP. The Actin-
GAL4/UAS-25 line was chosen to run ICC in order to determine the location of 
the novel gene CG43968. Actin-GAL4/UAS-CG43968-PTWV25 flies were checked 
using a fluorescent microscope with YFP channel. The flies were lit up in two 
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third of the body, giving confidence that this line had the fluorescent signals. 
The control line is UAS-CG43968-PTWV25 flies or Canton S flies. 
Firstly, tubules were dissected from Actin-GAL4/UAS-CG43968-PTWV25 line and 
UAS-CG43968-PTWV25 line, and viewed by fluorescent microscope. The YFP 
signal was viewed by choosing the green light channel (Figure 5-27). The 
fluorescent signals of Actin-GAL4/UAS-CG43968-PTWV25 line were mainly seen in 
the tubule ureter, the main segments of tubules and the basolateral of tubules 
(principal cells?) indicating CG43968 may be located in these places. 
  
Figure 5-27 Overexpression of Actin-GAL4/ UAS-CG43968-PTWV25 line. 
The tubules from Actin-GAL4/ UAS-CG43968-PTWV25 line that were viewed by fluorescent 
microscope showed the signals being detected in tubules ureter, main segments and basolateral 
principal cells. (A) Tubules from UAS-CG43968-PTWV25 line as control. The leaky YFP gave rise 
to a weak fluorescent background but no real fluorescent signals. (B) Tubules from Actin-GAL4/ 
UAS-CG43968-PTWV25 overexpression line. The ureter, the main segments of tubules and the 
basolateral of tubules were lit up by Venus (principal cells?) which showed the green fluorescent 
signals. 
Second, live GFP imaging does not always produce clear images, so the tubules 
were also fixed and stained with anti-GFP antibody. Tubules from Actin-GAL4/ 
UAS-CG43968-PTWV25 line and control Canton S fly line were dissected and 
stained by antibodies, using the primary antibody Anti-GFP antibody (1:000) and 
the secondary antibody Fluorescent Goat anti-mouse- IgG-FITC (1:500) (section 
2.18). The images were viewed by confocal microscope (section 2.20.2) as 
depicted in Figure 5-28. 
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Figure 5-28 ICC of tubules, hindguts of Actin-GAL4/UAS-CG43968-PTWV25 fly line. 
ICC of tubules, hindguts of Actin-GAL4/UAS-CG43968-PTWV25 line showed the YFP signals 
might locate in membrane or cytoplasm or both. (A) ICC of Canton S tubules, viewed by confocal 
microscope, showing no signals were detected. (B) ICC of Actin-GAL4/ UAS-CG43968-PTWV25 
tubules, viewed by confocal microscope showing YFP signals (green fluorescent) were seen in 
principal apical membrane, probably in microvilli and cytoplasm. The blue fluorescent signals were 
from DAPI which were stained nuclei. (C) ICC of Canton S rectum, viewed by confocal microscope, 
showing no YFP signals were detected. The blue fluorescent signals were from DAPI which were 
stained nuclei. (D) ICC of Actin-GAL4/ UAS-CG43968-PTWV25 rectum, showing YFP signals 
(green fluorescent) were detected in cytoplasm and membrane. 
The ICC signals from the confocal microscope suggested that in tubule, the 
fusion protein from tubule-enriched gene CG43968 was located either in cell 
apical membrane probably concentrated in the microvilli, or possibly in 
cytoplasm as well. 
5.2.8.5 Western blotting to search the protein of novel gene CG43968 
Actin-GAL4/CyO females were crossed with UAS-CG43968-PTWV25/CyO male 
flies to overexpress the CG43968 in whole flies. Six flies of F1 progeny Actin-
A B 
C D 
212 
GAL4/UAS-CG43968-PTWV25 were selected to be frozen in protein lysis buffer 
RIPA. Six Canton S flies were frozen in protein lysis buffer. Protein were 
extracted and quantified by using Bradford assay (section 2.17). 20 µg protein 
was used to run the gel. The primary antibody was anti-GFP antibody (1:1000), 
the secondary antibody was goat anti mouse IgG-HRP (1:5000). 
The result is shown in Figure 5-29. The size of protein for CG43968 was 118.76 
KDA. The YFP size is 28kDa. We expected to see the detected size of the protein 
attached to YFP at size 146.76, but we can only see one band detected at size 
28 kDa. This indicated that the YFP was not attached to the protein of the novel 
gene, but smear bands from 28 kDa to 148 kDa were detected. 
                         
Figure 5-29 Western blotting of CG43968 overexpression line. 
Western blotting showed the signals from YFP but not from the novel protein CG43968. Western 
blotting of five replicate samples of Actin-GAL4/UAS-CG43968-PTWV25, lane1-5 showed the 
same size bands 28 kDa, which was the same size as the YFP only. Three triplicates of Canton S 
control flies proteins were shown from lane 6-8. No signals were detected. 
Different methods to treat the proteins were tested including denaturing the 
protein by heating at 95oC instead of 100oC to protect the protein-YFP bond: the 
results were the same. Pre-denaturing the protein by adding 0.05M EDTA was 
also tested: the results were the same. Given this, there are multiple reasons 
why the protein-YFP products cannot be detected. Firstly, the novel protein is 
soluble; GFP is normally distributed throughout the cytoplasm. So perhaps the 
protein is partially degraded in the cell, leading to a smear band at the expected 
size and a prominent degradation product at 28kDa. Secondly, the protein-YFP 
28kDa 
148KDa 
1  2 3 5 4 7 6 8 
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bond was broken during the sample preparation or during the west blotting 
process. Thirdly, the construct failed, and the UAS-CG43968-PTWV25 line only 
contained YFP but not attached on the novel protein from novel gene CG43968. 
If this protein was a soluble protein, it might have more chance to exist in 
cytoplasm rather than membrane. Membrane protein has helix interactions so 
they are more stable and tight. However soluble proteins are alpha-bundle 
proteins, which are easily dissolved in water (Eilers et al., 2002). 
CG43968 is only confirmed as a coding gene if the coded protein is detected. So I 
plan to design a CG43968 specific antibody in order to prove the novel protein 
will be necessary in the future. 
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5.3 Discussion 
In this chapter, a tubule-enriched novel coding gene, named recently as 
CG43968 by FlyBase recently, was found by the RNA-seq poly(A) selection 
method. The reverse genetic approach was used to elucidate the function of 
CG43968. 
5.3.1 CG43968 is a real protein coding gene 
The following evidence supports CG43968 as a tubule-enriched coding gene. 
Firstly, the splicing junction was found by tubule RNA-seq poly(A) selection 
method in our project. The splicing junction was also confirmed by modENCODE 
RNA-seq trace in FlyBase. The novel gene was named as CG43968 by FlyBase on 
16/08/2012, FlyBase 5.48. The novel gene CG43968 was also supported by 
strand-specific RNA-seq data of tubule in this project (Figure 5-7). 
Secondly, the splicing event was confirmed by RT-PCR (Figure 5-17) with the 
cDNA and genomic DNA having two different sizes, and also confirmed by 
sequencing the CG43968 construct of pENTR/D-TOPO® vector (Figure 5-18). 
Thirdly, open reading frame (ORF) search found a long ORF coded by this gene 
(Figure 5-12), and the blastx search found the novel protein conserved in 
Drosophila mojavensis and Drosophila willistoni, also conserved in mosquito and 
beetle (Figure 5-13).The coding genes are more conserved in other species than 
noncoding genes (Eddy, 2001). 
Fourthly, Coding Potential Calculator (CPC calculator) program had predicted 
that this gene was coding gene (Kong et al., 2007; Roberts et al., 2011). 
Lastly, a CG43968 transfragment was also found by Drosophila Tiling 2.0R Array 
of tubules in this project (Figure 5-10). Tiling microarrays are another 
technology for novel gene discovery with more limitations when compared to 
RNA-seq (Manak et al., 2006; Wang et al., 2009). However, it can be used to 
confirm the RNA-seq results. 
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5.3.2 The possible location of CG43968 
Different techniques have been employed to search the in situ localization of 
CG43968. 
Firstly, the expression of CG43968 is found in tubule main segment. In situ 
hybridization confirmed the Dig detection signals of anti-sense probes were in 
the tubule main segment (Figure 5-16). 
Secondly, the protein prediction programs, both PSORT II (Protein Subcellular 
Location Prediction) and WoLF PSORT predicted CG43968 to be more cytoplasmic 
but still may locate in plasma membrane. 
Thirdly, CG43968 presents in principal cells. Taking advantage of the Drosophila 
Gal4/UAS system, transgenic RNAi flies were generated by Invitrogen Gateway 
system using pRISE RNAi vector (Kondo et al., 2006) (Materials and Methods 
Chapter 2.15). c42-Gal4 (principal cell specific driver) crossed with UAS-
CG43968-RNAi produced a gene knockdown specific in principal cells was 
confirmed by qPCR, however c724-Gal4 (stellate cell specific driver) crossed 
with UAS-CG43968-RNAi failed to ablate the expression also confirming CG43968 
is only expressed in principal cells but not in stellate cells. 
Tubule secretion assay using cell-specific RNAi knockdown line c42-Gal4/UAS-
CG43968-RNAi compared with parental line c42-Gal4/Canton S confirmed the 
knockdown line having less secreted fluid than the parental line. After 
stimulating the tubules with cell-specific diuretic neuropeptides (Capa-1 acts on 
principal cells and Drosokinin acts on stellate cells), c42-Gal4/UAS-CG43968-
RNAi tubules showed no response to CAPA in contrast to drosokinin stimulation 
compared to parental line c42-Gal4/Canton S. This result further supported that 
CG43968 is in principal cells. Lastly, CG43968 showed apical plasmamembrane 
localisation, concentrated in microvilli of the principal cells. Transgenic 
overexpression flies were generated by Invitrogen Gateway system using PTWV 
vector with the fuses CG43968 with fluorescent YFP to help identify subcellular 
localization of the protein (Figure 5-24). Actin-Gal4 a ubiquitous GAL4 driver 
crossed with UAS-CG43968-PTWV s suggested CG43968 localization in principal 
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cell plasma apical membrane microvilli (Figure 5-28), but also possibly located in 
cytoplasm. 
5.3.3 Possible function of CG43968 
Secretion assay performed between c42-Gal4/UAS-CG43968-RNAi and parental 
line showed less secretion in c42-Gal4/UAS-CG43968-RNAi line compared with 
the parental line suggested CG43968 may play an essential role in apical plasma 
membrane secretion upon stimulation. 
Secondly, CG43968 has a Latrophilin/CL-1-like GPS domain that may modulate 
intracellular calcium signaling events. The same domain is implicated in renal 
tubular development in humans. 
The blastx search found out CG43968 is conserved in other Drosophila species 
and there are good similarities to other species including mosquito and beetle 
proteins. Further reciprocal BLAST found CG43968 has a Latrophilin/CL-1-like 
GPS domain. 
The GPS domain presents in Latrophilin/CL-1, sea urchin REJ and polycystin. 
Polycystin-1 is a protein in humans is encoded by the PKD1 gene related to 
human kidney disease. Polycystin-1 is a glycoprotein which contains a large N-
terminal extracellular region, multiple transmembrane domains and a 
cytoplasmic C-tail. The CG43968 protein only back half is conserved may be 
related to the structure of the protein. PKD1, CL-1 and REJ possess functional 
similarities that are likely to be due to their common GPS domains and 
transmembrane regions. Each of these molecules is suggested to mediate 
transmembrane influx of Ca2+ (Ponting et al., 1999). Polycystin-1 also may 
function as an integral membrane protein involved in cell-cell/matrix 
interactions, and may modulate intracellular calcium homoeostasis and other 
signal-transduction pathways. It plays a role in renal tubular development, and 
mutations in this gene have been associated with autosomal dominant polycystic 
kidney disease (Van Adelsberg and Frank, 1995). 
In Drosophila, Calcium (Ca2+) is a ubiquitous second messenger molecule in all 
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cell types and tissues. Calcium signalling and calcium homeostasis are essential 
for life. Drosophila tubule function requires extracellular calcium influx into 
principal cells via plasma membrane channels (Davies and Terhzaz, 2009). 
Calcium entry is essential for CAP2b to induce a physiological response in the 
whole organ (Rosay et al., 1997). CAP2b, a cardioactive neuropeptide that 
stimulates fluid secretion by a mechanism involving nitric oxide, causes a rapid, 
dose dependent rise in cytosolic calcium in 77 principal cells in the main 
(secretory) segment of the tubule. So calcium signalling plays important role in 
the modulation of the nitric oxide signalling pathway in tubules. 
 
The impact of extracellular calcium on [Ca2+]cyt and fluid transport by the 
Malpighian tubule is dramatic. In the absence of external calcium, the CAP2b-
induced calcium response is abolished (Davies and Terhzaz, 2009). 
 
Rise in tubule cAMP, cGMP or calcium in the principal cells stimulates fluid 
secretion by tubule. However raising calcium in stellate cells also stimulated 
fluid secretion, so did both cAMP and cGMP (Dow, 2007). 
 
If CG43968 localised in plasma membrane, it may be a membrane protein of 
tubule which contains a GPS domain, and is responsible for taking extracellular 
calcium into the principal cell. So CAP2b will be induced and cytosolic calcium 
being raised, nitric oxide production will be activated and cGMP will be 
stimulated to increase tubule secretion. If CG43968 is in cytoplasm, it may be 
involved in stimulating the nitric oxide pathway to accelerate the secretion of 
tubule. That is the reason when CG43968 is knocked-down, the secretion of 
tubules less than control (Figure 5-22). 
5.3.4 Future work 
More assays needed to be done to further confirm the function of CG43968. 
Firstly, calcium assays. There are many methods for calcium assay, including 
protein-based recombinant Aequorin probes to assay the intracellular calcium 
level after CG43968 knockdown to compare with control. This will confirm if GPS 
domain of CG43968 impacts on calcium signalling or transport events. 
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Calmodulin-based fluorescent reporters as calcium probes have also been of 
immense value in calcium signalling/transport research (Meldolesi, 2004). 
In Drosophila protein-based aequorin calcium probes allow expression in specific 
cells and tissues in vivo via targeted expression of recombinant aequorin. The 
GAL4-UAS system has been developed in order to investigate calcium signalling 
using aequorin in Drosophila, UAS–apoaequorin flies were generated (Rosay et 
al., 1997). These flies, the first transgenic animals for a calcium reporter, were 
used to monitor calcium signals in live intact tissue and provided the first in vivo 
measurements of cytosolic calcium concentration ([Ca2+]cyt) in Drosophila 
Malpighian tubule (Rosay et al., 1997) and brain. This is more popular method to 
measure the calcium in the lab. 
Secondly, design antibody for CG43968 protein to further confirm the coding 
ability and the location of the protein are important for the function search. 
Thirdly, In situ hybridization of the CC43968 knockdown line may further confirm 
the gene location. 
5.4 Conclusions 
RNA-seq is most advantageous technology for novel gene discovery. Reverse 
genetics is an important technique for discovering the novel gene function. 
Drosophila is an ideal model organism for reverse genetics. So RNA-seq combines 
with reverse genetics and Drosophila model will be a powerful method to 
discover the novel genes and elucidate their functions. Integrative physiology 
and functional genomic will supply all the possible techniques to discover the 
phenotypes and close the ‘phenotype-gap’ in Drosophila tubules and other 
organisms.
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6. Species Array 
Summary 
Microarray technology is the first technology to measure gene expression at the 
whole genome level. This technology has been dominant in the transcriptomic 
field for more than a decade, represented by the success of the Affymetrix 
GeneChip. However the GeneChips are only available for model species. Using 
genomic DNA as a mask will increase the sensitivity of measuring  gene 
expression when apply heterologous microarrays for non-model species 
(Hammond et al., 2006; Hammond et al., 2005). 
Next-generation sequencing is a recently developed technology for 
transcriptome analysis at the whole genome level. This technology doesn’t 
require a priori knowledge of the genome sequence, and can be used to 
sequence the genomes whilst measuring gene expression. As a result, this 
technology can be applied to all species, and so it may render the microarray 
genomic mask method as obsolete in the future. However, the analysis of next 
generation sequence data is a challenge in that it requires computing resources 
and requires specialist bioinformatics knowledge. In contrast, applying the 
microarray genomic masks method is simple, quick and so may remain a useful 
approach in the future. 
This chapter will examine the method for applying a genomic mask to measure 
the Drosophila pseudoobscura and Drosophila simulans transcriptome on the 
Drosophila melanogaster Genechip. 
6.1 Introduction 
6.1.1 Cross-species and cross-strain hybridization 
Two methods are applied for using microarray technology for species that have 
no representative microarray platforms. One is cross-species hybridization (CSH), 
in which the RNA from one species (the target) is hybridized to a microarray 
representing another (reference) species. The other method is cross-strain 
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(within species) hybridization (CTH), which is used to study variation between 
strains of the same species. (Bar-Or et al., 2007). 
The advent of whole-genome transcriptome profiling using high-density 
microarrays has had a substantial impact on the understanding of biological 
systems, including development processes and disease responses and how these 
are regulated at the transcriptome level (Hammond et al., 2005). Several 
microarray platforms are used for these studies. The Affymetrix GeneChip is one 
of the most successful platforms. 
After ten years of development, GeneChips are available for a large numbers of 
species. However the GeneChips are still limited to model species. For example, 
Drosophila has only one type of Genechip available for Drosophila melanogaster 
but there are more than 1700 species of Drosophila known in the world. Only 
twelve of the Drosophila species have been sequenced. Little attention has been 
paid to the transcriptome analysis of these species. 
Cross-species approaches have been used widely to study the transcriptome of 
species that don’t have complete genome arrays available (Bar-Or et al., 2007; 
Davey et al., 2009; Hammond et al., 2006; Hammond et al., 2005; Nuzhdin SV, 
2004 ). However, microarrays are designed for species-specific hybridization or 
cross-strain hybridization. Cross-species use of the method is controversial and 
considered a non-standard application for microarrays, but mostly the results 
are still meaningful. To increase the ability to reflect biological processes, care 
should be taken when choosing microarray platforms, including issues 
encompassing experimental design to data analysis. 
6.1.2 Data analysis of cross-species hybridization 
In terms of data analysis, the data need to be filtered to obtain valid biological 
results. Two approaches have been used to filter the data. One approach is to 
filter sets of microarray probes using available genomic data. Matching is 
determined based on the sequence similarity between the probes; filtration 
excludes the probes that have a low level of similarity to the target species (Bar-
Or et al., 2006). However, this method can only be applied to species whose 
genome has been sequenced.  The second approach uses genomic DNA (gDNA) 
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hybridizations as a mask to exclude the weak hybridization probes and enable 
the selection of probes with higher level of matching to the transcripts. This 
method can also be applied to species whose sequence is not available 
(Hammond et al., 2005). 
Graham et al. put equine brain and liver samples on the human U133 plus 2 
chips. They used two methods to filter the data to generate the probe masks. 
One method involves using BLAST search to compare the equine genome and 
human genome to select the perfect match; the other method is gDNA selection 
to mask off the unmatched probes. Comparing these two methods found that 
fewer probe-pairs and probe-sets are retained using the BLAST search compared 
to the gDNA probe selection method (Graham et al., 2010). Differences due to 
non-perfect 25bp matches between the probes and the equine gDNA were still 
hybridized and thereby still retained in the probe-mask files. BLAST search and 
gDNA selection combined method may be more accurate in the analysis. 
6.1.3 Platforms for cross-species hybridization 
What is the best type of probes for CSH: Affymetrix short oligomer (~25 mer) 
probe-sets, longer oligomer (~30-60-mer) probes, or even cDNA microarray 
probes? Research by Walker et al suggested that the longer the probes, the 
better the CSH performance (Walker et al., 2006). Although long-probe 
microarray seems to be the preferred platform for CSH, data filtration can 
increase the validity of CSH results obtained from either long- or short-probe 
microarrays. The design of Affymetrix GeneChips makes them ideal for cross-
species hybridization (Bar-Or et al., 2007) because Affymetrix GeneChips are 
designed to use 11-20 probes pairs to represent one transcript. Each probe-pair 
consists of a perfect-match (PM) and mismatch (MM) probe. The PM probe is a 
25-base sequence complementary to the target gene, whilst the MM probe is 
identical to the PM probe but with a single mismatch at thirteenth base. Using a 
genomic mask can exclude probes with weak hybridization signals but retain the 
high level signal probes, so that the one or two probes retained after selection 
can still represent the expression of the genes. 
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6.1.4 Examples for cross-species hybridization 
The cross-species method using genomic DNA as a mask has been successfully 
used in the analysis of a number of different non-model species for which no 
commercial GeneChip is available. Hammond et al. examined Brassica oleracea 
under phosphate stress and a control group on the Arabidopsis thaliana chip, 
successfully detecting ninety-nine genes  that were significantly regulated in the 
shoot under phosphate stress (Hammond et al., 2005). Graham et al. applied 
sheep tissues on Human U133 plus 2 arrays. The results of the RNA analysis 
comparing skeletal muscle and liver transcriptomes  demonstrated that the gDNA 
probe selection method is suitable for studying gene expression profiles in sheep 
tissue and produces biologically relevant data (Graham et al., 2011). 
6.1.5 Cross-species hybridization in Drosophila  
There are more than 1700 species of Drosophila in the world. However, only one 
type of GeneChip for Drosophila melanogaster (Drosophila Genome 2.0 Array) is 
available at the moment. 
Nuzhdin et al. had compared 10 heterozygous D. simulans genotype and a pool 
sample of 10 D.melanogaster lines using Affymetrix  GeneChip (Drosophila 
Genome 1) provided a genome approach for cross species hybridization to 
identify candidate genes potentially responsible for adaption and specification in 
D.simulans and D.melanogaster on the basis of rapid divergence in expression. 
This was demonstrated that a large fraction of the genome may be involved in 
adaptation via expression (Nuzhdin SV, 2004 ). Their research revealed the 
common pattern of evolution of gene expression level and protein sequence in 
Drosophila. Ranz et al also used within-species microarrays to demonstrate the 
sex-dependent gene expression and evolution of the Drosophila transcriptome 
(Ranz et al., 2003). 
6.1.6 Advantages and disadvantages of cross-species 
hybridization 
Cross-species microarrays are used in comparative, evolutionary and ecological 
studies of closely related species. This method is particularly useful for those 
species for which the genome has not been sequenced, or no specific microarray 
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is available, or the annotation is poor or at the early stage. Designing a new 
array for those species is either not possible or would require spend a lot of 
money or effort. Research in this approach demonstrates that reasonable and 
biologically meaningful results can be obtained after data filtration either by 
BLAST or by gDNA hybridization. This method makes possible research using the 
already available GeneChips. However, this method is not a standard microarray 
approach; the results are to be interpreted with caution. Choosing suitable 
microarray platforms, careful experimental design, and more effort in data 
filtration are necessary to obtain good data. The performance of CSH depends on 
the degree of probe-transcript sequence-similarity matching. If during the 
hybridization, there were low match probes, probes not matching to any target 
species or more than one matching to target species, the data generated will 
bias the biological results (Bar-Or et al., 2007). 
6.1.7 Aim of the experiment 
The aim of this experiment was to investigate the feasibility of using the 
genomic mask method in conjunction with Drosophila microarrays. The 
experiment was designed to use cross-species hybridization to analyse tubule 
samples of Drosophila similans and Drosophila pseudoodscura using standard 
Drosophila melanogaster expression microarrays. A genomic DNA mask (one 
sample of D.similans whole fly, one sample of D. pseudoobscura whole fly) was 
applied to the standard Drosophila melanogaster microarrays to eliminate the 
different sequence probes and increase the sensitivity of the useful probes for 
expression measurement. 
Gene expression was compared for D. simulans (four replicate tubule samples on 
D. melanogaster microarrays, D.pseudoobscura (four replicate tubule samples on 
D. melanogaster microarray) and D. melanogaster (four replicate tubule samples 
of Oregon R) before and after genomic masks were applied.  The expression 
results were used to investigate the sensitivity of the cross-species hybridization 
and the function of the genomic masks. 
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6.2 Results 
6.2.1  Quality control analysis 
Figure 6-1 presents the results obtained by applying the replicates of the three 
tissues OR (D.melanogater, Oregon-R), PS (D. psedoobscura) and SM (D.simulans) 
to D. melanogaster GeneChip. Histograms present a 2-D view of the distribution 
of data, where the values of each variable are split into equal-size bins and the 
number of counts in each bin is represented by the height of the bar. The 
histogram showed that OR and SM grouped together but PS showed the different 
distribution. However, the replicate samples within the species of OR and SM 
were grouped together but PS showed the variation within the replicate 
samples. The results indicated that the variation of the hybridization within 
tissues is less than the variation between tissues. Second, the OR and SM are 
very close but PS are different from OR and SM. It indicated the main variation 
was caused by between tissues hybridization.  
 
Figure 6-1 Histogram view of three types of tissue samples.  
This is the histogram view of three types of tissue samples of OR (D. melanogaster Oregon-R) red, 
PS (D. psedoobscura) blue, SM (D.simulans) green to show the distribution of the three types of 
tissue samples. One line for each of the samples with the log2 intensity of the probes was graphed 
on the X-axis and the frequency of the probe intensity on the Y-axis. This allows viewing the 
distribution of the intensities to identify any outliers. OR and SM showed the similar distribution, 
However, PS showed the different distribution with OR and SM indicated that PS expression may 
affect by the D. melanogaster chip due the difference of sequences. 
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Principal Component Analysis (PCA) is a statistical procedure concerned with 
elucidating the covariance structure of a set of variables. In particular it allows 
us to identify the principal directions in which the data varies. The first principal 
component accounts for as much of the variability in the data as possible, and 
each succeeding component accounts for as much of the remaining variability as 
possible. 
PCA in Partek Genomics Suite (Patek Inc v6.6) was used to assess the behaviour 
of all of the genes in each individual tissue and then to build the relationships 
among the tissues (Figure 6-2). PCA analysis included firstly calculating PC scores 
by computing the standard correlation between each gene's expression profile 
vector and each principal component vector (eigenvector) and secondly, 
calculating the standard correlation between each condition vector and each 
eigenvector. A correlation matrix in the form of PCA scores was then presented 
to indicate the relation between two conditions (tissues). 
 
Figure 6-2 Principal component analysis (PCA) of OR, PS and SM transcriptomes.  
Principal component analysis of OR (D. melanogaster Oregon-R) red, PS (D. psedoobscura) blue, 
SM (D.simulans) green showed the variation between OR, PS and SM. PC1 was the first major 
factor affected the data that was different tissues. OR and SM were much close than PS indicated 
the sequence distance between the PS with OR and SM, and also the PCA showed the second 
variation PC2 was between the replicate samples. PS showed large variation within the replicate 
samples but not between OR replicate samples and SM replicate samples indicating that PS 
hybridized on D. melanogaster GeneChip could not obtain the consistent results. 
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From Figure 6-2, we can see the first principal component accounting for 55.7% 
of the variation is between the different tissues. The component values for D. 
melanogaster and D. simulans are closely grouped but those for D. 
pseudoobscura are far apart, indicating the significant difference between 
D.pseudoobscura and D. melanogaster and D.simulans. The second component is 
the variation within the same species. We can see the large variation between 
the replicate samples of D.pseudoobscura; however the replicate samples of D. 
simulans and D. melanogaster are grouped very closely. 
6.2.2 Genomic-DNA hybridization and probe-selection 
We used D. melanogaster Drosophila Genome 2.0 Array to study the 
transcriptome of D. simulans and D. pseudoobscura. The sequence polymorphism 
between the species will likely result in an underestimate of the transcripts 
abundance if all probe sets are used within individual sets (Ji et al., 2004). As a 
consequence, the probe pairs were selected by the hybridization efficiency of 
the genomic DNA of D. similans and D. pseudoobscura on the D. melanogaster 
GeneChip within the probesets in order to increase the sensitivity of detection. 
Four replicates of D. simulans tubules, four replicates of D. psedoobscura 
tubules and four replicates of D.melanogaster Oregon-R tubules were biotin-
labelled and hybridized on the D. melanogaster GeneChips. One sample genomic 
DNA of D. simulans, and one sample genomic DNA of D. pseudoobscura were 
biotin-labelled and put on the D. melanogaster GeneChip. 
Figure 6-3 and Figure 6-4 show the different gDNA hybridization threshold and 
probe selection and probe-sets obtained for D. simulans and D. pseudoobscura. 
Generating the different threshold of gDNA hybridization requires generating 
chip definition files (CDF). This was performed by converting the gDNA 
hybridization .CEL files for D. simulans and D. pseudoobscura from binary to text 
format using AGCC power tools suite apt-cell-convert tool. Next, the CDF-
_masking_2.1 Perl script available at 
http://affymetrix.arabidopsis.info/xspecies/ was used to convert these text 
files to chip definition files, generates different gDNA intensity threshold mask 
file for D. simulans and D. pseudoobscora  in the range as 0, 50, 100, 150, 200, 
300, 400, 500, 600,700, 800, 900, and 1000. The different CDF files were used 
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for a one-way ANOVA using the Partek software to compare against with D. 
melanogaster. Different gDNA hybridization intensity threshold and probe 
selection for D. simulans see Figure 6-3. For D. pseudoobscura see Figure 6-4. 
 
Figure 6-3 D.simulans gDNA intensity threshold and the probe-set and perfect-match probes 
retained on D.melanogaster GeneChip 
Number of D. melanogaster probe-pairs and probe-sets retained from the GeneChip Drosophila 
Genome 2.0 array by the number of gDNA hybridization intensity thresholds of D. simulans used to 
generate the probe mask files. Filled circles are scaled to the right-hand y-axis and filled triangles 
are scaled to the left-hand y-axis.  
 
 
Figure 6-4 D.pseudoobscura gDNA intensity threshold and the probe-set and perfect-match 
probes retained on D.melanogaster GeneChip 
Number of D. melanogaster probe-pairs and probe-sets retained from the GeneChip Drosophila 
Genome 2.0 array by the number of gDNA hybridization intensity thresholds of D. pseudoobscura 
used to generate the probe mask files. Filled circles are scaled to the right-hand y-axis and filled 
triangles are scaled to the left-hand y-axis 
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Figure 6-5 D.pseudoobscura and D.simulans gDNA intensity threshold and the probe-set 
and perfect-match probes retained on D.melanogaster GeneChip 
Number of D. melanogaster probe-pairs and probe-sets retained from the GeneChip Drosophila 
Genome 2.0 array by the number of gDNA hybridization intensity thresholds of D. simulans (red), 
D. pseudoobscura (blue) used to generate the probe mask files. Filled circles are scaled to the 
right-hand y-axis and filled triangles are scaled to the left-hand y-axis. 
Figure 6-3 and Figure 6-4 were optimized empirically by generating 13 probe 
mask files with gDNA hybridization thresholds ranging from 0 to 1000. The 13 
masks were evaluated in turn to investigate which threshold is the best to 
represent the transcriptome of D. simulans and D. pseudoobscura. Figure 6-3 
that for D. simulans shows the number of probe-sets dropped slowly as the gDNA 
intensity threshold increased. Figure 6-4 that for D. pseudoobscura shows the 
number of probe-sets dropped sharply only a gDNA intensity threshold of 200 was 
selected. Figure 6-5 shows the same gDNA intensity threshold but with different 
probe-sets and probe pairs of D. simulans and D. pseudoobscura retained in the 
D. melanogaster GeneChip. Figure 6-5 clearly shows the difference between the 
behaviour of the two species on the same chip indicating that in term of 
sequence polymorphism, D. simulans and D. melanogaster are quite similar but 
D. pseudoobscura and D. melanogaster are much different. 
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6.2.3  Comparing the differential gene expression of D. simulans 
and D. melanogaster by applying gDNA masks 
 
Figure 6-6 D. simulans and D. melanogaster comparison by one-way ANOVA with different 
gDNA masks 
Different D.simulans gDNA hybridization thresholds used to generate probe mask files for the 
transcriptome analysis. Different gDNA hybridization thresholds yield different amount of genes of 
D.simulans tubules which compared with D. melanogaster tubules by one-way ANOVA in Partek 
Genomic Suit 6.6 (p<0.05). Figure 6-6 indicated at D.simulans gDNA threshold 500-600 yield 
maximum amounts of different genes. 
Different D. simulans gDNA intensity thresholds generating different CDF files 
were applied to the one-way ANOVA analysis between D. simulans and D. 
melanogaster. The number of two folds genes with p value<0.05 and gDNA 
intensity thresholds were plotted in Figure 6-6. Figure 6-6 showed that at the D. 
simulans gDNA threshold 500-600 produced the maximum amount of differential 
expression genes between D. simulans and D. melanogaster. Figure 6-7 further 
using volcano plot showed the differential gene expression between D. simulans 
and D. melanogaster. 
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Figure 6-7 ‘Volcano’ plot of  fold change of D. simulans versus D. melanogaster by different 
gDNA masks 
‘Volcano’ plots illustrating the fold change of D. simulans vs D. melanogaster (X-axis) and the 
relations of p-value (Y-axis) derived from one-way ANOVA from Partek Genomic Suite v6.6 
(P<0.05). (A) no probe selection, during transcriptome analysis,(B), (C), (D) using probe mask file 
during transcriptome analysis, generating at gDNA hybridization intensity thresholds of 200, 400 
and 1000 respectively. 
Figure 6-7 showed the different gDNA intensity thresholds and the fold change 
between D. simulans and D. melanogaster. The different gDNA intensity 
thresholds produced the number of differential expression genes between the D. 
simulans and D. melanogaster was not much difference. However, gDNA 
intensity threshold at 400 was produced more differential gene expression than 
gDNA threshold at 200 and 1000 indicated the two species have very similar gene 
expression at the transcriptomic level. 
6.2.4 Comparing the differential gene expression of D. 
pseudoobscura and D. melanogaster by applying gDNA masks 
 
D C 
A B 
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Figure 6-8 D. pseudoobscura and D. melanogaster comparison by one-way ANOVA with 
different gDNA masks 
Different gDNA hybridization thresholds yield different amount of genes which compared 
D.pseudoobscura with D. melanogaster by one-way ANOVA in Partek Genomic Suit 6.6 (p<0.05). 
Figure 6-8 indicated at gDNA threshold 150-200 yield maximum amounts of different genes. 
Different D. pseudoobscura gDNA intensity threshold generating different CDF 
files were applied to the one-way ANOVA analysis between D. pseudoobscura and 
D. melanogaster. The number of two folds genes with p value<0.05 and gDNA 
intensity thresholds were plotted in Figure 6-8. Figure 6-8 showed that at the D. 
pseudoobscurs gDNA threshold at 150-200 produced the maximum amount of 
differential expression genes between D. pseudoobscura and D. melanogaster. 
Figure 6-9 further using volcano plot showed the differential gene expression 
between D. pseudoobscura and D. melanogaster. 
Figure 6-9 showed the different gDNA intensity threshold and the fold change 
between D. pseudoobscura and D. melanogaster. The different gDNA intensity 
thresholds produced the number of differential expression genes between the D. 
pseudoobscura and D. melanogaster was large difference. However, gDNA 
intensity threshold at 150 was produced much more differential gene expression 
than gDNA threshold at 400 and 1000 indicated the power of the cDNA selection 
affected gene expression at the transcriptomic level. 
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Figure 6-9 ‘Volcano’ plot of fold change of D. simulans versus D. melanogaster by different 
gDNA masks 
‘Volcano’ plots illustrating the fold change of D. psedoobscura vs. D. melanogaster (X-axis) and the 
relations of p-value (Y-axis) derived from one-way ANOVA from Partek Genomic Suit v6.6. (A) no 
probe selection, during transcriptome analysis,(B), (C), (D) using probe mask file during 
transcriptome analysis, generating at gDNA hybridization intensity thresholds of 150, 400 and 1000 
respectively. 
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6.3 Discussion 
Following the sequences of 12 Drosophila species in 2007, the sequence 
information has provided an extensive resource for the study of the relationship 
between sequence and phenotypic diversity. As illustrated in Figure 6-10, the 
genomes of these species provide an excellent model for studying how conserved 
functions are maintained in the face of sequence divergence (Clark et al., 2007). 
Here we used gDNA masked cross-species hybridization method to investigate 
the possibility of measuring the transcriptomes of a species closely related to D. 
melanogaster namely D. simulans and are related at a medium distance namely 
D. pseudoobscura by using the Drosophila Genome 2.0 Array platform developed 
for D. melanogaster. 
 
 Figure 6-10 Phylogenetic tree of the Drosophila genus. 
This figure shows the phylogenetic relationships between the Drosophila species of which the 
genomes have been sequenced (adapted from http://rana.lbl.gov/drosophila website). Closely 
related - D. simulans and  medium distance – D. pseudoobscura. 
From Figure 6-10, we can see that D. simulans diverged from D. melanogaster 
approximately 5.4 million years ago. So it is a close relative of D. melanogaster 
in Africa. The whole-genome alignment  between D. simulans and D. 
melanogaster is around 82.7% (Garrigan et al., 2012).  D. pseudoobscura 
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diverged from D. melanogaster approximately 25 to 55 million years ago. So it is 
a medium distance relative of D. melanogaster. For the whole-genome 
alignment of D. melanogaster and D. pseudoobscura, just 48% of bases can be 
reliably aligned (Macdonald and Long, 2006; Richards et al., 2005). However, the 
level of homology with D. melanogaster in terms of protein-coding genes is 80% 
for D. simulans and 78.2% for D. pseudoobscura. So in terms of evolution, the 
coding sequences are more conserved than the genomic sequences. The 
GeneChips are designed using the 3-prime UTR genomic sequences so the 
sequences are much less conserved between the Drosophila species. The details 
of the sequence alignment between D. pseudoobscura and D. melanogaster can 
be seen in Figure 6-11. There is greater conservation in the coding region (CDS) 
(20-75%), but less conservation in the 3’UTR region (20-40%).   
 
 
Figure 6-11 The conservation between D. psedoobscura and D. melanogaster 
Figure 6-11 showed the average conservation of different segments of a “prototypical gene” 
between D. pseudoobscura and D. melanogaster. Conserved (green), Mismatch (red), Expected 
match (purple), Mel insertion (yellow) and unaligned (blue). At the CDS (3’ end) and CDS (5’ end) 
showed the highest conservation (green), lowest mismatch (red) and at the intron (3’ end) and 
intron (5’ end) showed the lowest conservation (green), highest mismatch (red) between 
D.pseudoobscura and D. melanogaster. Picture adapted from (Richards et al., 2005) 
Both the histogram of log2 intensity of the probe values in Figure 6-1 and the 
PCA results shown in Figure 6-2 indicate similarity between D. simulans and D. 
melanogaster, and the difference between D. pseudoobscura from both D. 
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simulans and D. melanogaster. In particularly, the PCA results show the first 
component difference corresponds to most of the variability was caused  by the 
difference between species, especially the big difference between D. 
pseudoobscura in comparison to both D. simulans and D. melanogaster. The 
second component difference is with the replicate samples within the species 
where shows the large variation within the replicate samples of D. 
pseudoobscura. 
The main reason of the variation is the sequence difference between D. 
melanogaster and D. pseudoobscura, which may cause variation during the 
hybridization. As a consequence, the hybridization results may not be 
reproducible. For cross-species hybridization (CSH), a certain number of 
microarray probes are imperfectly hybridized to transcripts of the target 
species. Therefore, CSH performance depends on the degree of probe-transcript 
sequence-similarity matching (Bar-Or et al., 2007). During hybridization, a 
variable number of probes to target species may exhibit a perfect match, a low 
match, more than one match (cross-hybridization) or  no match. These variations 
may bias the biological results (Bar-Or et al., 2007). For Drosophila, the further 
the distance between species is, the greater the variation that will occur in 
hybridization. The variation within the replicate samples of D. pseudoobscura  
but not between the replicate samples of D. simulans and D. melanogaster also 
support the less conserved sequences at the 3’ end of D. pseudoobscura and D. 
melanogaster (Figure 6-11) caused the irreproducible results of hybridization 
within the species. 
The percentage of present calls is reported by the Affymetrix GeneChip 
Operating Software (GCOS), where present calls indicate that the targeted 
transcript was present. The average percentage present calls for D. 
pseudoobscura tubules hybridized on Drosophila Genome 2.0 Array was reported 
by GCOS as 5.8%, for D.simulans tubules as 34.8%, and for D. melanogaster 
tubules as 41.3%. The sequences difference between D. pseudoobscura and the 
D. melanogaster is evident. 
Figure 6-3, 6-4, 6-5 demonstrate that as the gDNA threshold increased, the 
number of perfect-match probes dropped sharply but the number of probe-sets 
which represent the target genes dropped slowly. At a gDNA threshold of 400 for 
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D. simulans, the number of perfect-match probes dropped by 30% but the probe-
set represents the target genes remained at 95%. At a gDNA threshold of 150, for 
D. pseudoobscura, the number of perfect-match probes dropped by nearly 70% 
but the probe-set representing the genes of interest remained at 97%. This 
indicates the gDNA selection only reduces the mismatch probes of the probe-sets 
but not affect the number of probe-sets which represent the target genes. It 
also means that the gDNA selection will increase the sensitivity of the GeneChip 
measurement. 
Figure 6-6, 6-8 show that as the gDNA intensity threshold increases, the level of 
detection of differential expression genes changes. The maximum number of 
differential genes at greater than 2 or less than 0.5 fold changes compared to D. 
melanogaster was detected for D. simulans at gDNA threshold of 500-600. 
Relative good numbers of differential genes were also detected for D. simulans 
at gDNA intensity threshold 400 and lower. In contrast, for D. pseudoobscura, 
the maximum number of differential genes at greater than 2 or less than 0.5 fold 
changes relative to D. melanogaster was detected at a gDNA threshold of 150-
200. Based on a combination of the gene expression change and the number of 
genes retained, gDNA intensity threshold at 400 for D. simulans was chosen and 
a gDNA intensity threshold at 150 for D. pseudoobscura as the best optimized 
thresholds. The ‘volcano’ plot in Figure 6-7, 6-9 also show the large number of 
genes  change at a gDNA intensity threshold of 400 for D. simulans, gDNA 
intensity of 150 for D. pseudoobscura  suggest the gDNA selection method 
increases the sensitivity of GeneChip used by the heterologous species. 
The gDNA mask results are reasonable based on a consistent level of 
hybridization quality. However, the PCA results lead to question the   
reproducibility of the gene expression result in the case of D. pseudoobscura.  
Although after the gDNA mask, the number of differential genes increase in the 
comparison between D. pseudoobscura and D. melanogaster. The results will be 
invalid if it was a poor hybridization (low match or no match). This suggests that 
the gDNA mask principle is only suitable for application to the closely related 
species. Greater caution must be taken for medium and distanced species, 
depending on the sequence similarity and hybridization reproducibility.  
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With the ongoing development of next-generation sequencing, it may prove 
advantageous to use RNA-seq technology in preference to cross-species 
hybridization array technology for transcriptome profiling of medium or distantly 
related Drosophila species or other species without a genome array available. 
However array technology may prove easier, faster and cheaper to use for 
transcriptome profiling for closely related species. 
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7. Conclusions and Future work 
Summary 
The main conclusions identified during this project are summarised in this 
chapter, including 3-way comparison of Drosophila tiling arrays; Drosophila 
expression arrays and Drosophila RNA-seq; RNA-seq is a best technology for novel 
gene discovery so far and reverse genetics method is a best tool to investigate 
the novel gene functions. Genomic DNA can be used as a mask to increase the 
sensitivity of arrays when applied to heterologous species. 
7.1 Conclusions 
Tiling arrays, three-prime expression arrays and RNA-seq are popular 
technologies for quantifying the gene expression levels of the entire genome. 
This thesis demonstrates that RNA-seq is currently the best technology, which 
overcomes the disadvantages of microarrays for novel gene discovery. Reverse 
genetics is a valuable tool for searching for novel gene functions. Microarrays 
remain useful, particularly in terms of using genomic DNA as a mask can increase 
the sensitivity to apply arrays to heterologous species. 
7.1.1 3-way comparison of Drosophila tiling arrays, expression 
arrays and RNA-seq 
Drosophila expression arrays have been applied in Drosophila research for over a 
decade as a tool for expression detection. Drosophila tiling arrays have been 
used as an analytical tool in recent years. RNA-seq is a cutting technology that 
has been used as a discovery tool as well as a gene expression tool in recent 
years, and has come to dominate the field of genomic research. The 3-way 
comparison of these three technologies can give us a view of their relative 
merits and drawbacks, and help us to choose the most suitable technology for 
our research. 
Comparing Drosophila RNA-seq with Drosophila expression arrays has 
demonstrated that these two technologies are correlated well for detecting gene 
expression; both technologies have problems with genes at low expression 
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levels. Microarrays have problems with cross-hybridization, hybridization noise, 
miss target affects, lower dynamic range and three-prime bias, all of which will 
reduce its capability. However, it still offer a means to measure three-prime end 
processing (Cui and Loraine, 2009). In contrast, RNA-seq supports a wider 
dynamic range than microarrays through its increased read coverage, and so is 
able to detect genes at low expression levels. RNA-seq does not depend on 
previous knowledge of the genome, can be used for any organism, and also 
offers increased power for novel gene and alternative splicing discovery. RNA-
seq had taken genomic research into a new level. Microarrays remain useful and 
complementary to RNA-seq for transcriptome profiling. 
Comparing Drosophila tiling arrays with Drosophila expression arrays revealed 
that the two technologies have a reasonable correlation for gene expression 
levels. However, the two technologies suffered from cross-hybridization, 
background noise and low dynamic range, and so it can prove difficult to obtain 
agreement about the lower and higher expression genes. 
Comparing RNA-seq with tiling arrays showed that both technologies had the 
ability to discover the transcription “dark matter” within the genome. However, 
tiling arrays have a high false-positive discovery rate, may over estimate the 
transcriptional activities in the genome, and are ill-suited to accurately detect 
transcripts at low levels (van Bakel et al., 2010). As a consequence, the results 
of tiling arrays must be interpreted with caution or must be confirmed by other 
molecular methods. 
In summary, RNA-seq, tiling arrays and expression arrays complement each other 
in terms of their performance for transcriptome profiling as well as novel gene 
discovery. 
7.1.2 RNA-seq is the best gene discovery technology so far 
Poly (A) selection RNA-seq has been used as a tool for discovering novel genes in 
Drosophila tubules. By applying the TopHat and Cufflinks pipeline, we have been 
able to find a number of novel genes that belonged to coding and noncoding 
RNAs and were confirmed by RT-PCR. The results suggested that the novel genes 
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were lowly expressed, most of them had two exons, belonged to noncoding RNAs 
and existed in a tissue-specific manner. 
7.1.3 Reverse genetics is the best technique so far for functional 
study of novel genes 
Drosophila as an experimental organism for functional genomics is suitable for 
applying reverse genetics. The Gal4/UAS system made Drosophila uniquely 
suitable to knock-down any genes within the genome. In the work presented in 
this thesis, RNA-seq was used to find the novel gene CG43968. Reverse genetics 
had been applied to CG43968 for investigation of gene function. 
Using Gal4/UAS-RNAi, the novel gene CG43968 was knocked down to confirm the 
functional involvement in tubule secretion located in tubule principle cells. The 
possible function of CG43968 may play an essential role in apical plasma 
membrane secretion upon stimulation. CG43968 has a Latrophilin/CL-1-like GPS 
domain, which may play a role in renal tubular development. CG43968 may be a 
membrane protein of tubule which contains a GPS domain, and is responsible for 
taking extracellular calcium into the principal cell. 
Using Gal4/UAS-PTWV to over express CG43968, the novel gene has been shown 
to be present in cytoplasm and cell membrane. In situ hybridization also 
revealed the novel gene CG43968 located in the main segments of tubules. 
7.1.4 Species array 
Applying genomic DNA-based probe-selection method increased the sensitivity of 
the arrays in order to measure gene expression from the Drosophila 
melanogaster closely-related species Drosophila simulans, and the medium-
distance-related species Drosophila pseudoobscura by using Drosophila 
melanogaster expression arrays. The results revealed that genomic DNA-based 
probe-selection method would indeed increase the sensitivity of the arrays, 
making them suitable to apply to closely-related species of the model organism 
but not suitable to apply to medium- or far-distance-related species. 
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7.2 Future Work  
Many aspects of the work presented in this thesis could be extended to provide 
further insight into the function of Drosophila Malpighian tubules. Future work 
could be carried out in the following areas: 
1. Further investigation of the function of novel gene CG43968. 
a) By using a calcium assay, since CG43968 has been confirmed as having 
function in tubule secretion, possibly related to calcium transport in 
principal cell of tubules. Measuring the calcium levels in the normal 
flies and the CG43968 knockdown flies will help us understand if 
CG43968 has function related to calcium transport. 
b) By designing an antibody, since CG43968 is a novel gene for which no 
antibody is available at the moment. Designing an antibody for 
CG43968 will further help to identify the location of the protein 
product of this gene in the cell. 
c) By signaling pathway investigation: CG43968 has a Latrophilin/CL-1-
like GPS domain that may modulate intracellular calcium, and is 
responsible for taking extracellular calcium into the principal cells to 
induce CAP2b to activate nitric oxide production and then stimulate 
cGMP for tubule secretion. Further investigating the pathways will 
help in understanding the function of CG43868. 
d) By fluid secretion metabolomics. Comparing the different 
metabolomics of the secreted fluid of the tubules of CG43968 
knockdown flies and that of normal flies may help us to further 
understand the function of CG43968. 
2. The 3-way comparison results from this thesis suggested that tiling arrays 
overestimated the genome transcription activities. Investigating previous 
Drosophila tiling arrays research by using matched RNA-seq data will find out if 
the novel transcriptional fragments are real or affected by false-positive signals 
(Manak et al., 2006; van Bakel et al., 2010). 
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3. Search for novel alternative splicing units in Drosophila tubules by using the 
existing data set, especially those alternative splicings that change the coding 
sequence. Confirm any results by molecular genetics method. 
4. Search for more novel genes (including noncoding genes) and their functions 
in tubules. 
a) By using ribosome reduction strand-specific RNA-seq. Poly (A) 
selected RNA-seq mainly finds the poly (A) related transcripts. 
However, more novel transcripts are noncoding genes. In recent years, 
more efforts have been put into investigating the functions of 
noncoding genes. Noncoding genes have been considered to play 
important gene regulatory roles in the genome such as in directing 
post-transcriptional regulation of gene expression or in guiding RNA 
modifications (Carpenter et al., 2013; Eddy, 2001).  
b) Looking for regions transcribed on both strands. Using existing data 
or ribosome reduction RNA-seq data to look for the regions transcribed 
on both strands. This will help us understand the role of antisense 
RNA. 
c) Perform reverse genetics to non-coding RNAs. There is not (yet) a 
huge catalogue of mutations in ncRNAs that have been shown to affect 
phenotype, compared to those in protein-coding sequences. However, 
on the assumption that most ncRNAs have regulatory roles and that 
most regulatory regions have not yet being identified, next-generation 
sequencing technology may help to identify the ncRNAs in Drosophila 
and reverse genetics methods may help to verify the function of those 
ncRNAs.  
d) Assigning genetic signatures: it is no surprise that this may be the 
case (Mattick, 2009). Drosophila has been armed with the GAL4/UAS 
system and wealthy physiology data that make it an ideal model to 
perform reverse genetics technique (siRNA-mediated gene knockdown 
and overexpression). These techniques are emerging major tools to 
investigate noncoding gene function. 
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e) Metabolomics studies for function of noncoding RNAs: Noncoding 
RNAs has been reported to play important roles in metabolic 
pathways. For example, small RNAs  such as Spot42, Glmz and others 
are post-transcription regulators of bacteria sugar and control sugar 
metabolism (Gorke and Vogel, 2008). Gene expression data combined 
with metabolomics data may help us understand the noncoding RNA 
function at system biology levels. 
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Appendix I: Fly food recipe 
Fly food recipe (Mix the contents in 1 litre of H2O in the below order of preference. 
10 g Tayo agar 
1 tbsp Soya fluor 
15 g Sucrose 
33 g Glucose 
15 g Maize meal 
10 g Wheat germ 
30 g Treacle 
35 g Yeast 
Bring to boil, stirring constantly; simmer 10 min; allow to cool slightly to about 70 
ºC; leave for 20 min and then add: 
10 ml Nipagin (of below formulation) 
5 ml Propionic acid 
[Nipagin = 25 g. Nipagin M (Tegosept M, p-hydroxybenzoic acid methyl ester) in 250 
ml Ethanol] 
Dispense: 
Fly Vials = 8 ml 
Fly Bottles = 70 ml  
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Appendix II: Phosphate Buffer Saline (PBS) 
Phosphate Buffer Saline (PBS) (in H2O)  
137 mM NaCl 
2.7 mM KCl 
10 mM Na3PO4 
2 mM KH2PO4,          pH 7.4 
Other solutions using PBS 
For PBST: 0.25% TritonX-100 was added. 
For PBSTw: 1% Tween20 was added. 
For blocking buffer for westerns: 10% non-fat milk power was added to PBSTw. 
For blocking buffer for ICCs: 10% goat serum was added to PBST. 
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Appendix III: Drosophila Schneider’s media 
www.invitrogen.com, (accessed on 26th August 2011) 
COMPONENTS Molecular 
Weight 
Concentration 
(mg/L) 
mM 
Amino Acids    
Glycine 75 250 3.33 
L-Arginine 174 400 2.3 
L-Aspartic acid 133 400 3.01 
L-Cysteine 121 60 0.496 
L-Cystine 240 100 0.417 
L-Glutamic Acid 147 800 5.44 
L-Glutamine 146 1800 12.33 
L-Histidine 155 400 2.58 
L-Isoleucine 131 150 1.15 
L-Leucine 131 150 1.15 
L-Lysine hydrochloride 183 1650 9.02 
L-Methionine 149 800 5.37 
L-Phenylalanine 165 150 0.909 
L-Proline 115 1700 14.78 
L-Serine 105 250 2.38 
L-Threonine 119 350 2.94 
L-Tryptophan 204 100 0.49 
L-Tyrosine 181 500 2.76 
L-Valine 117 300 2.56 
beta-Alanine 89 500 5.62 
Inorganic Salts    
Calcium Chloride (CaCl2-
2H2O) 
147 794 5.4 
Magnesium Sulfate 
(MgSO4-7H2O) 
246 3700 15.04 
Potassium Chloride (KCl) 75 1600 21.33 
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Potassium Phosphate 
monobasic (KH2PO4) 
136 450 3.31 
Sodium Bicarbonate 
(NaHCO3) 
84 400 4.76 
Sodium Chloride (NaCl) 58 2100 36.21 
Sodium Phosphate 
monobasic (NaH2PO4-
2H2O) 
156 1321 8.47 
Other Components    
Alpha-Ketoglutaric acid 146 200 1.37 
D-Glucose (Dextrose) 180 2000 11.11 
Fumaric acid 116 100 0.862 
Malic acid 134 100 0.746 
Succinic acid 118 100 0.847 
Trehalose 342 2000 5.85 
Yeastolate  2000 - 
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Appendix IV: E. coli growth media 
COMPONENTS grams/litre 
LB-broth  
Bacto-tryptone 10 
Dried Yeast 5 
NaCl 10 
LB-agar  
Bacto-tryptone 10 
Dried yeast  5 
NaCl 10 
Bacto-agar 15 
SOC broth  
Bacto-tryptone 2 % (w/v)  
Dried yeast 0.5 % (w/v)  
NaCl 10 mM 
KCl 2.5 mM  
MgCl2 10 mM 
MgSO4 10 mM 
Glucose  20 mM  
 
  
249 
Appendix V: Buffers for SDS-PAGE and Westerns 
From Sambrook and Russell, 2001 
6 x SDS-PAGE Loading buffer 
0.35 M Tris HCl,  pH6.8 
10.28 % (w/v) SDS 
36 % v/v glycerol 
5 % v/v b-mercaptoethanol 
0.012 % w/v bromophenol blue 
in 0.5 ml aliquots stored at -20°C 
Tris-Glycine Running Buffer  (in 500 ml of H2O) 
7.2 g Glycine 
1.5 g Tris Base  
6 ml 10% (w/v) SDS 
Staining Solution 
465 ml Brilliant blue R concentrate (Sigma) 
535 ml H2O 
Destaining Solution (in H2O) 
10 % (v/v) Acetic Acid 
45% (v/v) Methanol 
Ponceau S Staining Solution (in 500 ml H2O) 
1.5 g TCA 
0.5 g Ponceau S stain 
Transfer Buffer (in 1 litre of H2O) 
20 % (v/v) Methanol 
14.4 g Glycine 
3 g Tris Base 
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Resolving and Stacking gels for SDS-PAGE (from Sambrook and Russell, 2001) 
COMPONENTS Vol. (ml) 
Resolving gel 10%, volume for 2x 5 ml gels    
H2O                                                      4 
30 % acrylamide mix                          3.3 
1.5 M Tris (pH 8.8)                              2.5 
10 % (v/v) SDS                                    0.1 
10 % (v/v) APS                                    0.1 
TEMED                                                0.004 
  
Stacking gel 5%,  volume for 2x 1.5 ml  
H2O                                                      2.1 
30 % acrylamide mix                          0.5 
1.0 M Tris (pH 6.8)                                                                     0.38 
10 % (v/v) SDS                                    0.03 
10 % (v/v) APS                                    0.03 
TEMED                                                0.003 
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Appendix VI RT-PCR products and primers for 
novel genes 
RT-PCR products and primers for novel genes from section 3.2.10 
>Chr3L 23777293-23780611 cDNA RT-PCR product 
GTAGCATTTATGTGCCTATTGCCTAATTTCGCACTTTTTCAAGAAAACTTGACAAGGGATAAAA
TGCCTTGACGAATTTACTAATACAACATCAGGCACGGCATATTGGAAGTATAAAGGCATTCCTT
ACGCAATATCTGAAGATCTGCTGTGCCTTAAGTCTAACCATC 
 
Primer Forward GTAGCATT TATGTGCCTATTGC 
Primer Reverse GATGGTTAGACTTAAGGCACAG 
> Chr2R 16189454-16190517 cDNA RT-PCR products (red sequence are introns)  
Product1. 
ACTCGGAGGCTTCTTCTGGTTGCGGCCAAGTGTCAGTACATTAATCATGAGGTGATTTATGGC
GCCCACGCCATCGACGCATGTGCTCACGTTTTTCTCGCTGCCAGCAGCAACATCAGCGCGTG
TGGGCAGCCCACCGCCACCCACCCACTCCCACTGCCACCACCACCTCCTCCGATTCCCCCGA
AAACACCTGGCCCCAACGCATGCATTGTTATGCTCCGTTAGCCGTTTTAGAAGCG 
 
Product2. 
ACTCGGAGGCTTCTTCTGGTTGCGGCCAAGTGTCAGTACATTAATCATGAAACATCAGCGCGT
GTGGGCAGCCCACCGCCACCCACCCACTCCCACTGCCACCACCACCTCCTCCGATTCCCCC
GAAAACACCTGGCCCCAACGCATGCATTGTTATGCTCCGTTAGCCGTTTTAGAAGCG 
 
Primer Forward ACTCGGAGGCTTCTTCTGGT 
Primer Reverse CGCTTCTAAAACGGCTAACG 
 
> Chr2R 184996-184503 cDNA RT-PCR products (red sequence are introns) 
 
Product1 
GCAAGAACTTGGCTTCGTAAGGGTGAGAGGAGTCAGTGGTCGGTACAGGTGGCCCCAGGAC
GAGCGTTGCCTCGCGGACGATATACCCTGCCCCATAATAATCCTAAACCCATACCGACCGGC
AGGTGGTCTTCCAGAGAGAC 
Product 2 
GCAAGAACTTGGCTTCGTAAGGGTGAGAGGCCCCATAATAATCCTAAACCCATACCGACCGG
CAGGTGGTCTTCCAGAGAGAC 
 
Primer Forward GTCTCCTCTGGAAGACCACC 
Primer Reverse GCAAGAACTTGGCGTGTTCG 
 
>Chr3R 1096703-095876 cDNA and gDNA RT-PCR Product (346bp) 
 
TAATTCGCACAATTCGCGGCAGATATTCGGCCAGGTATGCTTCAGATATGCATATAATATACAC
ATACATATGTACCCCTTCTTAGAGATAGATTTGCGATTGTTAGGTGCTGAAGACGACCTCCGCT
TTTTCAGTTCGACCCTGTAGAATGCTGATTGTAGAACCGCGCGATTGTATAAACTCCACGTAG
AAGGGAGCACCACTCTATCTATCCAGGCCACAACTTAATGTCCATGCCACATGCCACACATGT
ATGTTAAGTGGGTGACTGGACGAGAGGAAGGATTTTACAAAGGATACAGATAAATCGATCGGA
GATTGAGGCAGTTGGATGTGGATGCAGCA 
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Primer Forward TGCTGCATCCACATCCAACT 
Primer Reverse TAATTCGCACAATTCGCGGC 
 
>Chr3R 5951869-5965492 cDNA RT-PCR product 
CCTAGAGAATGGCGGAACGGACTGTTCGGCTGACAAACACAGAAGGCAATATTTACTGTTCTG
TCATAGGTGTCACTGATGTTTAAAAATACACTACCCGAACACTAGAGATGCAAAAATAAACAAA
CGAAATGAAAGGTCTATTAAATGTGTGTGGCATGTGAATGGCTG 
 
Primer Forward CCTAGAGAATGGCGGAACGG 
Primer Reverse CAGCCATTCACACTGCCACAC 
 
>Chr2L 9669700-9670824 gDNA RT-PCR product (835bp) 
 
ACAATGGCCGGGTAATAACTGAAAGGTGAGCACAGAACACAACTGTCAGTTGGATCTAAAAAT
ATTTTAAAATTTCCGATAAGCTGTCACTTCTAGTATATCCCTTACTTTTAGTCACACGGCTTCCG
TCTTTCACAGATATCTCTAATCGAGCCACCACCTTTCGATTAGCTGCACTCCAATCAAGGCAGC
TTATCTGTTCGTGATTGGCATGATTCCTGCCAGCGGGTGCCCACTGTAATAAATAGTGCCCGA
AATGGCACTCAAGTGTCGGCCACTTAATAACGAATTTCTGGCTGCCCGAACAAGTCGTAAAGA
TGCATCGCAGCTCGGATTGTGGTCCCATCGGAACTGCACTTTAAGAGATGTTTGCAAAAAGAA
AGTGAAAGAGCGCAAAGGTCAGCGGTGGGGGGAAATTCAATGTGAAAAGCGGCGATGTCGG
CTGGGTTACAGCGTTTTCAGAAGGGCTTCCCATCTGCATTTTCCTCCTCCATTCACTGACTATT
TATTTGTTCTTATTGTTTTTTTTTTTGCTGCTCTTCATAACTGTTGCATATACATATAAATGCGAA
CCATTGCGTATACTCAATTAATTGAGACAAATTACCCATACGCCGGGTGGGTGAATGACTGTC
GAGAGTTCAATTCAGTTTGAATTGAAGTGTTTTACTTTGGTTGTTATTTTTTATTGCATTGTCTG
GTTGCACCAACCGAATAAAAATGAAAATTTCGCCATAATAACTTTAATTTGCCCCAATCGATCC
AATGGCAATTATTATTAGATTTCGTTTCGTTTTGTTTGATTCTGATTCTGATTTCTGCTCCCATTC
GGCA 
 
>Chr3R 2441161-14417150 gDNA RT-PCR product (428bp) 
 
CTAATACTAAATGTATCTATATTTGAACCATTACCTTACGCCGAAGTAGGATAGCTGCAAATGT
ATTATGAAAATATAAGAAATAAATAAAAGAACCGAACTTATCGCAGTGGCGTTGTGATTTTTTGA
GTGTCGAAACGCCAAAGCAAATATGATTGGAGTTTTATTTACTCTGGCCCGTCCGATTGGGTC
TTAATTACTTCCGAAAACAATGACAACCGATGACCAGTGGCGATACGAGCCCCGTCGCCGAG
CATTAATCAATTTACAACGAGATTTAAGCAATGACATCGGTAAATAATAAAATAAATACAATTTG
AATACCGGTTTGCCATTTTCTGGCTATCATTCATAAACTTTTGTGCGGCCTGACATGAAAATTA
GCTCTTCAGCCAAGGCAGACAGCGCAGCGATCTCCGAGATCTCGTAGATCGGAGATCGCAGA
TCGGAGTCGTCTAAAGCTGGAACTCCGATCGCTGAAGAGCTCCAGACTCCGGAGTTCGAGTT
GGCGATGGAGATGGAGACCTG 
 
Primer Forward CTTATCGCAGTGGCGTTGTG 
Primer Reverse CAGGTCTCCATCTCCATCGC 
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Appendix VII Comparison of rank of top 30 genes 
Comparison of rank of top 30 genes from FlyAtlas and RNA-seq (tubule/whole 
fly) by fold change 
Gene Symbol RNA-seq Microarray 
 FC p-value FDR Rank FC p-value FDR Rank 
CG18095 132 0.00E+00 0.00E+00 24 135 2.78E-09 1.30E-07 1 
CG15408 98 0.00E+00 0.00E+00 47 108 9.06E-06 9.66E-06  2 
CG42235 133  0.00E+0 0.00E+00 23 105  2.01E-07  8.01E-07 3 
CG11407 11 2.62E-14 2,32E-13  411 86 9.16E-07 2.04E-07 4 
CG5697 60 0.00E+00 0.00E+00 104  74 7.18E-06 5.95E-06  5 
Oatp58Da 59  0.00E+00 0.00E+00 111 72 9.36E-07 2.07E-06 6 
st 82 0.00E+00 0.00E+00 70 71 1.53E-07 1.53E-07 7 
CG13905  139 0.00E+00  0.00E+00 21 71 5.41E-08 4.43E-07  8 
Pkg21D 52  6.37E-13 5.08E-12 132 70 3.86E-09 1.49E-07 9 
CG3690  72 0.00E+00  0.00E+00 82 68 4.54E-06 5.96E-06 10 
CG8028 103 0.00E+00 0.00E+00 42 67 1.73E-08 2.87E-07 11 
CG33282  46 0.00E+00 0.00E+00  144  67 1.30E-07  6.40E-07  12 
CG18473 51 0.00E +00  0.00E+00 33 67 2.72E-07 9.53E-07 13 
Swi2 91 0.00E+00 0.00E+00 55 67  0.000113 6.39E-05 14 
CG8620 87 0.00E+0.00 0.00E+00  65 65 1.31E-09 1.08E-07  15 
CG32024  82 0.00E+00 0.00E+00 69 65 6.49E-06 7.64E-06 16 
CG14606 61 0.00E+00 0.00E+00 103  61 2.01E-12 3.39E-09 17 
CG33281 39 0.00E+00  0.00E+00 166 63 1.28E-07 6.37E-07  18 
CG17751 73 0.00E+00  0.00E+00 80 63 1.47E-05 1.36E-05 19 
CG10006  157 0.00E+00 0.00E+00 17 63 5.17E-08 4.37E-07 20 
Sr-CIV 181 0.00E+00 0.00E+00 181 62 1.21E-08 2.46E-07 21 
CG8837 47 0.00E+00 0.00E+00 145 61 2.81E-08 3.49E-07 22 
CG9270 111 0.00E+00 0.00E+00 33 61 7.46E-09 2.13E-07 23 
CG31090 not found    61 1.12E-06 2.34E-06 24 
CG1139  47 0.00E+00 0.00E+00 143 58 2.00E-09 1.30E-07 25 
CG42235  132 0.00E+00 0.00E+00 23 56 9.92E-07 2.15E-06 26 
CG14963 68 0.00E+00 0.00E+00 68 56 1.43E-05 1.33E-05  27 
Cyp6a18 68 0.00E+00 0.00E+00 91 55 5.68E-09 1.95E-07 28 
CG1736 79 0.00E+00 0.00E+00 73 55 1.63E-07 7.06E-07 29 
CG14957 53 0.00E+00 0.00E+00 131 54 0.000788 0.000303 30 
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Appendix VIII Contributions from the PhD project 
Chintapalli, V., Wang, J., and Dow, J. (2007). Using FlyAtlas to identify better 
Drosophila melanogaster models of human disease. Nat Genet 39, 715-720.  
 
Venkateswara R. Chintapalli, Selim Terhzaz, Jing Wang, Mohammed Al Bratty, 
David G. Watson, Pawel Herzyk, Shireen A. Davies and Julian A. T. Dow (2012).  
Functional correlates of positional and gender-specific renal asymmetry in 
Drosophila. PLoS ONE 7(4): e32577. 
Chintapalli R Venkateswara, Wang Jing, Herzyk Pawel, Davies A Shireen, Dow AT 
Julian (2013). Data-mining the FlyAtlas online resource to identify core 
functional motifs across transporting epithelia. BMC Genomics 14, 518-529   
Jing Wang, Pawel Herzyk, Julian A. T. Dow. 3-way analyzes of Drosophila RNA-
seq, Drosophila tiling microarrays and Drosophila expression microarrays. (in 
Prep) 
Jing Wang, Venkateswara R. Chintapalli, Pawel Herzyk, Shireen A. Davies and 
Julian A. T. Dow. New views on the Drosophila transcriptome. (in Prep) 
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